<?xml version="1.0"?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "http://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Cancer</journal-id>
      <journal-title-group>
        <journal-title>BMC Cancer</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2407</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27316467</article-id>
      <article-id pub-id-type="pmc">4912774</article-id>
      <article-id pub-id-type="publisher-id">2365</article-id>
      <article-id pub-id-type="doi">10.1186/s12885-016-2365-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
          <name>
            <surname>Govindarajan</surname>
            <given-names>Rangaswamy</given-names>
          </name>
          <address>
            <phone>501 686 8511</phone>
            <fax>501 686 7474</fax>
            <email>govindarajanrang@uams.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Posey</surname>
            <given-names>James</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chao</surname>
            <given-names>Calvin Y.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>Ruixiao</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jadhav</surname>
            <given-names>Trafina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Javed</surname>
            <given-names>Ahmed Y.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Javed</surname>
            <given-names>Awais</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mahmoud</surname>
            <given-names>Fade A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Osarogiagbon</surname>
            <given-names>Raymond U.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Manne</surname>
            <given-names>Upender</given-names>
          </name>
          <address>
            <email>upendermanne@uabmc.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>University of Arkansas for Medical Sciences, 4301 W Markham, Slot 508, Little Rock, AR 72205 USA </aff>
        <aff id="Aff2"><label/>University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL USA </aff>
        <aff id="Aff3"><label/>Genomic Health Inc., Redwood City, CA; Genomic Health, Inc., Redwood City, CA USA </aff>
        <aff id="Aff4"><label/>Boston Baskin Cancer Foundation, Baptist Cancer Center, Memphis, TN USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>18</day>
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>368</elocation-id>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>5</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Govindarajan et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>African American (AA) colon cancer patients have a worse prognosis than Caucasian (CA) colon cancer patients, however, reasons for this disparity are not well understood. To determine if tumor biology might contribute to differential prognosis, we measured recurrence risk and gene expression using the Onco<italic>type</italic> DX<italic>&#xAE;</italic> Colon Cancer Assay (12-gene assay) and compared the Recurrence Score results and gene expression profiles between AA patients and CA patients with stage II colon cancer.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>We retrieved demographic, clinical, and archived tumor tissues from stage II colon cancer patients at four institutions. The 12-gene assay and mismatch repair (MMR) status were performed by Genomic Health (Redwood City, California). Student&#x2019;s <italic>t</italic>-test and the Wilcoxon rank sum test were used to compare Recurrence Score data and gene expression data from AA and CA patients (SAS Enterprise Guide 5.1).</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Samples from 122 AA and 122 CA patients were analyzed. There were 118 women (63 AA, 55 CA) and 126 men (59 AA, 67 CA). Median age was 66&#xA0;years for AA patients and 68 for CA patients. Age, gender, year of surgery, pathologic T-stage, tumor location, the number of lymph nodes examined, lymphovascular invasion, and MMR status were not significantly different between groups (<italic>p</italic>&#x2009;=&#x2009;0.93). The mean Recurrence Score result for AA patients (27.9&#x2009;&#xB1;&#x2009;12.8) and CA patients (28.1&#x2009;&#xB1;&#x2009;11.8) was not significantly different and the proportions of patients with high Recurrence Score values (&#x2265;41) were similar between the groups (17/122 AA; 15/122 CA). None of the gene expression variables, either single genes or gene groups (cell cycle group, stromal group, BGN1, FAP, INHBA1, Ki67, MYBL2, cMYC and GADD45B), was significantly different between the racial groups. After controlling for clinical and pathologic covariates, the means and distributions of Recurrence Score results and gene expression profiles showed no statistically significant difference between patient groups.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>The distribution of Recurrence Score results and gene expression data was similar in a cohort of AA and CA patients with stage II colon cancer and similar clinical characteristics, suggesting that tumor biology, as represented by the 12-gene assay, did not differ between patient groups.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Colon cancer</kwd>
        <kwd>12-gene assay</kwd>
        <kwd>Gene expression</kwd>
        <kwd>Stage II</kwd>
        <kwd>African-American</kwd>
        <kwd>Caucasian</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>Genomic Health, Inc.</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>At a glance</title>
      <p>
        <list list-type="bullet">
          <list-item>
            <p>Tumor biology as reflected in differential gene expression may contribute to differential outcomes for African-American patients as compared to Caucasian colon cancer patients.</p>
          </list-item>
          <list-item>
            <p>A cohort of patients well balanced for clinical and demographic factors was selected for gene expression testing using the Onco<italic>type</italic> DX colon cancer assay as a measure of tumor biology.</p>
          </list-item>
          <list-item>
            <p>The distribution of Recurrence Score results for African-American patients (<italic>n</italic>&#x2009;=&#x2009;122) was not significantly different than that of Caucasian patients (<italic>n</italic>&#x2009;=&#x2009;122).</p>
          </list-item>
          <list-item>
            <p>Expression of single genes or gene groups (cell cycle group, stromal group, BGN1, FAP, INHBA1, Ki67, MYBL2, cMYC and GADD45B) also did not differ significantly between ethnic groups.</p>
          </list-item>
          <list-item>
            <p>Although differences in outcomes have been observed between AA and CA patients, this study found no difference in tumor biology as represented by the 12-gene assay when no differences in demographic or clinical factors were present.</p>
          </list-item>
        </list>
      </p>
    </sec>
    <sec id="Sec2">
      <title>Background</title>
      <p>Racial disparities in the outcomes of many cancers are a well-recognized phenomenon. Although the survival of patients with colorectal cancer has improved in recent years, disparity in outcomes between African American (AA) and Caucasian (CA) patients persists [<xref ref-type="bibr" rid="CR1">1</xref>]. This may be due to a variety of factors, such as socioeconomic factors influencing access to good quality care, differences in screening participation, or tumor biology [<xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>The Onco<italic>type</italic> DX&#xAE; Colon Cancer Assay (12-gene assay, Genomic Health, Inc., Redwood City, California) is a 12-gene RT-PCR based test that yields a Recurrence Score&#xAE; result that has been clinically validated to predict the probability of recurrence following resection of stage II and stage III colon cancer [<xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR8">8</xref>]. The 12 genes measured consist of 7 cancer-related genes, which include 3 cell cycle genes (MK167, MYBL2, and MYC), 3 stromal genes (BGN, INHBA and FAP), and an early response gene (GADD45B), and 5 reference normalization genes. The Recurrence Score result (ranging from 0 to 100 with lower values representing lower risk of recurrence) is derived from RNA expression levels of these genes as determined by RT-PCR in formalin-fixed paraffin-embedded (FFPE) tumor tissue using a quantitative algorithm. The assay has been shown to add significant information beyond conventional clinical and pathologic factors regarding the risk of recurrence and has been shown to be clinically valid in multiple studies [<xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>The distribution of Recurrence Score&#xAE; results and associated gene expression profiles based on race/ethnicity have not been previously assessed. We used the 12-gene assay as a measure of gene expression activity to evaluate possible biological differences between AA and CA patients with resected stage II colon cancer.</p>
    </sec>
    <sec id="Sec3">
      <title>Methods</title>
      <p>Patients with resected stage II colon cancer and with archived tumor tissue were identified from tumor registries at four institutions (University of Arkansas for Medical Sciences, Little Rock, AR; Central Arkansas Veterans Healthcare System, Little Rock, AR; University of Tennessee Cancer Institute, Memphis, TN; and the University of Alabama at Birmingham, Birmingham, AL). Institutional Review Board approval was obtained from the respective institutions. Demographic and clinical data, including pathologic stage, was obtained by manual chart review. Two hundred ninety three stage II colon cancer patients, matched for the year of diagnosis, age, and sex, were selected for the study. Race/ethnicity was self-reported. Patients with rectal cancer and those with synchronous tumors were excluded from the study. Paraffin blocks or unstained sections on slides were obtained for the selected patients. After verification of the diagnosis and stage by an independent pathologist, the 12-gene assay and mismatch repair status (MMR) by immunohistochemistry for MLH1 and MSH2 were performed on these samples at the Genomic Health laboratory.</p>
    </sec>
    <sec id="Sec4" sec-type="materials|methods">
      <title>Statistical methods</title>
      <sec id="Sec5">
        <title>Primary analysis</title>
        <p>To address the primary objective of the study, the distributions of the Recurrence Score results for AA and CA patients were compared. Specifically, t-tests for two independent samples were used to determine if there were significant differences between the Recurrence Score results and the expression of individual genes in the two patient groups. If the normality assumption of the distributions of the Recurrence Score results was found to be invalid, a nonparametric Wilcoxon rank-sum test was used. In addition, the Recurrence Score distributions by race were summarized using histograms and descriptive statistics, such as means, medians, standard deviations, and ranges. Similar analyses were carried out to compare the expression levels of gene groups and individual genes within the 12-gene assay between the two patient groups.</p>
      </sec>
      <sec id="Sec6">
        <title>Secondary analyses</title>
        <p>We compared the distribution of demographic and pathology variables between AA and CA patients using Chi-square tests for categorical variables and two-sided t-tests for continuous variables. We also compared the distributions of the Recurrence Score results, gene groups and individual genes between the two patient groups, controlling for demographic and pathologic characteristics. We used multiple linear regression models to evaluate the relationships of the continuous Recurrence Score value, gene groups, and individual genes to relevant demographic and pathologic covariates, including race, gender, age at surgery, number of nodes examined, pathologic T stage, MMR status, and lymphatic vascular invasion (LVI).</p>
        <p>All tests of hypotheses were conducted at a two-sided alpha level of 0.05 unless otherwise noted. In this exploratory study, we have made no adjustments for multiple comparisons. All analyses were conducted with SAS 9.3 (SAS Institute, Cary, NC).</p>
      </sec>
    </sec>
    <sec id="Sec7">
      <title>Results</title>
      <p>Stage II colon cancer patients (<italic>n</italic>&#x2009;=&#x2009;293) were selected from tumor registries of four institutions (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Forty patients were excluded from analysis at pathology review (24 with insufficient or no invasive cancer, 5 with rectal cancer, 4 with no lymph node data, 2 with appendicular cancers and 5 for other reasons). Six patients were excluded due to laboratory failures (4 for insufficient RNA and 2 for poor quantitative PCR quality), and 3 patients were excluded due to missing MMR testing results. The remaining 244 samples (from 122 AA and 122 CA patients) were used in the analysis. The racial distribution of patients from each institution is listed in Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>CONSORT diagram for the study. Study cohort of subjects selected for the study after exclusion of those who did not meet the selection criteria. The analysis was based on 244 samples (122 Caucasian patients and 122 African-American patients). IHC: immunohistochemistry; U Tennessee: University of Tennessee; UAB: University of Alabama Birmingham; UAMS: University of Arkansas for Medical Sciences; VA: Central Arkansas Veterans Healthcare System</p></caption><graphic xlink:href="12885_2016_2365_Fig1_HTML" id="MO1"/></fig></p>
      <p>In the cohort of 244 patients, there were 118 women (63 AA, 55 CA) and 126 men (59 AA, 67 CA) (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). The median age at surgery was 66&#xA0;years (range 35&#x2013;88 years) for AA patients, and 68&#xA0;years (range 40&#x2013;97 years) for CA patients. Surgery was performed before the year 2000 in 31&#xA0;% of AA and CA patients, from 2000 to 2009 in 40&#xA0;% of AA and 49&#xA0;% of CA patients, and from 2010 onwards in 29&#xA0;% of AA and 20&#xA0;% of CA patients. Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref> shows the distribution of the demographic, clinical, and pathological characteristics of the patients eligible for analysis. Age, gender, year of surgery, pathologic stage, tumor location, number of nodes examined, LVI, and MMR status were not significantly different between the two racial groups as determined by Chi-square tests.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Demographic and clinical characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristics</th><th>African American (AA)</th><th>Caucasian (CA)</th></tr></thead><tbody><tr><td colspan="3">Age at Surgery (Yrs.)</td></tr><tr><td>&#x2003;&#x2009;Median (Range)</td><td>66 (35, 88)</td><td>68 (40, 97)</td></tr><tr><td>&#x2003;&#x2009;IQR (1<sup>st</sup> quartile, 3<sup>rd</sup> quartile)</td><td>21 (55&#x2013;76)</td><td>20 (57&#x2013;77)</td></tr><tr><td colspan="3">Gender</td></tr><tr><td>&#x2003;&#x2009;Female (<italic>n</italic>&#x2009;=&#x2009;118)</td><td>63 (51.6&#xA0;%)</td><td>55 (45.1&#xA0;%)</td></tr><tr><td>&#x2003;&#x2009;Male (<italic>n</italic>&#x2009;=&#x2009;126)</td><td>59 (48.4&#xA0;%)</td><td>67 (54.9&#xA0;%)</td></tr><tr><td colspan="3">Surgery Year</td></tr><tr><td>&#x2003;&#x2009;&lt;2000</td><td>38 (31.2&#xA0;%)</td><td>38 (31.2&#xA0;%)</td></tr><tr><td>&#x2003;&#x2009;&#x2265;2000 and &lt;2010</td><td>49 (40.2&#xA0;%)</td><td>60 (49.2&#xA0;%)</td></tr><tr><td>&#x2003;&#x2009;&#x2265;2010</td><td>35 (28.7&#xA0;%)</td><td>24 (19.7&#xA0;%)</td></tr><tr><td colspan="3">Number of Nodes Examined</td></tr><tr><td>&#x2003;&#x2009;Median (Range)</td><td>15 (1, 52)</td><td>17 (1, 50)</td></tr><tr><td>&#x2003;&#x2009;IQR (1<sup>st</sup> quartile, 3<sup>rd</sup> quartile)</td><td>14 (9, 23)</td><td>15 (10, 25)</td></tr><tr><td colspan="3">Tumor Location</td></tr><tr><td>&#x2003;&#x2009;Ascending (Ascending, Cecum, Hepatic flexure, Transverse)</td><td>71 (58.2&#xA0;%)</td><td>72 (59.0&#xA0;%)</td></tr><tr><td>&#x2003;&#x2009;Descending (Descending, Sigmoid, Splenic flexure)</td><td>45 (36.9&#xA0;%)</td><td>46 (37.7&#xA0;%)</td></tr><tr><td>&#x2003;&#x2009;Colon NOS</td><td>6 (4.9&#xA0;%)</td><td>4 (3.3&#xA0;%)</td></tr><tr><td colspan="3">T Stage</td></tr><tr><td>&#x2003;&#x2009;T3</td><td>107 (87.7&#xA0;%)</td><td>109 (89.3&#xA0;%)</td></tr><tr><td>&#x2003;&#x2009;T4</td><td>15 (12.3&#xA0;%)</td><td>13 (10.7&#xA0;%)</td></tr><tr><td colspan="3">MMR Status</td></tr><tr><td>&#x2003;&#x2009;Deficient</td><td>11 (9.0&#xA0;%)</td><td>21 (17.2&#xA0;%)</td></tr><tr><td>&#x2003;&#x2009;Proficient</td><td>111 (91.0&#xA0;%)</td><td>101 (82.8&#xA0;%)</td></tr><tr><td colspan="3">Lympho-vascular Invasion</td></tr><tr><td>&#x2003;&#x2009;Yes</td><td>7 (5.7&#xA0;%)</td><td>6 (4.9&#xA0;%)</td></tr><tr><td>&#x2003;&#x2009;No</td><td>95 (77.9&#xA0;%)</td><td>97 (79.5&#xA0;%)</td></tr><tr><td>&#x2003;&#x2009;Not Reported</td><td>20 (16.4&#xA0;%)</td><td>19 (15.6&#xA0;%)</td></tr></tbody></table></table-wrap></p>
      <p>The mean Recurrence Score result was 27.9&#x2009;&#xB1;&#x2009;12.8 for the AA group and 28.0&#x2009;&#xB1;&#x2009;11.8 for the CA group and was not significantly different between groups (<italic>p</italic>&#x2009;=&#x2009;0.93) (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). The proportion of patients with a high Recurrence Score result (&#x2265;41) was similar between the groups: 17/122 (14&#xA0;%) for AA patients and 15/122 (12&#xA0;%) for CA patients (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). None of the gene expression variables, either single genes or gene groups (Cell Cycle group, Stromal group, BGN, FAP, INHBA, Ki67, MYBL2, C-MYC, and GADD45B) was significantly different between the racial groups (<italic>p</italic>&#x2009;&gt;&#x2009;0.05 for all individual genes and gene groups) (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>The distribution of Recurrence Score results for African-American patients and Caucasian patients. The number of patients with a given Recurrence Score result is displayed on the vertical axis; the Recurrence Score values are displayed on the horizontal axis. The mean, SD, median, and range of the Recurrence Score result are inset in each graph. Panel <bold>a</bold>: display of the Recurrence Score results for AA patients (<italic>n</italic>&#x2009;=&#x2009;122). Panel <bold>b</bold>: display of the Recurrence Score results for CA patients (<italic>n</italic>&#x2009;=&#x2009;122). The mean Recurrence Score result for African-American patients (27.9&#x2009;&#xB1;&#x2009;12.8) was not statistically different from that of Caucasian patients (28.1&#x2009;&#xB1;&#x2009;11.8). The vertical line at 41 represents the cutoff for the high Recurrence Score risk group [<xref ref-type="bibr" rid="CR6">6</xref>]. SD: standard deviation; AA: African-American; CA: Caucasian</p></caption><graphic xlink:href="12885_2016_2365_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Recurrence Score result display by high recurrence risk cut off. The Recurrence Score result for each patient is displayed as a circle by ethnicity group. The Recurrence Score results &gt;41 are colored red. The proportion of patients with high Recurrence Score values (&#x2265;41) was similar between the patient groups (17/122 African-American patients; 15/122 Caucasian patients)</p></caption><graphic xlink:href="12885_2016_2365_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Distribution of the Gene Expression Levels for Gene Groups and Individual Genes. Gene expression variables, either single genes or gene groups, (Cell Cycle group, Stromal group, BGN, FAP, INHBA, Ki67, MYBL2, C-MYC, and GADD45B) were not significantly different between the racial groups</p></caption><graphic xlink:href="12885_2016_2365_Fig4_HTML" id="MO4"/></fig></p>
      <p>Linear regression modeling of Recurrence Score result, gene groups, and individual genes with the explanatory variables including race, clinical covariates, and pathological covariates (including number of nodes examined, pathologic T stage, tumor grade, MMR status and LVI status) revealed no statistically significant association with patient race (data not shown).</p>
    </sec>
    <sec id="Sec8">
      <title>Discussion</title>
      <p>Colorectal cancer is the third most common cancer in men and women in the United States and has the third highest mortality rate in both genders [<xref ref-type="bibr" rid="CR1">1</xref>]. Relative to CA patients, AA patients with colorectal cancer have a higher incidence, higher mortality, and worse stage-specific outcomes [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. The reasons for these disparities are not well understood. The recent improvement in survival of patients with colorectal cancer across all stages has not been seen equally in AA and CA patients: the overall mortality rate has steadily abated in the last three decades, but the decline is less pronounced among AA compared to CA populations [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. The mortality rate among AA populations with colorectal cancer at all stages is in dispute, with some studies showing worse rates among AA patients with all stages, including early stage disease [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>] while others show the trend only for those with advanced stage disease [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR9">9</xref>].</p>
      <p>The higher colorectal cancer incidence and mortality rates among AA have been attributed to differences in socioeconomic status leading to lack of access to healthcare, although this has been disputed by others [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Lack of access to healthcare, resulting in lower rates of screening and more advanced stage at presentation and consequently higher mortality, has been noted for the AA population [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. In Medicare beneficiaries, there is evidence for a difference in the treatment received for colon cancer [<xref ref-type="bibr" rid="CR13">13</xref>]; for younger populations, there is also evidence of lower utilization of available treatment with chemotherapy and radiation among AAs [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. In contrast, studies of the Veterans Affairs Health Care Systems did not find a statistical difference in overall survival between AA and CA patients with colorectal carcinoma and suggested that uniform treatment of their patient population may be the reason for the lack of a difference in survival [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Albain and colleagues reported that in prospective SWOG studies there was no difference in outcomes between AA and CA patients with respect to colon cancer, although AA patients with breast, prostate, or ovarian cancers had worse overall survival than CA patients; however, the small sample size and restriction of analysis to only those who were receiving adjuvant chemotherapy may have played a role in the differential results for colon cancer versus other tumor types [<xref ref-type="bibr" rid="CR17">17</xref>].</p>
      <p>Objective clinical factors have also been examined to identify underlying reasons for the racial disparity. A retrospective analysis of patients with colon cancer not receiving chemotherapy showed a higher mortality for AA subjects [<xref ref-type="bibr" rid="CR10">10</xref>]. The difference in disease progression and worse mortality may be attributed to variations in tumor pathobiology in patients of different race and ethnicity [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Several studies [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR11">11</xref>], including a study conducted by University of Alabama, Birmingham investigators found that, although there was no difference in the distribution of tumor grade between AA and CA colon cancer patients, AAs with high-grade (poorly differentiated) tumors were at three times higher risk of dying of colorectal cancer as CA patients even after controlling for treatment and prognostic factors [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
      <p>This is the first study to compare the 12-gene assay in colon cancer among AA and CA patients. This assay has been validated to predict the recurrence rate in patients with resected stage II colon cancer, whether treated with surgery alone or with surgery followed by adjuvant chemotherapy. We compared the Recurrence Score results of AA and CA patients who otherwise showed no differences in demographic or clinical factors. Although the number of genes assessed by the Oncotype DX assay is limited in number, the genes are known to be involved in cancer biology, therefore, the assay represents a useful, although not comprehensive, probe into the biology of these tumors. Among both AA and CA patients, there was a similar distribution of Recurrence Score results and equal numbers of subjects in both groups had high Recurrence Score results &#x2265;41. The year of diagnosis was matched for the two groups to balance for any inequality in the number of lymph nodes harvested due to the introduction of new standards [<xref ref-type="bibr" rid="CR21">21</xref>]. We did not exclude patients with fewer than 12 nodes examined because the aim of the study was to evaluate the expression of the genes underlying the biology of colon tumors in AA and CA patients, and not to evaluate the risk of recurrence. None of the gene expression variables, either gene groups or single genes (cell cycle group, stromal group, BGN1, FAP, INHBA1, Ki67, MYBL2, cMYC, and GADD45B), was significantly different between the patient groups.</p>
      <p>A limitation of this study is that the assessment of genes was limited to those represented by the 12-gene assay. Accordingly, we cannot rule out the possibility of other underlying differences in tumor biology and molecular profiles between AA and CA patients. Further, as we did not have access to long-term clinical outcomes for patients in this study, we were unable to assess whether similarities in gene expression profiles for AA and CA patients are associated with similar clinical outcomes. Finally, although the AA and CA cohorts were matched based on year of diagnosis, age, and sex, the retrospective nature of this study does not preclude other potential sources of selection bias.</p>
    </sec>
    <sec id="Sec9">
      <title>Conclusion</title>
      <p>The distribution of Recurrence Score results, gene expression levels of gene groups and individual genes were not significantly different between AA and CA patients; suggesting tumor biology, as measured by the 12-gene assay, did not differ between patient groups.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>AA</term>
          <def>
            <p>African American</p>
          </def>
        </def-item>
        <def-item>
          <term>CA</term>
          <def>
            <p>Caucasian</p>
          </def>
        </def-item>
        <def-item>
          <term>MMR</term>
          <def>
            <p>Mismatch Repair</p>
          </def>
        </def-item>
        <def-item>
          <term>FFPE</term>
          <def>
            <p>Formalin-fixed Paraffin Embedded</p>
          </def>
        </def-item>
        <def-item>
          <term>LVI</term>
          <def>
            <p>Lymphatic Vascular Invasion</p>
          </def>
        </def-item>
        <def-item>
          <term>SWOG</term>
          <def>
            <p>Southwest Oncology Group</p>
          </def>
        </def-item>
        <def-item>
          <term>UAB</term>
          <def>
            <p>University of Alabama</p>
          </def>
        </def-item>
        <def-item>
          <term>UAMS</term>
          <def>
            <p>University of Arkansas for Medical Sciences</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <title>Acknowlegments</title>
      <p>Editorial and writing support was provided by Eric R. Schuur, PhD.</p>
      <sec id="FPar1">
        <title>Authors&#x2019; contributions</title>
        <p>RG contributed to the conception and design, data collection, analysis and interpretation, manuscript drafting, revising, and approval for publishing; JP contributed to the conception and design, data collection, analysis and interpretation, manuscript drafting, revising, and approval for publishing; CC contributed to the conception and design, data collection, analysis and interpretation, manuscript drafting, revising, and approval for publishing; RL contributed to the data analysis and interpretation; manuscript drafting and revising; TJ contributed to the tissue procurement, data collection and manuscript approval for publishing; AYJ contributed to the data collection and manuscript approval; AJ contributed to the data collection and manuscript approval; FM contributed to the data collection and manuscript approval; RO contributed to the conception and design, data collection, analysis and interpretation, manuscript drafting, revising, and approval for publishing; and UM contributed to the conception and design, tissue procurement, data collection, analysis and interpretation, manuscript drafting, revising, and approval for publishing. All authors have read and approved the manuscript.</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>The data set used is stored in the clinical trials office at the University of Arkansas for Medical Sciences and the clinical trials office at the Central Arkansas Veterans Healthcare System where they can be accessed.</p>
      </sec>
      <sec id="FPar3">
        <title>Funding</title>
        <p>This study was supported by funds from Genomic Health, Inc.</p>
      </sec>
    </ack>
    <notes notes-type="conflict-interest">
      <sec id="FPar5">
        <title>Competing interests</title>
        <p>Calvin Chao and Ruixiao Lu report employment by Genomic Health, Inc. The other authors report no conflicts of interest.</p>
      </sec>
      <sec id="FPar4">
        <title>Ethics approval and consent to participate</title>
        <p>This study was approved by the following Institutional Review Boards: University of Arkansas IRB committee; Central Arkansas Veterans Healthcare System IRB and R&amp;D (Research and Development); the Institutional Review Board of the University of Tennessee and the Baptist Memorial Healthcare Corporation, Memphis, TN; and the Institutional Review Board of the University of Alabama at Birmingham. In accordance with the approvals, informed consent from the patients was not required.</p>
      </sec>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siegel</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Jemal</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cancer statistics, 2015</article-title>
          <source>CA Cancer J Clin</source>
          <year>2015</year>
          <volume>65</volume>
          <issue>1</issue>
          <fpage>5</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="doi">10.3322/caac.21254</pub-id>
          <pub-id pub-id-type="pmid">25559415</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Govindarajan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Erkman</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Hutchins</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
          <article-title>Racial differences in the outcome of patients with colorectal carcinoma</article-title>
          <source>Cancer</source>
          <year>2003</year>
          <volume>97</volume>
          <issue>2</issue>
          <fpage>493</fpage>
          <lpage>498</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.11067</pub-id>
          <pub-id pub-id-type="pmid">12518374</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polite</surname>
              <given-names>BN</given-names>
            </name>
            <name>
              <surname>Dignam</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Olopade</surname>
              <given-names>OI</given-names>
            </name>
          </person-group>
          <article-title>Colorectal cancer model of health disparities: understanding mortality differences in minority populations</article-title>
          <source>J Clin Oncol</source>
          <year>2006</year>
          <volume>24</volume>
          <issue>14</issue>
          <fpage>2179</fpage>
          <lpage>2187</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2005.05.4775</pub-id>
          <pub-id pub-id-type="pmid">16682737</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robbins</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Siegel</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Jemal</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008</article-title>
          <source>J Clin Oncol</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>4</issue>
          <fpage>401</fpage>
          <lpage>405</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2011.37.5527</pub-id>
          <pub-id pub-id-type="pmid">22184373</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayberry</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Coates</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Click</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>VW</given-names>
            </name>
            <name>
              <surname>Austin</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Redmond</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Fenoglio-Preiser</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Haynes</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Determinants of black/white differences in colon cancer survival</article-title>
          <source>J Natl Cancer Inst</source>
          <year>1995</year>
          <volume>87</volume>
          <issue>22</issue>
          <fpage>1686</fpage>
          <lpage>1693</lpage>
          <pub-id pub-id-type="doi">10.1093/jnci/87.22.1686</pub-id>
          <pub-id pub-id-type="pmid">7473817</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gray</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Quirke</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Handley</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Validation study of a quantitative multi-gene RT-PCR assay for assessment of recurrence risk in stage II colon cancer patients</article-title>
          <source>J Clin Oncol</source>
          <year>2011</year>
          <volume>29</volume>
          <fpage>4611</fpage>
          <lpage>4619</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2010.32.8732</pub-id>
          <pub-id pub-id-type="pmid">22067390</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Venook</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Niedzwiecki</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lopatin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>PN</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Clark-Langone</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Millward</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shak</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581</article-title>
          <source>J Clin Oncol</source>
          <year>2013</year>
          <volume>31</volume>
          <issue>14</issue>
          <fpage>1775</fpage>
          <lpage>1781</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2012.45.1096</pub-id>
          <pub-id pub-id-type="pmid">23530100</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yothers</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>O'Connell</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lopatin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Clark-Langone</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Millward</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Paik</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sharif</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shak</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wolmark</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin</article-title>
          <source>J Clin Oncol</source>
          <year>2013</year>
          <volume>31</volume>
          <issue>36</issue>
          <fpage>4512</fpage>
          <lpage>4519</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2012.47.3116</pub-id>
          <pub-id pub-id-type="pmid">24220557</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soneji</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Iyer</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Asch</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Racial disparities in stage-specific colorectal cancer mortality: 1960&#x2013;2005</article-title>
          <source>Am J Public Health</source>
          <year>2010</year>
          <volume>100</volume>
          <issue>10</issue>
          <fpage>1912</fpage>
          <lpage>1916</lpage>
          <pub-id pub-id-type="doi">10.2105/AJPH.2009.184192</pub-id>
          <pub-id pub-id-type="pmid">20724684</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexander</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chatla</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Funkhouser</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Meleth</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Grizzle</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Manne</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma</article-title>
          <source>Cancer</source>
          <year>2004</year>
          <volume>101</volume>
          <issue>1</issue>
          <fpage>66</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.20337</pub-id>
          <pub-id pub-id-type="pmid">15221990</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Potosky</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Harlan</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer</article-title>
          <source>J Clin Oncol</source>
          <year>2002</year>
          <volume>20</volume>
          <issue>5</issue>
          <fpage>1192</fpage>
          <lpage>1202</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.20.5.1192</pub-id>
          <pub-id pub-id-type="pmid">11870160</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciccone</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Prastaro</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ivaldi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Giacometti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Vineis</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Access to hospital care, clinical stage and survival from colorectal cancer according to socio-economic status</article-title>
          <source>Ann Oncol</source>
          <year>2000</year>
          <volume>11</volume>
          <issue>9</issue>
          <fpage>1201</fpage>
          <lpage>1204</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1008352119907</pub-id>
          <pub-id pub-id-type="pmid">11061620</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vernon</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Franzini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>XL</given-names>
            </name>
          </person-group>
          <article-title>Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare's screening reimbursement</article-title>
          <source>Cancer Epidemiol Biomarkers Prev</source>
          <year>2011</year>
          <volume>20</volume>
          <issue>5</issue>
          <fpage>811</fpage>
          <lpage>817</lpage>
          <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-09-0963</pub-id>
          <pub-id pub-id-type="pmid">21546366</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gross</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002?</article-title>
          <source>Cancer</source>
          <year>2008</year>
          <volume>112</volume>
          <issue>4</issue>
          <fpage>900</fpage>
          <lpage>908</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.23228</pub-id>
          <pub-id pub-id-type="pmid">18181101</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Page</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Kuntz</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Racial and socioeconomic factors in cancer survival. A comparison of Veterans Administration results with selected studies</article-title>
          <source>Cancer</source>
          <year>1980</year>
          <volume>45</volume>
          <issue>5</issue>
          <fpage>1029</fpage>
          <lpage>1040</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(19800301)45:5&lt;1029::AID-CNCR2820450533&gt;3.0.CO;2-3</pub-id>
          <pub-id pub-id-type="pmid">7020913</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zullig</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Carpenter</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Provenzale</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Reeve</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Examining potential colorectal cancer care disparities in the Veterans Affairs health care system</article-title>
          <source>J Clin Oncol</source>
          <year>2013</year>
          <volume>31</volume>
          <issue>28</issue>
          <fpage>3579</fpage>
          <lpage>3584</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2013.50.4753</pub-id>
          <pub-id pub-id-type="pmid">24002515</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albain</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Unger</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Crowley</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Coltman</surname>
              <given-names>CA</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Hershman</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group</article-title>
          <source>J Natl Cancer Inst</source>
          <year>2009</year>
          <volume>101</volume>
          <issue>14</issue>
          <fpage>984</fpage>
          <lpage>992</lpage>
          <pub-id pub-id-type="doi">10.1093/jnci/djp175</pub-id>
          <pub-id pub-id-type="pmid">19584328</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Relling</surname>
              <given-names>MV</given-names>
            </name>
          </person-group>
          <article-title>Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks</article-title>
          <source>Pharmacogenetics</source>
          <year>1996</year>
          <volume>6</volume>
          <issue>2</issue>
          <fpage>187</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="doi">10.1097/00008571-199604000-00005</pub-id>
          <pub-id pub-id-type="pmid">9156696</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhong</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wyllie</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Spurr</surname>
              <given-names>NK</given-names>
            </name>
          </person-group>
          <article-title>Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer</article-title>
          <source>Carcinogenesis</source>
          <year>1993</year>
          <volume>14</volume>
          <issue>9</issue>
          <fpage>1821</fpage>
          <lpage>1824</lpage>
          <pub-id pub-id-type="doi">10.1093/carcin/14.9.1821</pub-id>
          <pub-id pub-id-type="pmid">8403204</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexander</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jhala</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Chatla</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Steinhauer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Funkhouser</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Coffey</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Grizzle</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Manne</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas</article-title>
          <source>Cancer</source>
          <year>2005</year>
          <volume>103</volume>
          <issue>10</issue>
          <fpage>2163</fpage>
          <lpage>2170</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.21021</pub-id>
          <pub-id pub-id-type="pmid">15816050</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sobin</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <article-title>TNM: principles, history, and relation to other prognostic factors</article-title>
          <source>Cancer</source>
          <year>2001</year>
          <volume>91</volume>
          <issue>8 Suppl</issue>
          <fpage>1589</fpage>
          <lpage>1592</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(20010415)91:8+&lt;1589::AID-CNCR1170&gt;3.0.CO;2-K</pub-id>
          <pub-id pub-id-type="pmid">11309755</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Pulm Circ</journal-id>
      <journal-id journal-id-type="iso-abbrev">Pulm Circ</journal-id>
      <journal-id journal-id-type="publisher-id">PC</journal-id>
      <journal-title-group>
        <journal-title>Pulmonary Circulation</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2045-8932</issn>
      <issn pub-type="epub">2045-8940</issn>
      <publisher>
        <publisher-name>University of Chicago Press</publisher-name>
        <publisher-loc>Chicago, IL</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27252846</article-id>
      <article-id pub-id-type="pmc">4869924</article-id>
      <article-id pub-id-type="doi">10.1086/685547</article-id>
      <article-id pub-id-type="publisher-id">PC2013320</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Reactive oxygen species&#x2013;associated molecular signature predicts survival in patients with sepsis</article-title>
        <alt-title alt-title-type="short-authors">Bime et al.</alt-title>
        <alt-title alt-title-type="short">ROS-associated biomarker predicting survival in sepsis patients</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Bime</surname>
            <given-names>Christian</given-names>
          </name>
          <xref ref-type="aff" rid="af1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>Tong</given-names>
          </name>
          <xref ref-type="aff" rid="af1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Ting</given-names>
          </name>
          <xref ref-type="aff" rid="af1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Slepian</surname>
            <given-names>Marvin J.</given-names>
          </name>
          <xref ref-type="aff" rid="af1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="af2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garcia</surname>
            <given-names>Joe G. N.</given-names>
          </name>
          <xref ref-type="aff" rid="af1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hecker</surname>
            <given-names>Louise</given-names>
          </name>
          <xref ref-type="aff" rid="af1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="af3">
            <sup>3</sup>
          </xref>
        </contrib>
        <aff id="af1"><label>1</label>Department of Medicine, University of Arizona, Tucson, Arizona, USA</aff>
        <aff id="af2"><label>2</label>Department of Biomedical Engineering, University of Arizona, Tucson, Arizona, USA</aff>
        <aff id="af3"><label>3</label>Southern Arizona Veterans Administration Health Care System, Tucson, Arizona, USA</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address correspondence to Dr. Christian Bime. E-mail: <email xlink:href="cbime@deptofmed.arizona.edu">cbime@deptofmed.arizona.edu</email>.</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <volume>6</volume>
      <issue>2</issue>
      <fpage>196</fpage>
      <lpage>201</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 by the Pulmonary Vascular Research Institute. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <copyright-holder>Pulmonary Vascular Research Institute</copyright-holder>
        <license license-type="open-access">
          <license-p>For permission to reuse, contact journalpermissions@press.uchicago.edu.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>Abstract</label>
        <p>Sepsis-related multiple organ dysfunction syndrome is a leading cause of death in intensive care units. There is overwhelming evidence that oxidative stress plays a significant role in the pathogenesis of sepsis-associated multiple organ failure; however, reactive oxygen species (ROS)&#x2013;associated biomarkers and/or diagnostics that define mortality or predict survival in sepsis are lacking. Lung or peripheral blood gene expression analysis has gained increasing recognition as a potential prognostic and/or diagnostic tool. The objective of this study was to identify ROS-associated biomarkers predictive of survival in patients with sepsis. In-silico analyses of expression profiles allowed the identification of a 21-gene ROS-associated molecular signature that predicts survival in sepsis patients. Importantly, this signature performed well in a validation cohort consisting of sepsis patients aggregated from distinct patient populations recruited from different sites. Our signature outperforms randomly generated signatures of the same signature gene size. Our findings further validate the critical role of ROSs in the pathogenesis of sepsis and provide a novel gene signature that predicts survival in sepsis patients. These results also highlight the utility of peripheral blood molecular signatures as biomarkers for predicting mortality risk in patients with sepsis, which could facilitate the development of personalized therapies.</p>
      </abstract>
      <kwd-group>
        <label>Keywords</label>
        <kwd>microarray</kwd>
        <kwd>gene expression</kwd>
        <kwd>reactive oxygen species</kwd>
        <kwd>sepsis</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Dev Biol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Dev. Biol</journal-id>
      <journal-title-group>
        <journal-title>BMC Developmental Biology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-213X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27206491</article-id>
      <article-id pub-id-type="pmc">4875762</article-id>
      <article-id pub-id-type="publisher-id">116</article-id>
      <article-id pub-id-type="doi">10.1186/s12861-016-0116-y</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Representation of anatomy in online atlases and databases: a survey and collection of patterns for interface design</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Clarkson</surname>
            <given-names>Melissa D.</given-names>
          </name>
          <address>
            <email>melissa@melissaclarkson.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Department of Biological Structure, School of Medicine, University of Washington, Seattle, WA USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>21</day>
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>18</elocation-id>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>5</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Clarkson. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>A large number of online atlases and databases have been developed to mange the rapidly growing amount of data describing embryogenesis. As these community resources continue to evolve, it is important to understand how representations of anatomy can facilitate the sharing and integration of data. In addition, attention to the design of the interfaces is critical to make online resources useful and usable.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>I first present a survey of online atlases and gene expression resources for model organisms, with a focus on methods of semantic and spatial representation of anatomy. A total of 14 anatomical atlases and 21 gene expression resources are included. This survey demonstrates how choices in semantic representation, in the form of ontologies, can enhance interface search functions and provide links between relevant information. This survey also reviews methods for spatially representing anatomy in online resources. I then provide a collection of patterns for interface design based on the atlases and databases surveyed. These patterns include methods for displaying graphics, integrating semantic and spatial representations, organizing information, and querying databases to find genes expressed in anatomical structures.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>This collection of patterns for interface design will assist biologists and software developers in planning the interfaces of new atlases and databases or enhancing existing ones. They also show the benefits of standardizing semantic and spatial representations of anatomy by demonstrating how interfaces can use standardization to provide enhanced functionality.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Atlas</kwd>
        <kwd>Database</kwd>
        <kwd>Interface</kwd>
        <kwd>Ontology</kwd>
        <kwd>Anatomy</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Developmental biology is a data-intensive science. During the last two decades the primary means of archiving and accessing experimental results has shifted from traditional printed publications to digital repositories and web sites [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. This transition was driven by the need to mange the rapidly growing amount of data describing embryogenesis, integrate heterogeneous data, represent this data within the context of space and time, and enable cross-species comparisons.</p>
      <p>Development of the first digital atlas took place in the early 1990s. These authors constructed a 9-day mouse embryo in 3D using serial sections at histological resolution, with plans to later incorporate spatially-based gene expression data [<xref ref-type="bibr" rid="CR3">3</xref>]. Since that time, many anatomical atlases and gene expression databases have been developed for a number of species, by both individual laboratories and multi-institution teams.</p>
      <p>Development of these resources has required partnering with computer science and informatics researchers. Areas of partnership include not only designing interactive web-based tools and improving methods of image capture and analysis, but also developing standards for data integration. Efforts to standardize elements of research (such as gene nomenclature, experimental protocols, descriptions of phenotypes, and the organisms themselves) began decades before the introduction of digital repositories [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. But standards are particularly important for digital repositories because the ability of users to find information relevant to their needs&#x2014;and to make sense of what they find&#x2014;is determined by the quality and consistency of the data and its annotations.</p>
      <p>The Gene Ontology (GO) is a prominent example of an effort to develop semantic standards for molecular biology. GO allows biologists to describe the role of gene products shared across eukaryotic organisms [<xref ref-type="bibr" rid="CR6">6</xref>]. It is widely used to cluster results of large-scale differential gene expression studies into functional categories, and has an important role in representing and aiding the discovery of gene regulatory networks [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p>
      <p>The representation of anatomy often receives less attention than the representation of genes, but is crucial because studies of gene expression must document not only the genes studied but also the anatomical location(s) of the expression. These annotations are most useful when they represent anatomy in ways that are explicit, standardized, and can be understood by researchers without expert knowledge of the species represented.</p>
      <p>Methods for curating information about the anatomy of model organisms have evolved in parallel with methods for disseminating experimental data. Traditional print-based atlases have long been used to document anatomy and standardize terminology for structures and developmental stages. Online atlases provide additional benefits because they (a) allow data such as high-resolution two-dimensional (2D) images, three-dimensional (3D) reconstructions, and movies to be shared, (b) can be updated frequently, and (c) can link to external resources or incorporate content maintained by other sites.</p>
      <p>The task of representing an organism&#x2019;s anatomy during development is inherently complex. As shown in Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, a complete description would account for three-dimensional structure at scales spanning gross, histological, and molecular anatomy, each throughout the time of development. Managing knowledge and data within this space-scale-time matrix presents a tremendous challenge. But it is also an opportunity to develop online atlases that not only provide anatomical descriptions, but also use anatomy as a framework for organizing and sharing data [<xref ref-type="bibr" rid="CR9">9</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>The components of a complete anatomical description. A complete description of an organism&#x2019;s anatomy during development would account for three-dimensional structure at scales from gross to histological to molecular anatomy, and throughout the time of development</p></caption><graphic xlink:href="12861_2016_116_Fig1_HTML" id="MO1"/></fig></p>
      <p>In order to develop atlases that will successfully serve as data portals for developmental biologists, research in a number of areas is crucial. These include development of web technologies for delivering volumetric image data over the web [<xref ref-type="bibr" rid="CR10">10</xref>] and tools to support comparing data from disparate sources within a common spatial environment [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Work related to gene expression data includes capture of quantitative expression data [<xref ref-type="bibr" rid="CR13">13</xref>], mapping expression data to 3D graphics [<xref ref-type="bibr" rid="CR14">14</xref>], visualization of data across time and space [<xref ref-type="bibr" rid="CR15">15</xref>], and automating annotation of expression patterns with anatomical terms [<xref ref-type="bibr" rid="CR16">16</xref>]. Atlases could also provide tools to aid researchers in analysis of their own data, such as feature for more precisely describing a specimen&#x2019;s stage based on interpolating between reference stages [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>].</p>
      <p>Atlases serving as data portals will require tightly integrated spatial and semantic representations as users alternate between image-based and term-based navigation and data retrieval. Therefore, in addition to research rooted in the fields of computer science and informatics, expertise is also needed from the fields of interaction design (to develop intuitive interfaces and effective visualizations) and knowledge representation (to provide semantic representations to enable data integration).</p>
      <p>As shown in Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>, the type of semantic representation determines the level of meaning captured within the representation. A controlled vocabulary is a list of terms within a specific domain. A taxonomy is a controlled vocabulary with hierarchical <italic>is_a</italic> relationships. An ontology is a taxonomy with additional relationships such as <italic>has_part</italic> and <italic>develops_into</italic>. The information provided by these relationships is necessary for developing atlases that link together data across space and time.<fig id="Fig2"><label>Fig. 2</label><caption><p>Levels of complexity in semantic representation. A controlled vocabulary is a list of defined terms. <italic>A taxonomy</italic> is a controlled vocabulary with a hierarchical structure formed by <italic>is_a</italic> relationships between pairs of terms. An <italic>ontology</italic> is a taxonomy with additional relationships, such as <italic>part_of</italic>
</p></caption><graphic xlink:href="12861_2016_116_Fig2_HTML" id="MO2"/></fig></p>
      <p>This article examines online resources for developmental biologists with an emphasis on semantic and spatial representation and interface design. I first survey 14 anatomical atlases and 21 gene expression resources for methods of anatomical representation. I then present a collection of patterns for interface design that demonstrate the variety of approaches used for anatomical representation, user interaction, and navigation with the atlases and databases. The purposes of this work are to (a) assist biologists and software developers in planning the interfaces of new atlases and databases or enhancing existing ones, and (b) demonstrate the benefits of standardizing semantic and spatial representations of anatomy.</p>
    </sec>
    <sec id="Sec2">
      <title>Results</title>
      <sec id="Sec3">
        <title>Anatomical atlases</title>
        <p>For the purpose of this work, an anatomical atlas is defined as a resource that provides spatial representations of a body or region of a body, plus a set of anatomical terms which are associated with regions of the representations. I identified 14 online anatomical atlases describing organisms commonly used by developmental biologists.</p>
        <p>Descriptions of each atlas are provided in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. The six species represented (and number of atlases for each) are <italic>Caenorhabditis elegans</italic> (two), <italic>Ciona intestinalis</italic> (two), <italic>Drosophila</italic> (two), medaka (one), mouse (two), and zebrafish (four). Eight atlases have a spatial scope of the entire body, while others are limited to the brain (<italic>Drosophila</italic>, mouse), vasculature (medaka, zebrafish), midgut (<italic>Drosophila</italic>), or craniofacial skeleton (zebrafish). With the exception of one atlases for <italic>C. elegans</italic> and both <italic>Drosophila</italic> atlases, all atlases include a description of at least some developmental stages.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of anatomical atlases surveyed</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Atlas</th><th>Description</th><th>Spatial scope</th><th>Developmental stages</th><th>URL, full project name, project leadership</th><th>Publication</th></tr></thead><tbody><tr><td colspan="6">
<italic>C. elegans</italic>
</td></tr><tr><td>WormAtlas</td><td>A collection of resources including the SlidableWorm (for viewing annotated electron micrograph sections) and descriptions of individual neurons.</td><td>body</td><td>adult hermaphrodite, adult male, dauer larva</td><td>
<ext-link ext-link-type="uri" xlink:href="http://wormatlas.org/">http://wormatlas.org</ext-link>
<break/>From the laboratory of David Hall at Albert Einstein College of Medicine (Bronx, NY, USA).</td><td>[<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td>OpenWorm Browser<break/>(Virtual Worm)</td><td>A 3D virtual reconstruction consisting of surface models of 680 cells.</td><td>body</td><td>adult only</td><td>
<ext-link ext-link-type="uri" xlink:href="http://browser.openworm.org/">http://browser.openworm.org</ext-link>
<break/>A collaboration between WormBase and OpenWorm.</td><td>[<xref ref-type="bibr" rid="CR46">46</xref>]</td></tr><tr><td colspan="6">
<italic>Ciona intestinalis</italic>
</td></tr><tr><td>ANISEED<break/>(&#x201C;Anatomy&#x201D; section)</td><td>Illustrations of ascidian embryos at selected stages, annotated with cell names.</td><td>body</td><td>egg through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.aniseed.cnrs.fr/">http://www.aniseed.cnrs.fr</ext-link>
<break/>Ascidian Network for In Situ and Embryological Data<break/>A collaboration among ascidian researchers led by Patrick Lemaire at the CRM (Montpellier, France).</td><td>[<xref ref-type="bibr" rid="CR47">47</xref>]<break/>[<xref ref-type="bibr" rid="CR48">48</xref>]</td></tr><tr><td>FABA</td><td>Confocal micrographs for standardizing developmental stages.</td><td>body</td><td>zygote through hatched larva</td><td>
<ext-link ext-link-type="uri" xlink:href="http://tunicate-portal.org/faba/1.4/top.html">http://tunicate-portal.org/faba/1.4/top.html</ext-link>
<break/>Four-dimensional Ascidian Body Atlas<break/>From the laboratory of Kohji Hotta at Keio University (Yokohama, Japan).</td><td>[<xref ref-type="bibr" rid="CR49">49</xref>]</td></tr><tr><td colspan="6">
<italic>Drosophila</italic>
</td></tr><tr><td>Flygut</td><td>Description of the <italic>Drosophila</italic> midgut based on anatomy, histology, and expression patterns of reporter transgenes.</td><td>midgut</td><td>adult only</td><td>
<ext-link ext-link-type="uri" xlink:href="http://flygut.epfl.ch/">http://flygut.epfl.ch</ext-link>
<break/>This atlas complements a publication from Bruno Lemaitre&#x2019;s group at EPFL (Lausanne, Switzerland).</td><td>[<xref ref-type="bibr" rid="CR50">50</xref>]</td></tr><tr><td>Virtual Fly Brain</td><td>Virtual sections from a reference brain, with anatomical regions delineated.</td><td>brain</td><td>adult only</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.virtualflybrain.org/">http://www.virtualflybrain.org</ext-link>
<break/>Members of the Virtual Fly Brain team are from the University of Edinburgh (Edinburgh, Scotland) and the University of Cambridge (Cambridge, England).</td><td>[<xref ref-type="bibr" rid="CR51">51</xref>]</td></tr><tr><td colspan="6">Medaka</td></tr><tr><td>Medaka Blood Vessel Atlas</td><td>Annotated illustrations of the vasculature of embryos.</td><td>vasculature</td><td>mid-embryonic stages</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.shigen.nig.ac.jp/medaka/medaka_atlas">http://www.shigen.nig.ac.jp/medaka/medaka_atlas</ext-link>
<break/>Work by Misato Fujita and Sumio Isogai. Hosted online by the National BioResource Project Medaka (Japan).</td><td>[<xref ref-type="bibr" rid="CR52">52</xref>]<break/>[<xref ref-type="bibr" rid="CR53">53</xref>]</td></tr><tr><td colspan="6">Mouse</td></tr><tr><td>Allen Developing Mouse Brain Reference Atlas</td><td>Histological sections of brain with anatomical regions delineated.</td><td>brain</td><td>four embryonic stages, four post-natal stages</td><td>
<ext-link ext-link-type="uri" xlink:href="http://developingmouse.brain-map.org/static/atlas">http://developingmouse.brain-map.org/static/atlas</ext-link>
<break/>Produced by the Allen Institute for Brain Sciences (Seattle, WA, USA).</td><td>[<xref ref-type="bibr" rid="CR54">54</xref>]<break/>[<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td>e-Mouse Atlas</td><td>3D reconstructions of embryos (some with anatomical regions delineated), histological sections, and a guide to embryological stages.</td><td>body</td><td>all embryonic stages, three post-natal stages</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.emouseatlas.org/emap/ema/home.html">http://www.emouseatlas.org/emap/ema/home.html</ext-link> also known as the Edinburgh Mouse Atlas<break/>Project led by Duncan Davidson and Richard Baldock within the Medical Research Council Human Genetics Unit and the University of Edinburgh (Edinburgh, Scotland).</td><td>[<xref ref-type="bibr" rid="CR56">56</xref>]<break/>[<xref ref-type="bibr" rid="CR57">57</xref>]<break/>[<xref ref-type="bibr" rid="CR58">58</xref>]<break/>[<xref ref-type="bibr" rid="CR59">59</xref>]<break/>[<xref ref-type="bibr" rid="CR60">60</xref>]<break/>[<xref ref-type="bibr" rid="CR61">61</xref>]<break/>[<xref ref-type="bibr" rid="CR3">3</xref>]</td></tr><tr><td colspan="6">Zebrafish</td></tr><tr><td>FishFace</td><td>Graphics of fluorescently-labeled chondrocytes, osteoblasts, and bone matrix in the first two pharyngeal arches.</td><td>craniofacial skeleton</td><td>pharyngula through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="https://www.facebase.org/fishface/home">https://www.facebase.org/fishface/home</ext-link>
<break/>Created by the laboratory of Charles Kimmel at the University of Oregon (Eugene, OR, USA) as part of the FaceBase Consortium (USA).</td><td>[<xref ref-type="bibr" rid="CR62">62</xref>]</td></tr><tr><td>FishNet</td><td>Virtual sections from optical projection tomography (OPT) scans (with selected sections annotated).</td><td>body</td><td>pharyngula through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.fishnet.org.au/">http://www.fishnet.org.au</ext-link>
<break/>Produced by Robert Bryson-Richardson and Peter Currie at Monash University (Clayton, VIC, Australia).</td><td>[<xref ref-type="bibr" rid="CR63">63</xref>]</td></tr><tr><td>Interactive Atlas of Zebrafish Vascular Anatomy</td><td>Fluorescent angiograms as movies and annotated diagrams.</td><td>vasculature</td><td>pharyngula through larva</td><td>
<ext-link ext-link-type="uri" xlink:href="http://zfish.nichd.nih.gov/Intro%20Page/intro1.html">http://zfish.nichd.nih.gov/Intro%20Page/intro1.html</ext-link>
<break/>Produced by Brant Weinstein&#x2019;s group at the National Institutes of Health (Bethesda, MD, USA).</td><td>[<xref ref-type="bibr" rid="CR64">64</xref>]</td></tr><tr><td>ZFAP</td><td>Graphics from the FishNet atlas within a viewer that shows three orthogonal planes.</td><td>body</td><td>pharyngula through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://zebrafish.anatomyportal.org/">http://zebrafish.anatomyportal.org</ext-link>
<break/>Zebrafish Anatomy Portal<break/>From Robert Bryson-Richardson&#x2019;s group at Monash University (Clayton, VIC, Australia).</td><td>[<xref ref-type="bibr" rid="CR65">65</xref>]</td></tr><tr><td>Zebrafish Atlas</td><td>Histological sections and a virtual slide viewer. Slides from two developmental stages are annotated.</td><td>body</td><td>larva through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bio-atlas.psu.edu/zf">http://bio-atlas.psu.edu/zf</ext-link>
<break/>From the laboratory of Keith Cheng at Penn State College of Medicine (Hershey, PA, USA).</td><td>[<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr></tbody></table></table-wrap></p>
        <p>Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref> lists the types of anatomical representations used within each atlas. Types of graphics included confocal micrographs, transmission electron micrographs (TEMs), histological sections, 3D reconstructions from histological sections, 3D surface models, illustrations, and brightfield movies. Six of the atlases stated that a controlled vocabulary or ontology was used as a source of terms for anatomical structures.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Anatomical representations within the anatomical atlas</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Types of graphics<sup>a</sup>
</th><th>Controlled vocabulary or ontology for anatomy</th></tr></thead><tbody><tr><td colspan="3">
<italic>C. elegans</italic>
</td></tr><tr><td>WormAtlas</td><td>&#x2022; TEMs<break/>&#x2022; illustrations<break/>&#x2022; DIC micrographs<break/>&#x2022; fluorescence micrographs<break/>&#x2022; confocal micrographs (as movies of volumes)<break/>&#x2022; various movies, including 3D reconstructions from ssTEMs</td><td>not stated</td></tr><tr><td>OpenWorm Browser<break/>(Virtual Worm)</td><td>&#x2022; 3D surface models</td><td>not stated</td></tr><tr><td colspan="3">
<italic>Ciona intestinalis</italic>
</td></tr><tr><td>ANISEED (&#x201C;Anatomy&#x201D; section)</td><td>&#x2022; illustrations</td><td>
<italic>Ciona</italic> Developmental Ontology</td></tr><tr><td>FABA</td><td>&#x2022; confocal micrographs (as virtual sections and volumes)<break/>&#x2022; brightfield movies</td><td>not stated<sup>b</sup>
</td></tr><tr><td colspan="3">
<italic>Drosophila</italic>
</td></tr><tr><td>Flygut</td><td>&#x2022; schematic illustrations<break/>&#x2022; fluorescence micrographs<break/>&#x2022; 3D surface models</td><td>not stated</td></tr><tr><td>Virtual Fly Brain</td><td>&#x2022; confocal micrographs (as virtual sections)<break/>&#x2022; 3D surface models of neurons</td><td>
<italic>Drosophila</italic> Anatomy Ontology<sup>c</sup>
</td></tr><tr><td colspan="3">Medaka</td></tr><tr><td>Medaka Blood Vessel Atlas</td><td>&#x2022; illustrations<break/>&#x2022; confocal microangiographs</td><td>not stated</td></tr><tr><td colspan="3">Mouse</td></tr><tr><td>Allen Developing Mouse Brain Reference Atlas</td><td>&#x2022; histological sections with illustration overlays</td><td>Developing Mouse Brain Atlas ontology</td></tr><tr><td>e-Mouse Atlas</td><td>&#x2022; 3D reconstructions of histological sections (as virtual sections and volumes)<break/>&#x2022; histological sections<break/>&#x2022; OPT scans (as volumes)<break/>&#x2022; illustrations of stages</td><td>EMAP anatomy ontology</td></tr><tr><td colspan="3">Zebrafish</td></tr><tr><td>FishFace</td><td>&#x2022; confocal micrographs (as projections)<break/>&#x2022; OPT scans (as volumes)</td><td>Zebrafish Anatomy Ontology and [<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td>FishNet</td><td>&#x2022; OPT scans (as virtual sections and volumes)</td><td>not stated</td></tr><tr><td>Interactive Atlas of Zebrafish Vascular Anatomy</td><td>&#x2022; illustrations<break/>&#x2022; confocal microangiographs (as projections and volumes)</td><td>reference list on website</td></tr><tr><td>ZFAP</td><td>&#x2022; OPT scans (as virtual sections and volumes)</td><td>Zebrafish Anatomy Ontology</td></tr><tr><td>Zebrafish Atlas</td><td>&#x2022; histological sections</td><td>term list on website</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup> Abbreviations: <italic>DIC</italic> differential inference contrast, <italic>TEM</italic> transmission electron micrograph, <italic>ssTEM</italic> serial section transmission electron micrograph, <italic>OPT</italic> optical projection tomography</p><p>
<sup>b</sup> The FABA established the developmental stages used in the <italic>Ciona</italic> Developmental Ontology</p><p>
<sup>c</sup> The vocabulary from the Insect Brain Name Working Group [<xref ref-type="bibr" rid="CR68">68</xref>] was incorporated into the <italic>Drosophila</italic> Anatomy Ontology as part of the development of the Virtual Fly Brain atlas</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec4">
        <title>Gene expression atlases and databases</title>
        <p>For this work, a gene expression atlas or database is defined as a resource that combines evidence of gene expression with a representation of the anatomical region of the expression. Because this work emphasizes spatial representations, resources consisting only of microarray data were excluded. I identified 21 resources for gene expression.</p>
        <p>Descriptions of each atlas or database for gene expression are provided in Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>. The eight species represented (and number of resources for each) are <italic>Caenorhabditis elegans</italic> (two), chicken (one), <italic>Ciona intestinalis</italic> (one), <italic>Drosophila</italic> (four), medaka (one), mouse (eight), <italic>Xenopus</italic> (two), and zebrafish (two). The spatial scope for 18 of the resources is the entire body. Others are limited to brain, nervous system, or urogenital system (each for the mouse). All resources include at least one developmental stage.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Summary of gene expression atlases and databases surveyed</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Atlas or database</th><th>Description</th><th>Spatial scope</th><th>Developmental stages</th><th>URL, full project name, project leadership</th><th>Publication</th></tr></thead><tbody><tr><td colspan="6">
<italic>C. elegans</italic>
</td></tr><tr><td>Expression patterns for <italic>C. elegans</italic> promoter::GFP fusions</td><td>Database of expression patterns of transgenic animals with promoter::GFP fusions</td><td>body</td><td>embryo through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://gfpweb.aecom.yu.edu/index">http://gfpweb.aecom.yu.edu/index</ext-link>
<break/>A project of the British Columbia <italic>C. elegans</italic> Gene Expression Consortium</td><td>[<xref ref-type="bibr" rid="CR69">69</xref>]</td></tr><tr><td>WormBase (&#x201C;WormMine&#x201D; tool)</td><td>Community repository of molecular and genetic data from the literature, submissions, and collaborating projects</td><td>body</td><td>embryo through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.wormbase.org/">http://www.wormbase.org</ext-link>
<break/>An international consortium of researchers, based at Caltech (Pasadena, CA, USA)</td><td>[<xref ref-type="bibr" rid="CR70">70</xref>]<break/>[<xref ref-type="bibr" rid="CR46">46</xref>]</td></tr><tr><td colspan="6">Chicken</td></tr><tr><td>GEISHA</td><td>Community repository of in situ hybridization data acquired from high-throughput screens and the literature</td><td>body</td><td>egg through first six days of development</td><td>
<ext-link ext-link-type="uri" xlink:href="http://geisha.arizona.edu/geisha">http://geisha.arizona.edu/geisha</ext-link>
<break/>
<italic>Gallus</italic> Expression in Situ Hybridization Analysis<break/>Hosted by Parker Antin&#x2019;s group at the University of Arizona (Tuscaon, AZ, USA)</td><td>[<xref ref-type="bibr" rid="CR71">71</xref>]<break/>[<xref ref-type="bibr" rid="CR72">72</xref>]<break/>[<xref ref-type="bibr" rid="CR73">73</xref>]</td></tr><tr><td colspan="6">
<italic>Ciona intestinalis</italic>
</td></tr><tr><td>ANISEED (&#x201C;Gene Expression &amp; Function&#x201D; section)</td><td>Community repository of expression data from the literature, submissions, and collaborating projects</td><td>body</td><td>egg through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.aniseed.cnrs.fr/">http://www.aniseed.cnrs.fr</ext-link>
<break/>Ascidian Network for In Situ and Embryological Data<break/>A collaboration among ascidian researchers led by Patrick Lemaire at the CRM (Montpellier, France)</td><td>[<xref ref-type="bibr" rid="CR47">47</xref>]<break/>[<xref ref-type="bibr" rid="CR48">48</xref>]</td></tr><tr><td colspan="6">
<italic>Drosophila</italic>
</td></tr><tr><td>BDGP expression patterns</td><td>Database of in situ hybridization patterns</td><td>body</td><td>all embryonic stages</td><td>
<ext-link ext-link-type="uri" xlink:href="http://insitu.fruitfly.org/cgi-bin/ex/insitu.pl">http://insitu.fruitfly.org/cgi-bin/ex/insitu.pl</ext-link>
<break/>Berkeley Drosophila Genome Project<break/>From the laboratory of Susan Celniker at the Lawrence Berkeley Laboratory (Berkeley, CA, USA)</td><td>[<xref ref-type="bibr" rid="CR74">74</xref>]<break/>[<xref ref-type="bibr" rid="CR75">75</xref>]<break/>[<xref ref-type="bibr" rid="CR76">76</xref>]</td></tr><tr><td>FlyBase (&#x201C;QuickSearch&#x201D; tool)</td><td>Community repository of molecular and genetic data from the literature and direct submissions</td><td>body</td><td>egg through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://flybase.org/">http://flybase.org</ext-link>
<break/>From an international consortium of <italic>Drosophila</italic> researchers</td><td>[<xref ref-type="bibr" rid="CR77">77</xref>]<break/>[<xref ref-type="bibr" rid="CR78">78</xref>]<break/>[<xref ref-type="bibr" rid="CR79">79</xref>]</td></tr><tr><td>FlyExpress</td><td>A tool for searching expression patterns using images data from BDGP and Fly-FISH</td><td>body</td><td>all embryonic stages</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.flyexpress.net/">http://www.flyexpress.net</ext-link>
<break/>From the laboratory of Sudhir Kumar at Arizona State University (Tempe, AZ, USA)</td><td>[<xref ref-type="bibr" rid="CR40">40</xref>]<break/>[<xref ref-type="bibr" rid="CR80">80</xref>]</td></tr><tr><td>Fly-FISH</td><td>Database of in situ hybridization patterns</td><td>body</td><td>early embryonic stages and third instar larva</td><td>
<ext-link ext-link-type="uri" xlink:href="http://fly-fish.ccbr.utoronto.ca/">http://fly-fish.ccbr.utoronto.ca</ext-link>
<break/>From the laboratory of Henry Krause at the University of Toronto (Toronto, Ontario, Canada)</td><td>[<xref ref-type="bibr" rid="CR81">81</xref>]</td></tr><tr><td colspan="6">Medaka</td></tr><tr><td>MEPD</td><td>Database of expression patterns for genes (in situ hybridization) and regulatory sequences (fluorescent reporters)</td><td>body</td><td>egg through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://mepd.cos.uni-heidelberg.de/mepd">http://mepd.cos.uni-heidelberg.de/mepd</ext-link>
<break/>Medaka Expression Pattern Database<break/>A project within the Medaka Genome Initiative, from the laboratory of Joachin Wittbrody at University of Heidelberg Heidelberg, Germany)</td><td>[<xref ref-type="bibr" rid="CR82">82</xref>]<break/>[<xref ref-type="bibr" rid="CR83">83</xref>]<break/>[<xref ref-type="bibr" rid="CR84">84</xref>]</td></tr><tr><td colspan="6">Mouse</td></tr><tr><td>Allen Developing Mouse Brain Atlas (&#x201C;AGEA&#x201D; section)</td><td>Atlas of spatially correlated expression patterns derived from in situ hybridizations on histological sections</td><td>brain</td><td>four embryonic stages (E11.5, 13.5, 15.5, 18.5), four post-natal stages (P4, 14, 28)</td><td>
<ext-link ext-link-type="uri" xlink:href="http://developingmouse.brain-map.org/agea/show">http://developingmouse.brain-map.org/agea/show</ext-link>
<break/>Anatomic Gene Expression Atlas of the Allen Developing Mouse Brain Atlas<break/>Produced by the Allen Institute for Brain Sciences (Seattle, WA, USA)</td><td>[<xref ref-type="bibr" rid="CR85">85</xref>]<break/>[<xref ref-type="bibr" rid="CR86">86</xref>]<break/>[<xref ref-type="bibr" rid="CR87">87</xref>]<break/>[<xref ref-type="bibr" rid="CR36">36</xref>]</td></tr><tr><td>EMBRYS</td><td>Database of in situ hybridization patterns, using whole mounts</td><td>body</td><td>three embryonic stages (E9.5, 10.5, 11.5)</td><td>
<ext-link ext-link-type="uri" xlink:href="http://embrys.jp/embrys/html/MainMenu.html">http://embrys.jp/embrys/html/MainMenu.html</ext-link>
<break/>
<italic>Note: no longer available online</italic>
<break/>From the laboratory of Hiroshi Asahara at the Systems BioMedicine Laboratory of the National Research Institute for Child Health and Development (Tokyo, Japan)</td><td>[<xref ref-type="bibr" rid="CR88">88</xref>]<break/>[<xref ref-type="bibr" rid="CR89">89</xref>]</td></tr><tr><td>EMAGE</td><td>Community repository of molecular and genetic data from the literature and direct submissions</td><td>body</td><td>all post-implantation stages</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.emouseatlas.org/emage/home.php">http://www.emouseatlas.org/emage/home.php</ext-link>
<break/>e-Mouse Atlas of Gene Expression<break/>Led by Duncan Davidson and Richard Baldock within the Medical Research Council Human Genetics Unit at the University of Edinburgh (Edinburgh, Scotland)</td><td>[<xref ref-type="bibr" rid="CR56">56</xref>]<break/>[<xref ref-type="bibr" rid="CR90">90</xref>]<break/>[<xref ref-type="bibr" rid="CR91">91</xref>]<break/>[<xref ref-type="bibr" rid="CR58">58</xref>]<break/>[<xref ref-type="bibr" rid="CR92">92</xref>]<break/>[<xref ref-type="bibr" rid="CR93">93</xref>]</td></tr><tr><td>Eurexpress</td><td>Database of in situ hybridization patterns, using histoloogical sections</td><td>body</td><td>one embryonic stage (E14.5)</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.eurexpress.org/ee">http://www.eurexpress.org/ee</ext-link>
<break/>From a consortium of European researchers</td><td>[<xref ref-type="bibr" rid="CR94">94</xref>]</td></tr><tr><td>GXD</td><td>Community repository of expression data from the literature, direct submissions, and collaborating projects</td><td>body</td><td>all embryonic stages, postnatal</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/gxd">http://www.informatics.jax.org/gxd</ext-link>
<break/>Mouse Gene Expression Database<break/>A Mouse Genome Informatics resource from Jackson Laboratory (Bar Harbor, ME, USA)</td><td>[<xref ref-type="bibr" rid="CR95">95</xref>]<break/>[<xref ref-type="bibr" rid="CR96">96</xref>]<break/>[<xref ref-type="bibr" rid="CR97">97</xref>]<break/>[<xref ref-type="bibr" rid="CR98">98</xref>]</td></tr><tr><td>GENSAT</td><td>Database of in situ hybridization patterns and data from transgenic mice with EGFP reporter genes</td><td>nervous system</td><td>one embryonic stage (E15.5), postnatal (P7), adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.gensat.org/index.html">http://www.gensat.org/index.html</ext-link>
<break/>Gene Expression Nervous System Atlas<break/>From the laboratory of Nathaniel Heinz at The Rockefeller University (New York, NY, USA)</td><td>[<xref ref-type="bibr" rid="CR99">99</xref>]<break/>[<xref ref-type="bibr" rid="CR100">100</xref>]</td></tr><tr><td>GenePaint</td><td>Database of in situ hybridization patterns, using histological sections</td><td>body</td><td>three embryonic stages (E10.5, 14.5, 15.5), postnatal (P7), adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://genepaint.org/">http://genepaint.org</ext-link>
<break/>Led by Gregor Eichele at the Max Planck Institute of Biophysical Chemistry (G&#xF6;ttingen, Germany)</td><td>[<xref ref-type="bibr" rid="CR101">101</xref>]</td></tr><tr><td>GUDMAP</td><td>Community repository of expression data from the GUDMAP consortium</td><td>urogenital system</td><td>mid-embryonic development through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.gudmap.org/">http://www.gudmap.org</ext-link>
<break/>GenitoUrinary Molecular Anatomy Project<break/>From an international consortium of researchers</td><td>[<xref ref-type="bibr" rid="CR102">102</xref>]<break/>[<xref ref-type="bibr" rid="CR103">103</xref>]<break/>[<xref ref-type="bibr" rid="CR104">104</xref>]</td></tr><tr><td colspan="6">
<italic>Xenopus</italic>
</td></tr><tr><td>Xenbase</td><td>Community repository of expression data from the literature, submissions, and collaborating projects</td><td>body</td><td>all stages through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://www.xenbase.org/">http://www.xenbase.org</ext-link>
<break/>Led by Peter Vize at the University of Calgary (Calgary, Canada)</td><td>[<xref ref-type="bibr" rid="CR105">105</xref>]<break/>[<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td>XenMARK expression patterns</td><td>Database of in situ hybridization patterns, using whole mounts</td><td>body</td><td>32-cell stage through tadpole</td><td>
<ext-link ext-link-type="uri" xlink:href="http://genomics.crick.ac.uk/apps/XenMARK">http://genomics.crick.ac.uk/apps/XenMARK</ext-link>
<break/>From the laboratory of Michael Gilchrist at the MRC National Institute for Medical Research (London, UK)</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td colspan="6">Zebrafish</td></tr><tr><td>GEMS</td><td>Database of in situ hybridization patterns</td><td>body</td><td>gastrula through hatching</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bio-imaging.liacs.nl/liacsgems.html">http://bio-imaging.liacs.nl/liacsgems.html</ext-link>
<break/>
<italic>Note: no longer available online</italic>
<break/>Gene Expression Management System<break/>Produced by the Imagery &amp; Media Group at Leiden University (Leiden, Netherlands)</td><td>[<xref ref-type="bibr" rid="CR107">107</xref>]</td></tr><tr><td>ZFIN</td><td>Community repository of molecular and genetic data from literature and direct submissions</td><td>body</td><td>zygote through adult</td><td>
<ext-link ext-link-type="uri" xlink:href="http://zfin.org/">http://zfin.org</ext-link>
<break/>Zebrafish Model Organism Database (also known as the Zebrafish Information Network)<break/>Based at the University of Oregon (Eugene, OR, USA)</td><td>[<xref ref-type="bibr" rid="CR108">108</xref>]<break/>[<xref ref-type="bibr" rid="CR109">109</xref>]<break/>[<xref ref-type="bibr" rid="CR110">110</xref>]</td></tr></tbody></table></table-wrap></p>
        <p>Table&#xA0;<xref rid="Tab4" ref-type="table">4</xref> lists the anatomical representations used within each gene expression atlas or database. Types of graphics documenting expression patterns include brightfield micrographs showing a colorimetric assay for expression in both histological sections and whole mounts, confocal micrographs, and 3D models with the region of expression highlighted. At least eight of the resources rely primarily on submissions of data from the community, and therefore various types of graphics are presented across different database entries. All resources use anatomical terms to describe regions of expression. However, only 14 use terms from controlled vocabularies or ontologies. The other resources appear to use project-specific vocabularies.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Anatomical representations within the gene expression atlases and databases</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Atlas or database</th><th>Types of graphics<sup>a</sup>
</th><th>Controlled vocabulary or ontology for anatomy<sup>b</sup>
</th></tr></thead><tbody><tr><td colspan="3">
<italic>C. elegans</italic>
</td></tr><tr><td>Expression patterns for <italic>C. elegans</italic> promoter::GFP fusions</td><td>&#x2022; fluorescence micrographs<break/>&#x2022; confocal micrographs (as projections and volumes)<break/>&#x2022; DIC micrographs with fluorescence overlays</td><td>project-specific vocabulary</td></tr><tr><td>WormBase (&#x201C;WormMine&#x201D; tool)</td><td>&#x2022; various types submitted<break/>&#x2022; Virtual Worm model with regions of gene expression highlighted</td><td>
<italic>C. elegans</italic> Gross Anatomy Vocabulary<break/>
<italic>C. elegans</italic> Development Vocabulary</td></tr><tr><td colspan="3">Chicken</td></tr><tr><td>GEISHA</td><td>&#x2022; various types submitted</td><td>project-specific vocabulary</td></tr><tr><td colspan="3">
<italic>Ciona intestinalis</italic>
</td></tr><tr><td>ANISEED (Expression Data section)</td><td>&#x2022; various types submitted</td><td>
<italic>Ciona</italic> Developmental Ontology</td></tr><tr><td colspan="3">
<italic>Drosophila</italic>
</td></tr><tr><td>BDGP expression patterns</td><td>&#x2022; brightfield micrographs (whole mounts, colorimetric assay)</td><td>
<italic>Drosophila</italic> Anatomy Ontology</td></tr><tr><td>FlyBase (&#x201C;QuickSearch&#x201D; tool)</td><td>&#x2013;</td><td>
<italic>Drosophila</italic> Anatomy Ontology</td></tr><tr><td>FlyExpress</td><td>&#x2022; graphics from BDGP and Fly-FISH</td><td>vocabularies from BDGP and Fly-FISH</td></tr><tr><td>Fly-FISH</td><td>&#x2022; confocal micrographs</td><td>project-specific vocabulary</td></tr><tr><td colspan="3">Medaka</td></tr><tr><td>MEPD</td><td>&#x2022; brightfield micrographs (whole mounts, colorimetric assay for gene expression)<break/>&#x2022; fluorescence micrographs (for regulatory element expression)</td><td>MFO</td></tr><tr><td colspan="3">Mouse</td></tr><tr><td>Allen Developing Mouse Brain Atlas (&#x201C;AGEA&#x201D; section)</td><td>&#x2022; brightfield micrographs (histological sections, colorimetric assay)<break/>&#x2022; standardized 3D brain models with regions of expression highlighted</td><td>Allen Developing Mouse Brain Atlas ontology</td></tr><tr><td>EMBRYS</td><td>&#x2022; brightfield micrographs (whole mounts, colorimetric assay)<break/>&#x2022; AERO images (whole mounts, colorimetric assay)</td><td>project-specific vocabulary</td></tr><tr><td>EMAGE</td><td>&#x2022; various types submitted</td><td>EMAP anatomy ontology</td></tr><tr><td>Eurexpress</td><td>&#x2022; brightfield micrographs (histological sections, colorimetric assay)</td><td>EMAP anatomy ontology</td></tr><tr><td>GXD</td><td>&#x2022; various types submitted</td><td>EMAP anatomy ontology;<break/>MA</td></tr><tr><td>GENSAT</td><td>&#x2022; brightfield micrographs (histological sections, colorimetric assay)<break/>&#x2022; confocal micrographs</td><td>project-specific vocabulary</td></tr><tr><td>GenePaint</td><td>&#x2022; brightfield micrographs (histological sections, colorimetric assay)</td><td>project-specific vocabulary</td></tr><tr><td>GUDMAP</td><td>&#x2022; various types submitted</td><td>EMAP anatomy ontology</td></tr><tr><td colspan="3">
<italic>Xenopus</italic>
</td></tr><tr><td>Xenbase</td><td>&#x2022; various types submitted</td><td>XAO</td></tr><tr><td>XenMARK expression patterns</td><td>&#x2022; brightfield micrographs (whole mounts, colorimetric assay)</td><td>project-specific vocabulary</td></tr><tr><td colspan="3">Zebrafish</td></tr><tr><td>GEMS</td><td>&#x2022; confocal micrographs</td><td>DAOZ</td></tr><tr><td>ZFIN</td><td>&#x2022; various types submitted</td><td>ZAO</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup> Abbreviations: <italic>DIC</italic> differential inference contrast, AERO images are a series of 2D images captured at 2-degree intervals [<xref ref-type="bibr" rid="CR88">88</xref>]</p><p>
<sup>b</sup> Abbreviations: <italic>DAOZ</italic> Developmental Anatomy Ontology of Zebrafish, <italic>MFO</italic> Medaka Fish Anatomy and Development Ontology, <italic>XAO Xenopus</italic> Anatomy Ontology, <italic>ZAO</italic> Zebrafish Anatomy Ontology</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec5">
        <title>Semantic representation: Controlled vocabularies and ontologies</title>
        <p>Table&#xA0;<xref rid="Tab5" ref-type="table">5</xref> lists the controlled vocabularies and ontologies used in the resources surveyed. This survey revealed that a total of 12 vocabularies or ontologies are used. Each includes terms relevant to adult anatomy, developmental anatomy and stages, or both. Seven organisms are represented (<italic>C. elegans, C. intestinalis, Drosophila,</italic> medaka, mouse, <italic>Xenopus,</italic> and zebrafish). As shown in Table&#xA0;<xref rid="Tab5" ref-type="table">5</xref> (third column, indicated with superscript), each vocabulary and ontology was developed by one of the groups creating an atlas or database included in Tables&#xA0;<xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab3" ref-type="table">3</xref>.<table-wrap id="Tab5"><label>Table 5</label><caption><p>Controlled vocabularies and ontologies relevant to this survey</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Vocabulary or ontology</th><th>Domain</th><th>Used by this atlas or database</th><th>URL, full name</th><th>Publication</th></tr></thead><tbody><tr><td colspan="5">
<italic>C. elegans</italic>
</td></tr><tr><td>
<italic>C. elegans</italic> Gross Anatomy Vocabulary</td><td>&#x2022; developmental and adult anatomy, including individual cells</td><td>WormBase<sup>a</sup>
</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bioportal.bioontology.org/ontologies/WB-BT">http://bioportal.bioontology.org/ontologies/WB-BT</ext-link> also known as the <italic>C. elegans</italic> Cell and Anatomy Ontology</td><td>[<xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td>
<italic>C. elegans</italic> Development Vocabulary</td><td>&#x2022; developmental stages<break/>&#x2022; time points</td><td>WormBase<sup>a</sup>
</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bioportal.bioontology.org/ontologies/WB-LS">http://bioportal.bioontology.org/ontologies/WB-LS</ext-link>
</td><td>&#x2013;</td></tr><tr><td colspan="5">
<italic>Ciona intestinalis</italic>
</td></tr><tr><td>
<italic>Ciona intestinalis</italic> Anatomy and Development Ontology</td><td>&#x2022; developmental and adult anatomy, including individual cells<break/>&#x2022; developmental stages</td><td>ANISEED<sup>a</sup>
</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bioportal.bioontology.org/ontologies/CIINTEADO">http://bioportal.bioontology.org/ontologies/CIINTEADO</ext-link>
</td><td>[<xref ref-type="bibr" rid="CR47">47</xref>]<break/>[<xref ref-type="bibr" rid="CR48">48</xref>]</td></tr><tr><td colspan="5">
<italic>Drosophila</italic>
</td></tr><tr><td>
<italic>Drosophila</italic> Anatomy Ontology</td><td>&#x2022; developmental and adult anatomy<break/>&#x2022; includes vocabulary from the Insect Brain Name Working Group</td><td>VFB<break/>FlyBase<sup>a</sup>
</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bioportal.bioontology.org/ontologies/FB-BT">http://bioportal.bioontology.org/ontologies/FB-BT</ext-link> also known as the <italic>Drosophila</italic> Gross Anatomy Ontology</td><td>[<xref ref-type="bibr" rid="CR68">68</xref>]<break/>[<xref ref-type="bibr" rid="CR27">27</xref>]<break/>[<xref ref-type="bibr" rid="CR112">112</xref>]</td></tr><tr><td>
<italic>Drosophila</italic> Development Ontology</td><td>&#x2022; developmental stages<break/>&#x2022; cycles of nuclear division</td><td>FlyBase<sup>a</sup>
</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bioportal.bioontology.org/ontologies/FB-DV">http://bioportal.bioontology.org/ontologies/FB-DV</ext-link>
</td><td>_</td></tr><tr><td colspan="5">Medaka</td></tr><tr><td>MFO</td><td>&#x2022; developmental and adult anatomy<break/>&#x2022; developmental stages</td><td>MEPD<sup>a</sup>
</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bioportal.bioontology.org/ontologies/MFO">http://bioportal.bioontology.org/ontologies/MFO</ext-link>
<break/>Medaka Fish Anatomy and Development Ontology</td><td>[<xref ref-type="bibr" rid="CR83">83</xref>]</td></tr><tr><td colspan="5">Mouse</td></tr><tr><td>MA</td><td>&#x2022; adult anatomy</td><td>GXD<sup>a</sup>
</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bioportal.bioontology.org/ontologies/MA">http://bioportal.bioontology.org/ontologies/MA</ext-link>
<break/>Adult Mouse Anatomy, also known as the Mouse Adult Gross Anatomy Ontology</td><td>[<xref ref-type="bibr" rid="CR22">22</xref>]</td></tr><tr><td>Allen Developing Mouse Brain Atlas ontology</td><td>&#x2022; developmental anatomy</td><td>Allen Developing Mouse Brain Atlas<sup>a</sup>
</td><td>
<ext-link ext-link-type="uri" xlink:href="http://help.brain-map.org/display/api/Atlas+Drawings+and+Ontologies">http://help.brain-map.org/display/api/Atlas+Drawings+and+Ontologies</ext-link>
</td><td>[<xref ref-type="bibr" rid="CR55">55</xref>]</td></tr><tr><td>EMAP</td><td>&#x2022; developmental anatomy<break/>&#x2022; includes vocabulary from the GUDMAP consortium</td><td>e-Mouse Atlas<sup>a</sup>
<break/>GXD<break/>GUDMAP</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bioportal.bioontology.org/ontologies/EMAP">http://bioportal.bioontology.org/ontologies/EMAP</ext-link>
<break/>e-Mouse Atlas Project anatomy ontology</td><td>[<xref ref-type="bibr" rid="CR21">21</xref>]<break/>[<xref ref-type="bibr" rid="CR113">113</xref>]<break/>[<xref ref-type="bibr" rid="CR114">114</xref>]</td></tr><tr><td colspan="5">
<italic>Xenopus</italic>
</td></tr><tr><td>XAO</td><td>&#x2022; developmental and adult anatomy<break/>&#x2022; developmental stages</td><td>Xenbase<sup>a</sup>
</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bioportal.bioontology.org/ontologies/XAO">http://bioportal.bioontology.org/ontologies/XAO</ext-link>
<break/>
<italic>Xenopus</italic> Anatomy Ontology, also known as the <italic>Xenopus</italic> Anatomy and Development Ontology</td><td>[<xref ref-type="bibr" rid="CR24">24</xref>]<break/>[<xref ref-type="bibr" rid="CR115">115</xref>]</td></tr><tr><td colspan="5">Zebrafish</td></tr><tr><td>DAOZ</td><td>&#x2022; developmental anatomy<break/>&#x2022; developmental stages</td><td>GEMS<sup>a</sup>
</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bio-imaging.liacs.nl/liacsontology.html">http://bio-imaging.liacs.nl/liacsontology.html</ext-link>
<break/>Developmental Anatomy Ontology of Zebrafish</td><td>[<xref ref-type="bibr" rid="CR116">116</xref>]</td></tr><tr><td>ZFA</td><td>&#x2022; developmental and adult anatomy<break/>&#x2022; developmental stages</td><td>ZFIN<sup>a</sup>
</td><td>
<ext-link ext-link-type="uri" xlink:href="http://bioportal.bioontology.org/ontologies/ZFA">http://bioportal.bioontology.org/ontologies/ZFA</ext-link>
<break/>Zebrafish Anatomy Ontology, also known as the Zebrafish Anatomy and Development Ontology</td><td>[<xref ref-type="bibr" rid="CR117">117</xref>]</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup> The vocabulary or ontology was developed by the group constructing this atlas or database</p></table-wrap-foot></table-wrap></p>
        <p>Several atlases and gene expression resources demonstrate how the relationships within ontologies can contribute to the usefulness of interfaces by enhancing search functions or providing links between relevant information:<list list-type="bullet"><list-item><p><italic>Part relationships:</italic> EMAGE [<xref ref-type="bibr" rid="CR19">19</xref>] and GXD [<xref ref-type="bibr" rid="CR20">20</xref>] are databases for gene expression in the mouse, and both have a search function that accepts a term for an anatomical structure and returns genes expressed in that structure. These databases make use of the part hierarchies in the EMAP anatomy ontology [<xref ref-type="bibr" rid="CR21">21</xref>] and Adult Mouse Anatomy (MA) [<xref ref-type="bibr" rid="CR22">22</xref>] to return results annotated with either the term entered by the user or the parts of that structure. For example, a search for genes expressed in &#x201C;eye&#x201D; will return genes annotated with &#x201C;eye&#x201D;, &#x201C;retina&#x201D;, and &#x201C;lens vesicle&#x201D;.</p></list-item><list-item><p><italic>Developmental relationships:</italic> Searches for gene expression in an anatomical structure can be expanded by including structures linked by developmental relationships. The Xenbase gene expression database [<xref ref-type="bibr" rid="CR23">23</xref>] provides an option to include successor and predecessor structures in search results. These relationships are provided by the <italic>Xenopus</italic> Anatomy Ontology (XAO) [<xref ref-type="bibr" rid="CR24">24</xref>]. Developmental relationships also provide a way for users to navigate an atlas or database along developmental pathways. GUDMAP [<xref ref-type="bibr" rid="CR25">25</xref>] is a database of gene expression in the mouse urogenital system. It employs the <italic>derives_from</italic> and <italic>differentiates_into</italic> relationships as links between the tissue summary pages with include gene expression data. This enables a user examining data annotated with &#x201C;early distal tubule&#x201D; to follow the <italic>differentiates_into</italic> relationship to data annotated with &#x201C;renal distal tubule&#x201D;.</p></list-item><list-item><p><italic>Structural relationships:</italic> Structural relationships allow a resource to present knowledge specific to an anatomical context. For example, the Virtual Fly Brain [<xref ref-type="bibr" rid="CR26">26</xref>] provides an interface that uses the <italic>has_presynaptic_terminal_in</italic> and <italic>has_postsynaptic_terminal_in</italic> relationships for nerves in the <italic>Drosophila</italic> Anatomy Ontology [<xref ref-type="bibr" rid="CR27">27</xref>]. For example, when viewing the medulla in the atlas, lists are generated for neurons with presynaptic and postsynaptic terminals the medulla. Producing the list of neurons requires two types of knowledge from the ontology: (a) which anatomical structures are <italic>part_of</italic> the medulla, (b) each neuron that <italic>has_presynaptic_terminal_in</italic> or <italic>has_postsynaptic_terminal_in</italic> those parts.</p></list-item></list></p>
        <p>Ontologies also provide an opportunity to link resources to each other. For example, each anatomical term in the Zebrafish Anatomy Portal (ZFAP) [<xref ref-type="bibr" rid="CR28">28</xref>] is linked to a page in ZFIN [<xref ref-type="bibr" rid="CR29">29</xref>] that defines the term and provides ontological relationships.</p>
      </sec>
      <sec id="Sec6">
        <title>Spatial representation: 2D and 3D graphics</title>
        <p>The atlases and databases in this survey demonstrate several ways that spatial representation of anatomy can be enhanced in a web-based resource:<list list-type="bullet"><list-item><p><italic>Graphics of developmental stages:</italic> The process of development can be studied only if it is represented in ways that are sufficiently rich in detail and reasonably standardized &#x2014; a challenge as old as embryology itself [<xref ref-type="bibr" rid="CR30">30</xref>]. Web-based atlases are able to represent spatial structure and time-based processes in way that traditional print-based resources cannot. For example, the Four-dimensional Ascidian Body Atlas (FABA) [<xref ref-type="bibr" rid="CR31">31</xref>] defines stages for <italic>C. intestinalis</italic> with confocal image stacks and time-lapse movies, and the e-Mouse Atlas provides 3D reconstructions of embryos for many Theiler stages. Standardization of annotation for developmental stages is necessary for sharing data among laboratories, and atlases provide an easy way to access stage descriptions.</p></list-item><list-item><p><italic>High-resolution histological sections:</italic> Glass histology slides have long been used for studying histology. Virtual slides are created by scanning and digitizing glass slides, and the experience of using a microscope is simulated through web applications that allow zooming and panning of the image. Virtual slides are provided by the Zebrafish Atlas [<xref ref-type="bibr" rid="CR32">32</xref>] and e-Mouse Atlas [<xref ref-type="bibr" rid="CR33">33</xref>].</p></list-item><list-item><p><italic>Visual representation of ontological terms:</italic> Web-based resources provide an environment in which to link semantic and spatial representations of anatomical structures. For example, the Allen Developing Mouse Brain Atlas [<xref ref-type="bibr" rid="CR34">34</xref>] and the Virtual Fly Brain [<xref ref-type="bibr" rid="CR26">26</xref>] provide linked term-and-graphic windows that provide a view of both the ontology used and structures annotated with those terms. The Zebrafish Anatomy Portal (ZFAP) [<xref ref-type="bibr" rid="CR28">28</xref>] provides a search function that takes a term from the Zebrafish Anatomy Ontology and returns planes of reconstructions from optical projection tomography (OPT) scans labeled with the term.</p></list-item><list-item><p><italic>Correlating spatial data among specimens and experiments:</italic> For gene expression patterns to be useful, they must be annotated in a way that allows users to find genes that are expressed in regions of interest and to study co-expression patterns. Four methods are used to annotate expression patterns within the resources surveyed: (a) The first method is manual annotation of each specimen using terms from a controlled vocabulary or ontology. This method enables only text-based queries, and will be inaccurate where expression patterns do not correspond to the borders of defined anatomical regions. (b) The second approach relies on computational annotation and preserves the spatial nature of the data. In this approach, the expression pattern of each specimen is registered to a stage-matched standard volume through spatial warping enabling spatial queries to be performed across the dataset. This is used by the e-Mouse Atlas of Gene Expression (EMAGE) [<xref ref-type="bibr" rid="CR19">19</xref>] (as described in [<xref ref-type="bibr" rid="CR35">35</xref>]) and Allen Developing Mouse Brain Atlas [<xref ref-type="bibr" rid="CR34">34</xref>] (as described in [<xref ref-type="bibr" rid="CR36">36</xref>]). (c) A third approach, used by XenMARK [<xref ref-type="bibr" rid="CR37">37</xref>], relies on a manual annotation process in which specimen expression patterns are drawn onto stage-specific schematic diagrams [<xref ref-type="bibr" rid="CR38">38</xref>]. This method avoids the computational complexity of spatial warping, but allows spatial searches from the schematics. (d) A fourth approach is to compute similarity scores between pairs of images, instead of mapping to a stage-specific standard. This method is used by FlyExpress [<xref ref-type="bibr" rid="CR39">39</xref>] on sets of 2D images of <italic>Drosophila</italic> embryos that are uniformly oriented and assayed under the same conditions [<xref ref-type="bibr" rid="CR40">40</xref>].</p></list-item></list></p>
      </sec>
      <sec id="Sec7">
        <title>Patterns for interface design</title>
        <p>In order to document and generalize the approaches for conveying information about anatomy that are used in these atlas and databases, I compiled a set of patterns. Patterns are reusable solutions to design problems, and are of great interest in interface design [<xref ref-type="bibr" rid="CR41">41</xref>]. The patterns I have identified focus on graphic representation, user interaction, and navigation.</p>
        <p>From the anatomical atlases I identified a total of 23 design patterns, shown in Figs.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>, <xref rid="Fig4" ref-type="fig">4</xref>, <xref rid="Fig5" ref-type="fig">5</xref> and <xref rid="Fig6" ref-type="fig">6</xref>. These patterns provide methods for displaying graphics, integrating semantic and spatial representations, and organizing atlas information. They are grouped into eight categories:<fig id="Fig3"><label>Fig. 3</label><caption><p>Interface design patterns for displaying 2D graphics and sectional graphics</p></caption><graphic xlink:href="12861_2016_116_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Interface design patterns for displaying 3D graphics and labeling graphics</p></caption><graphic xlink:href="12861_2016_116_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>Interface design patterns for presenting topic-focused information and defining anatomical terms</p></caption><graphic xlink:href="12861_2016_116_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig. 6</label><caption><p>Interface design patterns for organizing information about developmental stages and describing development using graphical methods</p></caption><graphic xlink:href="12861_2016_116_Fig6_HTML" id="MO6"/></fig><list list-type="bullet"><list-item><p>Displaying 2D graphics</p></list-item><list-item><p>Displaying sectional graphics</p></list-item><list-item><p>Displaying 3D graphics</p></list-item><list-item><p>Labeling graphics</p></list-item><list-item><p>Presenting topic-focused information</p></list-item><list-item><p>Defining anatomical terms</p></list-item><list-item><p>Organizing information about developmental stages</p></list-item><list-item><p>Describing development using graphical methods</p></list-item></list></p>
        <p>Each pattern has a title, description, examples of use, and simple pictorial representation. For example, one pattern in the category of &#x201C;Displaying 2D graphics&#x201D; is &#x201C;Overview plus detail.&#x201D; This pattern pairs a small overview graphic with a large zoomable graphic. A box on the small graphic indicates the region shown in the zoomable graphic. This pattern can be used when high-resolutions graphics are available and it is important to allow the user to zoom into details. This pattern is used within the e-Mouse Atlas [<xref ref-type="bibr" rid="CR33">33</xref>], Virtual Fly Brain [<xref ref-type="bibr" rid="CR26">26</xref>], WormAtlas (SlidableWorm) [<xref ref-type="bibr" rid="CR42">42</xref>], and Zebrafish Atlas [<xref ref-type="bibr" rid="CR32">32</xref>].</p>
        <p>From the gene expression atlases and databases I identified 13 patterns that provide methods for querying databases to find genes expressed in anatomical structures and display the results. These patterns are shown in Figs.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref> and <xref rid="Fig8" ref-type="fig">8</xref>, and are grouped into four categories:<fig id="Fig7"><label>Fig. 7</label><caption><p>Interface design patterns for textual and graphical methods of querying a gene expression database</p></caption><graphic xlink:href="12861_2016_116_Fig7_HTML" id="MO7"/></fig><fig id="Fig8"><label>Fig. 8</label><caption><p>Interface design patterns for displaying query results from a gene expression database and explaining anatomical annotations</p></caption><graphic xlink:href="12861_2016_116_Fig8_HTML" id="MO8"/></fig><list list-type="bullet"><list-item><p>Providing textual methods for querying a gene expression database</p></list-item><list-item><p>Providing graphical methods for querying a gene expression database</p></list-item><list-item><p>Displaying query results from a gene expression database</p></list-item><list-item><p>Explaining anatomical annotations in a query result item</p></list-item></list></p>
        <p>A few of the patterns that I present here have been previously identified in other pattern collections. In these cases I have retained the names given by previous authors (for example, &#x201C;Overview plus detail&#x201D;, &#x201C;Autocompletion&#x201D;, and &#x201C;Thumbnail grid&#x201C;) [<xref ref-type="bibr" rid="CR41">41</xref>].</p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Discussion</title>
      <p>This collection of design patterns can be used as a catalyst for conversations between biologists and software developers. Because they provide a user-focused perspective, they can support discussions of methods for exploring and retrieving anatomically-based information and can serve as building blocks for interface specifications.</p>
      <p>The patterns also help to clarify how interface functionality is constrained by the investment in semantic and spatial standardization. For example, one of the most intuitive ways to query a gene expression pattern database is by specifying a point or region on a standardized image, but this requires that the expression data have been mapped to a spatial standard.</p>
      <p>This work documents the variety of ways anatomical information has been communicated in online atlases and databases. Part of this variability is due to differences in the types of data available, purposes of the resources, and the characteristics of the organism. But it also reflects the large number of design solutions that are possible. Because this survey did not include resources presented as downloadable software, there are likely to be additional patterns for representing anatomy.</p>
      <sec id="Sec9">
        <title>Using the patterns to support user needs</title>
        <p>When applied to developing or expanding a particular online resource, this work should be considered in the context of two important considerations: &#x201C;What are the information needs of the users?&#x201D; and &#x201C;What information assets are available to use in building the resource?&#x201D; The patterns act as intermediaries between the users&#x2019; questions and the information assets. Figure&#xA0;<xref rid="Fig9" ref-type="fig">9</xref> provides a scenario that uses ten of the patterns in an imagined resource. This resource provides an anatomical atlas and gene expression database, and uses information assets including an ontology (serving as the semantic standard), spatial standards, a graphics collection, and gene expression data. In this scenario, user needs include obtaining information about the meaning of anatomical terms and finding data related to development of a particular anatomical structure.<fig id="Fig9"><label>Fig. 9</label><caption><p>Scenario for an online resource combining an anatomical atlas with gene expression data. Questions by users (in thought clouds) serve as entry points to pages using the design patterns. Arrows represent links between pages using different patterns. Four types of information assets (an ontology, spatial standards, graphics collection, and gene expression data) are shown in the center. Lines extending from the information assets indicate some of the patterns that incorporate those assets</p></caption><graphic xlink:href="12861_2016_116_Fig9_HTML" id="MO9"/></fig></p>
      </sec>
      <sec id="Sec10">
        <title>Designing for new types of data</title>
        <p>Looking to the future, standardized spatial representations will be key to communicating and integrating new types of data. Emerging techniques for &#x201C;spatially resolved omics&#x201D; [<xref ref-type="bibr" rid="CR43">43</xref>] provide high-throughput measurements of gene expressions while preserving detailed spatial information. For example, microtomy sequencing provides gene expression data from individual cryosections of a specimen. Recent work with zebrafish embryos extends this approach by analyzing data from embryos sectioned along orthogonal body axes using image reconstruction algorithms to produce 3D expression patterns&#x2014;a technique called RNA tomography (or tomo-seq) [<xref ref-type="bibr" rid="CR44">44</xref>].</p>
        <p>The detailed spatial data produced by large-scale gene expression studies are unlikely to correspond to traditionally defined regions of anatomy. Therefore, standardized spatial representations of model organisms will need to serve as a mediator between the data collected by laboratories and the users of community databases. In this scenario, investigators will not annotate their data with semantic annotations. Rather, they will map their data to standard spatial representations. The role of semantic representations will be to serve as references to regions of the models and logical links between models at different stages or at different spatial scales. This will integrate disparate data at the level of spatial representation, while preserving the usefulness of semantic representations for filtering, searching, and browsing data.</p>
      </sec>
    </sec>
    <sec id="Sec11">
      <title>Conclusions</title>
      <p>This work highlights issues important for the continued evolution of online resources for developmental biology. If resources are to be effective in helping researchers to locate data relevant to their questions and to generate hypotheses, they must provide a structure that allows researchers to navigate within the space-scale-time matrix depicted in Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, as well as to explore homologous structures across different species. This next generation of resources&#x2014;perhaps better described as web portals&#x2014;will provide access to not only information from different laboratories stored within a single repository, but to information distributed across different repositories. These web portals (and perhaps networks of interlinked web portals) will rely on tightly integrated semantic and spatial representation, using anatomy as a framework for data integration, organization and navigation.</p>
      <p>As model organism communities move toward the goal of building a comprehensive understanding of development, the role of these web portals is crucial. They will serve both to document collective knowledge from previous work and to provide the infrastructure that enables future work. Achieving this vision will require not only advances in web and imaging technology, but careful consideration of semantic and spatial representation and research to design usable and intuitive interfaces. In order for these tools to meet the needs of biologists, biologists must partner with computer science, informatics, and design researchers.</p>
    </sec>
    <sec id="Sec12">
      <title>Methods</title>
      <p>The atlases and databases surveyed in this work were identified through keyword searches of the Science Direct, Scopus, and PubMed databases. The keywords used were <italic>atlas</italic> or <italic>database</italic> in combination with <italic>Arbacia, Caenorhabditis elegans, chick, chicken, Ciona, Danio rerio, Drosophila, fly, frog, Gallus gallus, medaka, mouse, Mus musculus, nematode, Oryzias latipes, rat, Rattus norvegicus, sea squirt, sea urchin, Strongylocentrotus, Xenopus,</italic> or <italic>zebrafish</italic>. Several additional atlases and databases were identified based on URL links within these resources. Keyword searches were performed on 26 July 2014 and 9 Oct 2015.</p>
      <p>Resources included in this survey are (a) described in a peer-reviewed journal article, (b) publicly available, (c) delivered on the web without requiring download, and (d) in English. In addition, a resource must have been available on at least one of the dates of testing (26 July 2014, 4 Aug 2014, 6 Sept 2014, and 9 Oct 2015). If a resources consists of both online material and downloadable material, only the online material was included in this survey. Two resources became unavailable during the course of this project (EMBRYS and GEMS). These are included in the survey, but their unavailability is noted with their URLs in Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>.</p>
      <p>Resources were excluded if they are primarily (a) databases of microarray data, (b) collections of figures from journal articles, (c) collections of graphics or movies with little or no annotation of anatomical structures, or (d) textbook-like resources with limited navigation structure. This work is limited to model organisms, and therefore resources for human anatomy and development are excluded.</p>
      <p>All resources were viewed using operating system Mac OSX 10.9.5 with Java 1.8.0 and the Firefox 41.0 browser. Components provided as self-signed Java applications were excluded from this survey due to security risks.</p>
    </sec>
    <sec id="Sec13">
      <title>Ethics approval and consent to participate</title>
      <p>Not applicable.</p>
    </sec>
    <sec id="Sec14">
      <title>Consent for publication</title>
      <p>Not applicable.</p>
    </sec>
    <sec id="Sec15" sec-type="materials|methods">
      <title>Availability of data and material</title>
      <p>This study did not generate datasets.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>2D</term>
          <def>
            <p>two dimensional</p>
          </def>
        </def-item>
        <def-item>
          <term>3D</term>
          <def>
            <p>three dimensional</p>
          </def>
        </def-item>
        <def-item>
          <term>DIC</term>
          <def>
            <p>differential inference contrast</p>
          </def>
        </def-item>
        <def-item>
          <term>OPT</term>
          <def>
            <p>optical projection tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>ssTEM</term>
          <def>
            <p>serial section transmission electron micrograph</p>
          </def>
        </def-item>
        <def-item>
          <term>TEM</term>
          <def>
            <p>transmission electron micrograph</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The author declares she has no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>All work was performed by M.C.</p>
      </fn>
    </fn-group>
    <ack>
      <sec id="FPar1">
        <title>Funding</title>
        <p>The author received no funding for this work.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Boer</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Ruijter</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Voorbraak</surname>
              <given-names>FPJM</given-names>
            </name>
            <name>
              <surname>Moorman</surname>
              <given-names>AFM</given-names>
            </name>
          </person-group>
          <article-title>More than a decade of developmental gene expression atlases: where are we now?</article-title>
          <source>Nucleic Acids Res</source>
          <year>2009</year>
          <volume>37</volume>
          <fpage>7349</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkp819</pub-id>
          <pub-id pub-id-type="pmid">19822576</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geffers</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Herrmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Eichele</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Web-based digital gene expression atlases for the mouse</article-title>
          <source>Mamm Genome</source>
          <year>2012</year>
          <volume>23</volume>
          <fpage>525</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="doi">10.1007/s00335-012-9413-3</pub-id>
          <pub-id pub-id-type="pmid">22936000</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baldock</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>What&#x2019;s New? A real mouse for your computer</article-title>
          <source>Bioessays</source>
          <year>1992</year>
          <volume>14</volume>
          <fpage>501</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="doi">10.1002/bies.950140713</pub-id>
          <pub-id pub-id-type="pmid">1445290</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bult</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Data integration standards in model organisms: from genotype to phenotype in the laboratory mouse</article-title>
          <source>TARGETS</source>
          <year>2002</year>
          <volume>1</volume>
          <fpage>163</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/S1477-3627(02)02215-8</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leonilli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ankeny</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Re-thinking organisms: the impact of databases on model organism biology</article-title>
          <source>Stud Hist Phil Biol Biomed Sci</source>
          <year>2012</year>
          <volume>43</volume>
          <fpage>29</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1016/j.shpsc.2011.10.003</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ashburner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Blake</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Botstein</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Cherry</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gene Ontology: tool for the unification of biology</article-title>
          <source>Nat Genet</source>
          <year>2000</year>
          <volume>25</volume>
          <fpage>25</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1038/75556</pub-id>
          <pub-id pub-id-type="pmid">10802651</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hill</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Berardini</surname>
              <given-names>TZ</given-names>
            </name>
            <name>
              <surname>Howe</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Van Auken</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>Representing ontogeny through ontology: a developmental biologist&#x2019;s guide to the gene ontology</article-title>
          <source>Mol Reprod Dev</source>
          <year>2010</year>
          <volume>77</volume>
          <fpage>314</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">19921742</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>W-P</given-names>
            </name>
            <name>
              <surname>Tzou</surname>
              <given-names>W-S</given-names>
            </name>
          </person-group>
          <article-title>Computational methods for discovering gene networks from expression data</article-title>
          <source>Brief Bioinform</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>408</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">19505889</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boline</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Digital atlases as a framework for data sharing</article-title>
          <source>Front Neurosci</source>
          <year>2008</year>
          <volume>2</volume>
          <fpage>100</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.3389/neuro.01.012.2008</pub-id>
          <pub-id pub-id-type="pmid">18982112</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Husz</surname>
              <given-names>ZL</given-names>
            </name>
            <name>
              <surname>Burton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Milyaev</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Baldock</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Web tools for large-scale 3D biological images and atlases</article-title>
          <source>BMC Bioinformatics</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>122</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2105-13-122</pub-id>
          <pub-id pub-id-type="pmid">22676296</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ruffins</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Sane</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Toga</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>MBAT: a scalable informatics system for unifying digital atlasing workflows</article-title>
          <source>BMC Bioinformatics</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>608</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2105-11-608</pub-id>
          <pub-id pub-id-type="pmid">21176225</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bakker</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tiesinga</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>K&#xF6;tter</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The Scalable Brain Atlas: instant web-based access to public brain atlases and related content</article-title>
          <source>Neuroinformatics</source>
          <year>2015</year>
          <volume>13</volume>
          <fpage>353</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1007/s12021-014-9258-x</pub-id>
          <pub-id pub-id-type="pmid">25682754</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fowlkes</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Hendriks</surname>
              <given-names>CLL</given-names>
            </name>
            <name>
              <surname>Ker&#xE4;nen</surname>
              <given-names>SVE</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>R&#xFC;bel</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>M-Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A quantitative spatiotemporal atlas of gene expression in the <italic>Drosophila</italic> blastoderm</article-title>
          <source>Cell</source>
          <year>2008</year>
          <volume>133</volume>
          <fpage>364</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2008.01.053</pub-id>
          <pub-id pub-id-type="pmid">18423206</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>E-F</given-names>
            </name>
            <name>
              <surname>Boline</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Toga</surname>
              <given-names>AW</given-names>
            </name>
          </person-group>
          <article-title>A high-resolution anatomical framework of the neonatal mouse brain for managing gene expression data</article-title>
          <source>Front Neuroinform</source>
          <year>2007</year>
          <volume>1</volume>
          <fpage>6</fpage>
          <pub-id pub-id-type="doi">10.3389/neuro.11.006.2007</pub-id>
          <pub-id pub-id-type="pmid">18974801</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Munzner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>DePace</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pfister</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>MulteeSum: a tool for comparative spatial and temporal gene expression data</article-title>
          <source>IEEE Trans Vis Comput Graph</source>
          <year>2010</year>
          <volume>16</volume>
          <fpage>908</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="doi">10.1109/TVCG.2010.137</pub-id>
          <pub-id pub-id-type="pmid">20975127</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>van Hemert</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Baldock</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Automatically identifying and annotating mouse embryo gene expression patterns</article-title>
          <source>Bioinformatics</source>
          <year>2011</year>
          <volume>27</volume>
          <fpage>1101</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btr105</pub-id>
          <pub-id pub-id-type="pmid">21357576</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boehm</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rautschka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Quintana</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Raspopovic</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jan</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sharpe</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A landmark-free morphometric staging system for the mouse limb bud</article-title>
          <source>Development</source>
          <year>2011</year>
          <volume>138</volume>
          <fpage>1227</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.057547</pub-id>
          <pub-id pub-id-type="pmid">21307091</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van Eede</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Spring</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jevtic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Boughner</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Lerch</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>4D atlas of the mouse embryo for precise morphological staging</article-title>
          <source>Development</source>
          <year>2015</year>
          <volume>142</volume>
          <fpage>3583</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.125872</pub-id>
          <pub-id pub-id-type="pmid">26487781</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="other">EMAGE. <ext-link ext-link-type="uri" xlink:href="http://www.emouseatlas.org/emage/home.php">http://www.emouseatlas.org/emage/home.php</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <mixed-citation publication-type="other">Jackson Laboratory. Mouse Gene Expression Database. <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/gxd">http://www.informatics.jax.org/gxd</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayamizu</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Wicks</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Burger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ringwald</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baldock</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>EMAP/EMAPA ontology of mouse developmental anatomy: 2013 update</article-title>
          <source>J Biomed Semantics</source>
          <year>2013</year>
          <volume>4</volume>
          <fpage>15</fpage>
          <pub-id pub-id-type="doi">10.1186/2041-1480-4-15</pub-id>
          <pub-id pub-id-type="pmid">23972281</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayamizu</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Mangan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Corradi</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Kadin</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Ringwald</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The Adult Mouse Anatomical Dictionary: a tool for annotating and integrating data</article-title>
          <source>Genome Biol</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>R:29</fpage>
          <pub-id pub-id-type="doi">10.1186/gb-2005-6-3-r29</pub-id>
          <pub-id pub-id-type="pmid">15774030</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="other">Xenbase. <ext-link ext-link-type="uri" xlink:href="http://www.xenbase.org/entry">http://www.xenbase.org/entry</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Segerdell</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ponferrada</surname>
              <given-names>VG</given-names>
            </name>
            <name>
              <surname>James-Zorn</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Fortriede</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Dahdul</surname>
              <given-names>WM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Enhanced XAO: the ontology of <italic>Xenopus</italic> anatomy and development underpins more accurate annotation of gene expression and queries on Xenbase</article-title>
          <source>J Biomed Semantics</source>
          <year>2013</year>
          <volume>4</volume>
          <fpage>31</fpage>
          <pub-id pub-id-type="doi">10.1186/2041-1480-4-31</pub-id>
          <pub-id pub-id-type="pmid">24139024</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <mixed-citation publication-type="other">GUDMAP Consortium. GUDMAP: Genitourinary Development Molecular Anatomy Project. <ext-link ext-link-type="uri" xlink:href="http://www.gudmap.org/">http://www.gudmap.org</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="other">Armstrong D, Milyaev N, Osumi-Sutherland D, Reeve S, Costa M, O&#x2019;Kane C, et al. Virtual Fly Brain. <ext-link ext-link-type="uri" xlink:href="http://www.virtualflybrain.org/">http://www.virtualflybrain.org</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Reeve</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Grumbling</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Osumi-Sutherland</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The <italic>Drosophila</italic> anatomy ontology</article-title>
          <source> J Biomed Semantics</source>
          <year>2013</year>
          <volume>4</volume>
          <fpage>32</fpage>
          <pub-id pub-id-type="doi">10.1186/2041-1480-4-32</pub-id>
          <pub-id pub-id-type="pmid">24139062</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <mixed-citation publication-type="other">Salgado D, Currie P, Marcelle C, Bryson-Richardons R. ZebraFish Anatomy Portal (ZFAP). <ext-link ext-link-type="uri" xlink:href="http://zebrafish.anatomyportal.org/">http://zebrafish.anatomyportal.org</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <mixed-citation publication-type="other">ZFIN: The Zebrafish Model Organism Database. <ext-link ext-link-type="uri" xlink:href="http://zfin.org/">http://zfin.org</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hopwood</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>A history of normal plates, tables and stages in vertebrate embryology</article-title>
          <source>Int J Dev Biol</source>
          <year>2007</year>
          <volume>51</volume>
          <fpage>1</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1387/ijdb.062189nh</pub-id>
          <pub-id pub-id-type="pmid">17183461</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <mixed-citation publication-type="other">FABA: Four-dimensional Ascidian Body Atlas. <ext-link ext-link-type="uri" xlink:href="http://tunicate-portal.org/faba/1.4/top.html">http://tunicate-portal.org/faba/1.4/top.html</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <mixed-citation publication-type="other">Jake Gittlen Cancer Research Foundation. Zebrafish Atlas. <ext-link ext-link-type="uri" xlink:href="http://bio-atlas.psu.edu/zf">http://bio-atlas.psu.edu/zf</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <mixed-citation publication-type="other">EMAP: The e-Mouse Atlas Project. <ext-link ext-link-type="uri" xlink:href="http://www.emouseatlas.org/emap/home.html">http://www.emouseatlas.org/emap/home.html</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <mixed-citation publication-type="other">Allen Institute for Brain Science. Allen Developing Mouse Brain Atlas. <ext-link ext-link-type="uri" xlink:href="http://developingmouse.brain-map.org/">http://developingmouse.brain-map.org</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hill</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Baldock</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Constrained distance transforms for spatial atlas registration</article-title>
          <source>BMC Bioinformatics</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>90</fpage>
          <pub-id pub-id-type="doi">10.1186/s12859-015-0504-5</pub-id>
          <pub-id pub-id-type="pmid">25887037</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lein</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Hawrylycz</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Ao</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ayres</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bensinger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bernard</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide atlas of gene expression in the adult mouse brain</article-title>
          <source>Nature</source>
          <year>2007</year>
          <volume>445</volume>
          <fpage>168</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1038/nature05453</pub-id>
          <pub-id pub-id-type="pmid">17151600</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <mixed-citation publication-type="other">XenMARK. <ext-link ext-link-type="uri" xlink:href="http://genomics.crick.ac.uk/apps/XenMARK">http://genomics.crick.ac.uk/apps/XenMARK</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilchrist</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Christensen</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Bronchain</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Brunet</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Chesneau</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fenger</surname>
              <given-names>U</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Database of queryable gene expression patterns for <italic>Xenopus</italic></article-title>
          <source>Dev Dyn</source>
          <year>2009</year>
          <volume>238</volume>
          <fpage>1379</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="doi">10.1002/dvdy.21940</pub-id>
          <pub-id pub-id-type="pmid">19347954</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <mixed-citation publication-type="other">FlyExpress. <ext-link ext-link-type="uri" xlink:href="http://www.flyexpress.net/">http://www.flyexpress.net</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Konikoff</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Karr</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>McCutchan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Newfeld</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Comparison of embryonic expression within multigene families using the FlyExpress discovery platform reveals more spatial than temporal divergence</article-title>
          <source>Dev Dyn</source>
          <year>2012</year>
          <volume>241</volume>
          <fpage>150</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1002/dvdy.22749</pub-id>
          <pub-id pub-id-type="pmid">21960044</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <mixed-citation publication-type="other">Tidwell J. Designing interfaces. second edition. O&#x2019;Reilly Media; 2011.</mixed-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <mixed-citation publication-type="other">Altun ZF, Herndon LA, Crocker C, Lints R, Hall DH. WormAtlas. <ext-link ext-link-type="uri" xlink:href="http://wormatlas.org/">http://wormatlas.org</ext-link>. Accessed 25 Mar 2015.</mixed-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crosetto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bienko</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van Oudenaarden</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Spatially resolved transcriptomics and beyond</article-title>
          <source>Nat Rev Genet</source>
          <year>2014</year>
          <volume>16</volume>
          <fpage>57</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1038/nrg3832</pub-id>
          <pub-id pub-id-type="pmid">25446315</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Junker</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>No&#xEB;l</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Guryev</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Huisken</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome-wide RNA tomography in the zebrafish embryo</article-title>
          <source>Cell</source>
          <year>2014</year>
          <volume>159</volume>
          <fpage>662</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.038</pub-id>
          <pub-id pub-id-type="pmid">25417113</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>The</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Worm</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title><italic>C. elegans,</italic> Worm Atlas, Worm Image and the Slidable Worm: from the webpage to the classroom</article-title>
          <source>Microsc Microanal</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>208</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yook</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Bieri</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cabunoc</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>WJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>WormBase 2012: more genomes, more data, new website</article-title>
          <source>Nucleic Acids Res</source>
          <year>2012</year>
          <volume>40</volume>
          <fpage>D735</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkr954</pub-id>
          <pub-id pub-id-type="pmid">22067452</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brozovic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dantec</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dauga</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mendez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Simion</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ANISEED 2015: a digital framework for the comparative developmental biology of ascidians</article-title>
          <source>Nucleic Acids Res</source>
          <year>2016</year>
          <volume>44</volume>
          <fpage>D808</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkv966</pub-id>
          <pub-id pub-id-type="pmid">26420834</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tassy</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Dauga</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Daian</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sobral</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Robin</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Khoueiry</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The ANISEED database: digital representation, formalization, and elucidation of a chordate developmental program</article-title>
          <source>Genome Res</source>
          <year>2010</year>
          <volume>20</volume>
          <fpage>1459</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.108175.110</pub-id>
          <pub-id pub-id-type="pmid">20647237</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hotta</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mitsuhara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Inaba</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Oka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gojobori</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A web-based interactive developmental table for the ascidian <italic>Ciona intestinalis</italic>, including 3D real-image embryo reconstructions: I. From fertilized egg to hatching larva</article-title>
          <source>Dev Dyn</source>
          <year>2007</year>
          <volume>236</volume>
          <fpage>1790</fpage>
          <lpage>805</lpage>
          <pub-id pub-id-type="doi">10.1002/dvdy.21188</pub-id>
          <pub-id pub-id-type="pmid">17557317</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buchon</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Osman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>David</surname>
              <given-names>FPA</given-names>
            </name>
            <name>
              <surname>Yu Fang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Boquete</surname>
              <given-names>J-P</given-names>
            </name>
            <name>
              <surname>Deplancke</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Morphological and molecular characterization of adult midgut compartmentalization in <italic>Drosophila</italic></article-title>
          <source>Cell Rep</source>
          <year>2013</year>
          <volume>3</volume>
          <fpage>1725</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2013.04.001</pub-id>
          <pub-id pub-id-type="pmid">23643535</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Milyaev</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Osumi-Sutherland</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Reeve</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Burton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Baldock</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>The Virtual Fly Brain browser and query interface</article-title>
          <source>Bioinformatics</source>
          <year>2012</year>
          <volume>28</volume>
          <fpage>411</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btr677</pub-id>
          <pub-id pub-id-type="pmid">22180411</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Isogai</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Naruse</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Anatomical atlas of blood vascular system of medaka</article-title>
          <source>Medaka: A model organism for organogenesis, human disease, and evolution</source>
          <year>2011</year>
          <publisher-loc>Tokyo</publisher-loc>
          <publisher-name>Springer Japan</publisher-name>
          <fpage>95</fpage>
          <lpage>109</lpage>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fujita</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Isogai</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kudo</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Vascular anatomy of the developing medaka, <italic>Oryzias latipes</italic>: a complementary fish model for cardiovascular research on vertebrates</article-title>
          <source>Dev Dyn</source>
          <year>2006</year>
          <volume>235</volume>
          <fpage>734</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="doi">10.1002/dvdy.20696</pub-id>
          <pub-id pub-id-type="pmid">16450400</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sunkin</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dolbeare</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gilbert</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>CL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Allen Brain Atlas: an integrated spatio-temporal portal for exploring the central nervous system</article-title>
          <source>Nucleic Acids Res</source>
          <year>2013</year>
          <volume>41</volume>
          <fpage>D996</fpage>
          <lpage>1008</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gks1042</pub-id>
          <pub-id pub-id-type="pmid">23193282</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <mixed-citation publication-type="other">Allen Institute for Brain Science. Technical white paper: Reference atlases for the Allen Developing Mouse Brain Atlas. 2010. <ext-link ext-link-type="uri" xlink:href="http://developingmouse.brain-map.org/docs/ReferenceAtlas.pdf">http://developingmouse.brain-map.org/docs/ReferenceAtlas.pdf</ext-link></mixed-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armit</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Baldock</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>eMouseAtlas informatics: embryo atlas and gene expression database</article-title>
          <source>Mamm Genome</source>
          <year>2015</year>
          <volume>26</volume>
          <fpage>431</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="doi">10.1007/s00335-015-9596-5</pub-id>
          <pub-id pub-id-type="pmid">26296321</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richardson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Burton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Roochun</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Armit</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Developing the eHistology Atlas</article-title>
          <source>Database</source>
          <year>2015</year>
          <volume>2015</volume>
          <fpage>bav105</fpage>
          <pub-id pub-id-type="doi">10.1093/database/bav105</pub-id>
          <pub-id pub-id-type="pmid">26500249</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Armit</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Venkataraman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>eMouseAtlas, EMAGE, and the spatial dimension of the transcriptome</article-title>
          <source>Mamm Genome</source>
          <year>2012</year>
          <volume>23</volume>
          <fpage>514</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="doi">10.1007/s00335-012-9407-1</pub-id>
          <pub-id pub-id-type="pmid">22847374</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baldock</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Bard</surname>
              <given-names>JBL</given-names>
            </name>
            <name>
              <surname>Burger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Burton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Christiansen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EMAP and EMAGE: a framework for understanding spatially organized data</article-title>
          <source>Neuroinformatics</source>
          <year>2003</year>
          <volume>1</volume>
          <fpage>309</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1385/NI:1:4:309</pub-id>
          <pub-id pub-id-type="pmid">15043218</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davidson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baldock</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The Mouse Atlas Database: a community resource for mouse development</article-title>
          <source>Trends Genet</source>
          <year>2001</year>
          <volume>17</volume>
          <fpage>49</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1016/S0168-9525(00)02167-3</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Baldock</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Dubreuil</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Letovsky</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The Edinburgh Mouse Atlas: basic structure and informatics</article-title>
          <source>Bioinformatics: Databases and Systems</source>
          <year>1999</year>
          <publisher-loc>Boston</publisher-loc>
          <publisher-name>Kluwer Academic Publishers</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eames</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>DeLaurier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ullmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Huycke</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Nichols</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Dowd</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>FishFace: interactive atlas of zebrafish craniofacial development at cellular resolution</article-title>
          <source>BMC Dev Biol</source>
          <year>2013</year>
          <volume>13</volume>
          <fpage>23</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-213X-13-23</pub-id>
          <pub-id pub-id-type="pmid">23714426</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bryson-Richardson</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schilling</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>FishNet: an online database of zebrafish anatomy</article-title>
          <source>BMC Biol</source>
          <year>2007</year>
          <volume>5</volume>
          <fpage>34</fpage>
          <pub-id pub-id-type="doi">10.1186/1741-7007-5-34</pub-id>
          <pub-id pub-id-type="pmid">17705855</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Isogai</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Horiguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Weinstein</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development</article-title>
          <source>Dev Biol</source>
          <year>2001</year>
          <volume>230</volume>
          <fpage>278</fpage>
          <lpage>301</lpage>
          <pub-id pub-id-type="doi">10.1006/dbio.2000.9995</pub-id>
          <pub-id pub-id-type="pmid">11161578</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salgado</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Marcelle</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Currie</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Bryson-Richardson</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>The Zebrafish Anatomy Portal: a novel integrated resource to facilitate zebrafish research</article-title>
          <source>Dev Biol</source>
          <year>2012</year>
          <volume>372</volume>
          <fpage>1</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ydbio.2012.08.031</pub-id>
          <pub-id pub-id-type="pmid">22981871</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>KC</given-names>
            </name>
          </person-group>
          <article-title>A life-span atlas for the zebrafish</article-title>
          <source>Zebrafish</source>
          <year>2004</year>
          <volume>1</volume>
          <fpage>69</fpage>
          <pub-id pub-id-type="doi">10.1089/zeb.2004.1.69</pub-id>
          <pub-id pub-id-type="pmid">18248218</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cubbage</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Mabee</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Development of the cranium and paired fins in the zebrafish <italic>Danio rerio</italic> (Ostariophysi, Cyprinidae)</article-title>
          <source>J Morphol</source>
          <year>1996</year>
          <volume>229</volume>
          <fpage>121</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-4687(199608)229:2&lt;121::AID-JMOR1&gt;3.0.CO;2-4</pub-id>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shinomiya</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Boyan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hartenstein</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A systematic nomenclature for the insect brain</article-title>
          <source>Neuron</source>
          <year>2014</year>
          <volume>81</volume>
          <fpage>755</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2013.12.017</pub-id>
          <pub-id pub-id-type="pmid">24559671</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hunt-Newbury</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Viveiros</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Johnsen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mah</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Anastas</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High-throughput in vivo analysis of gene expression in <italic>Caenorhabditis elegans</italic></article-title>
          <source>PLoS Biol</source>
          <year>2007</year>
          <volume>5</volume>
          <fpage>e237</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pbio.0050237</pub-id>
          <pub-id pub-id-type="pmid">17850180</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Baran</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bieri</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cabunoc</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>WJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>WormBase 2014: new views of curated biology</article-title>
          <source>Nucleic Acids Res</source>
          <year>2014</year>
          <volume>42</volume>
          <fpage>D789</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkt1063</pub-id>
          <pub-id pub-id-type="pmid">24194605</pub-id>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Antin</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Yatskievych</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Davey</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Darnell</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
          <article-title>GEISHA: an evolving gene expression resource for the chicken embryo</article-title>
          <source>Nucleic Acids Res</source>
          <year>2014</year>
          <volume>42</volume>
          <fpage>D933</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkt962</pub-id>
          <pub-id pub-id-type="pmid">24150938</pub-id>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Darnell</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Kaur</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stanislaw</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Davey</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Konieczka</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Yatskievych</surname>
              <given-names>TA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>GEISHA: an in situ hybridization gene expression resource for the chicken embryo</article-title>
          <source>Cytogenet Genome Res</source>
          <year>2007</year>
          <volume>117</volume>
          <fpage>30</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1159/000103162</pub-id>
          <pub-id pub-id-type="pmid">17675842</pub-id>
        </element-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bell</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Yatskievych</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Antin</surname>
              <given-names>PB</given-names>
            </name>
          </person-group>
          <article-title>GEISHA, a whole-mount in situ hybridization gene expression screen in chicken embryos</article-title>
          <source>Dev Dyn</source>
          <year>2004</year>
          <volume>229</volume>
          <fpage>677</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="doi">10.1002/dvdy.10503</pub-id>
          <pub-id pub-id-type="pmid">14991723</pub-id>
        </element-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hammonds</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Bristow</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Weiszmann</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hartenstein</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatial expression of transcription factors in <italic>Drosophila</italic> embryonic organ development</article-title>
          <source>Genome Biol</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>R140</fpage>
          <pub-id pub-id-type="doi">10.1186/gb-2013-14-12-r140</pub-id>
          <pub-id pub-id-type="pmid">24359758</pub-id>
        </element-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomancak</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Berman</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Beaton</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Weiszmann</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kwan</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hartenstein</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Global analysis of patterns of gene expression during <italic>Drosophila</italic> embryogenesis</article-title>
          <source>Genome Biol</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>R145</fpage>
          <pub-id pub-id-type="doi">10.1186/gb-2007-8-7-r145</pub-id>
          <pub-id pub-id-type="pmid">17645804</pub-id>
        </element-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomancak</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Beaton</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Weiszmann</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kwan</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Shu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>SE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Systematic determination of patterns of gene expression during <italic>Drosophila</italic> embryogenesis</article-title>
          <source>Genome Biol</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>research0088</fpage>
          <pub-id pub-id-type="doi">10.1186/gb-2002-3-12-research0088</pub-id>
          <pub-id pub-id-type="pmid">12537577</pub-id>
        </element-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St. Pierre</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Ponting</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Stefancsik</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>McQuilton</surname>
              <given-names>P</given-names>
            </name>
            <collab>the FlyBase Consortium</collab>
          </person-group>
          <article-title>FlyBase 102: advanced approaches to interrogating FlyBase</article-title>
          <source>Nucleic Acids Res</source>
          <year>2014</year>
          <volume>42</volume>
          <fpage>D780</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkt1092</pub-id>
          <pub-id pub-id-type="pmid">24234449</pub-id>
        </element-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McQuilton</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>St. Pierre SE, Thurmond J, the FlyBase Consortium. FlyBase 101: the basics of navigating FlyBase</article-title>
          <source>Nucleic Acids Res</source>
          <year>2012</year>
          <volume>40</volume>
          <fpage>D706</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkr1030</pub-id>
          <pub-id pub-id-type="pmid">22127867</pub-id>
        </element-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grumbling</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Strelets</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>The FlyBase Consortium. FlyBase: anatomical data, images and queries</article-title>
          <source>Nucleic Acids Res</source>
          <year>2006</year>
          <volume>34</volume>
          <fpage>D484</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkj068</pub-id>
          <pub-id pub-id-type="pmid">16381917</pub-id>
        </element-citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Konikoff</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Van Emden</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Busick</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>FlyExpress: visual mining of spatiotemporal patterns for genes and publications in <italic>Drosophila</italic> embryogenesis</article-title>
          <source>Bioinformatics</source>
          <year>2011</year>
          <volume>27</volume>
          <fpage>3319</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btr567</pub-id>
          <pub-id pub-id-type="pmid">21994220</pub-id>
        </element-citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>L&#xE9;cuyer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Parthasarathy</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Alm</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Babak</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cerovina</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Global analysis of mRNA localization reveals a prominent role in organizing cellular architecture and function</article-title>
          <source>Cell</source>
          <year>2007</year>
          <volume>131</volume>
          <fpage>174</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2007.08.003</pub-id>
          <pub-id pub-id-type="pmid">17923096</pub-id>
        </element-citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alonso-Barba</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>R-U</given-names>
            </name>
            <name>
              <surname>Wittbrodt</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mateo</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>MEPD: medaka expression pattern database, genes and more</article-title>
          <source>Nucleic Acids Res</source>
          <year>2015</year>
          <volume>44</volume>
          <fpage>D819</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkv1029</pub-id>
          <pub-id pub-id-type="pmid">26450962</pub-id>
        </element-citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henrich</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ramialison</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wittbrodt</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Assouline</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bourrat</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MEPD: a resource for medaka gene expression patterns</article-title>
          <source>Bioinformatics</source>
          <year>2005</year>
          <volume>21</volume>
          <fpage>3195</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bti478</pub-id>
          <pub-id pub-id-type="pmid">15879458</pub-id>
        </element-citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henrich</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>MEPD: a medaka gene expression pattern database</article-title>
          <source>Nucleic Acids Res</source>
          <year>2003</year>
          <volume>31</volume>
          <fpage>72</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkg017</pub-id>
          <pub-id pub-id-type="pmid">12519950</pub-id>
        </element-citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thompson</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Menon</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>C-K</given-names>
            </name>
            <name>
              <surname>Glattfelder</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A high-resolution spatiotemporal atlas of gene expression of the developing mouse brain</article-title>
          <source>Neuron</source>
          <year>2014</year>
          <volume>83</volume>
          <fpage>309</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2014.05.033</pub-id>
          <pub-id pub-id-type="pmid">24952961</pub-id>
        </element-citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <mixed-citation publication-type="other">Allen Institute for Brain Science. Technical white paper: Allen Developing Mouse Brain Atlas, informatics data processing. 2013. <ext-link ext-link-type="uri" xlink:href="http://help.brain-map.org/download/attachments/4325389/DevMouse_InformaticsDataProcessing.pdf">http://help.brain-map.org/download/attachments/4325389/DevMouse_InformaticsDataProcessing.pdf</ext-link>.</mixed-citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <mixed-citation publication-type="other">Allen Institute for Brain Science. Technical white paper: Allen Developing Mouse Brain Atlas. 2010. <ext-link ext-link-type="uri" xlink:href="http://developingmouse.brain-map.org/docs/Overview.pdf">http://developingmouse.brain-map.org/docs/Overview.pdf</ext-link></mixed-citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimizu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kubo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Uchibe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yokoyama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takada</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The AERO System: a 3D-like approach for recording gene expression patterns in the whole mouse embryo</article-title>
          <source>PLoS One</source>
          <year>2013</year>
          <volume>8</volume>
          <fpage>e75754</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0075754</pub-id>
          <pub-id pub-id-type="pmid">24146773</pub-id>
        </element-citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yokoyama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ueno-Kudoh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Uchibe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Albini</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A systems approach reveals that the myogenesis genome network is regulated by the transcriptional repressor RP58</article-title>
          <source>Dev Cell</source>
          <year>2009</year>
          <volume>17</volume>
          <fpage>836</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="doi">10.1016/j.devcel.2009.10.011</pub-id>
          <pub-id pub-id-type="pmid">20059953</pub-id>
        </element-citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richardson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Venkataraman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EMAGE mouse embryo spatial gene expression database: 2014 update</article-title>
          <source>Nucleic Acids Res</source>
          <year>2014</year>
          <volume>42</volume>
          <fpage>D835</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkt1155</pub-id>
          <pub-id pub-id-type="pmid">24265223</pub-id>
        </element-citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Richardson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Venkataraman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Burton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Lewandoski</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EMAGE: Electronic Mouse Atlas of Gene Expression</article-title>
          <source>Mouse Molecular Embryology</source>
          <year>2014</year>
          <publisher-loc>Boston, MA</publisher-loc>
          <publisher-name>Springer US</publisher-name>
          <fpage>61</fpage>
          <lpage>79</lpage>
        </element-citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richardson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Venkataraman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stevenson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Burton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rao</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EMAGE mouse embryo spatial gene expression database: 2010 update</article-title>
          <source>Nucleic Acids Res</source>
          <year>2010</year>
          <volume>38</volume>
          <fpage>D703</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkp763</pub-id>
          <pub-id pub-id-type="pmid">19767607</pub-id>
        </element-citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christiansen</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>EMAGE: A spatial database of gene expression patterns during mouse embryo development</article-title>
          <source>Nucleic Acids Res</source>
          <year>2006</year>
          <volume>34</volume>
          <fpage>D637</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkj006</pub-id>
          <pub-id pub-id-type="pmid">16381949</pub-id>
        </element-citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diez-Roux</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Banfi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sultan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Geffers</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Anand</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rozado</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A high-resolution anatomical atlas of the transcriptome in the mouse embryo</article-title>
          <source>PLoS Biol</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>e1000582</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pbio.1000582</pub-id>
          <pub-id pub-id-type="pmid">21267068</pub-id>
        </element-citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Finger</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Hayamizu</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>McCright</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Berghout</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The mouse Gene Expression Database (GXD): 2014 update</article-title>
          <source>Nucleic Acids Res</source>
          <year>2014</year>
          <volume>42</volume>
          <fpage>D818</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkt954</pub-id>
          <pub-id pub-id-type="pmid">24163257</pub-id>
        </element-citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Finger</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Kadin</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Ringwald</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The gene expression database for mouse development (GXD): Putting developmental expression information at your fingertips: GXD: the Mouse Gene Expression Database</article-title>
          <source>Dev Dyn</source>
          <year>2014</year>
          <volume>243</volume>
          <fpage>1176</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.1002/dvdy.24155</pub-id>
          <pub-id pub-id-type="pmid">24958384</pub-id>
        </element-citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finger</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Hayamizu</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>McCright</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Eppig</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Kadin</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The mouse Gene Expression Database (GXD): 2011 update</article-title>
          <source>Nucleic Acids Res</source>
          <year>2011</year>
          <volume>39</volume>
          <fpage>D835</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkq1132</pub-id>
          <pub-id pub-id-type="pmid">21062809</pub-id>
        </element-citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Finger</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Hayamizu</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>McCright</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Eppig</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Kadin</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The mouse Gene Expression Database (GXD): 2007 update</article-title>
          <source>Nucleic Acids Res</source>
          <year>2007</year>
          <volume>35</volume>
          <fpage>D618</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkl1003</pub-id>
          <pub-id pub-id-type="pmid">17130151</pub-id>
        </element-citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Kus</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Heintz</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>BAC Transgenic Mice and the GENSAT Database of Engineered Mouse Strains</article-title>
          <source>Cold Spring Harb Protoc</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>pdb.top073692</fpage>
          <pub-id pub-id-type="doi">10.1101/pdb.top073692</pub-id>
          <pub-id pub-id-type="pmid">23457350</pub-id>
        </element-citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heintz</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Gene Expression Nervous System Atlas (GENSAT)</article-title>
          <source>Nat Neurosci</source>
          <year>2004</year>
          <volume>7</volume>
          <fpage>483</fpage>
          <pub-id pub-id-type="doi">10.1038/nn0504-483</pub-id>
          <pub-id pub-id-type="pmid">15114362</pub-id>
        </element-citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Visel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Thaller</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Eichele</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>GenePaint.org: an atlas of gene expression patterns in the mouse embryo</article-title>
          <source>Nucleic Acids Res</source>
          <year>2004</year>
          <volume>32</volume>
          <fpage>552D</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkh029</pub-id>
        </element-citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Aronow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lloyd-MacGilp</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Michos</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Access and use of the GUDMAP database of genitourinary development</article-title>
          <source>Kidney Development</source>
          <year>2012</year>
          <publisher-loc>Totowa, NJ</publisher-loc>
          <publisher-name>Humana Press</publisher-name>
          <fpage>185</fpage>
          <lpage>201</lpage>
        </element-citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harding</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Armit</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Haggarty</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The GUDMAP database: an online resource for genitourinary research</article-title>
          <source>Development</source>
          <year>2011</year>
          <volume>138</volume>
          <fpage>2845</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.063594</pub-id>
          <pub-id pub-id-type="pmid">21652655</pub-id>
        </element-citation>
      </ref>
      <ref id="CR104">
        <label>104.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McMahon</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Aronow</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Gaido</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Grimmond</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>GUDMAP: the Genitourinary Developmental Molecular Anatomy Project</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2008</year>
          <volume>19</volume>
          <fpage>667</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2007101078</pub-id>
          <pub-id pub-id-type="pmid">18287559</pub-id>
        </element-citation>
      </ref>
      <ref id="CR105">
        <label>105.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>James-Zorn</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ponferrada</surname>
              <given-names>VG</given-names>
            </name>
            <name>
              <surname>Jarabek</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Segerdell</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Xenbase: expansion and updates of the <italic>Xenopus</italic> model organism database</article-title>
          <source>Nucleic Acids Res</source>
          <year>2013</year>
          <volume>41</volume>
          <fpage>D865</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gks1025</pub-id>
          <pub-id pub-id-type="pmid">23125366</pub-id>
        </element-citation>
      </ref>
      <ref id="CR106">
        <label>106.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bowes</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Segerdell</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gibb</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jarabek</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Noumen</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Xenbase: a <italic>Xenopus</italic> biology and genomics resource</article-title>
          <source>Nucleic Acids Res</source>
          <year>2008</year>
          <volume>36</volume>
          <fpage>D761</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkm826</pub-id>
          <pub-id pub-id-type="pmid">17984085</pub-id>
        </element-citation>
      </ref>
      <ref id="CR107">
        <label>107.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belmamoune</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Verbeek</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>Data integration for spatio-temporal patterns of gene expression of zebrafish development: the GEMS database</article-title>
          <source>J Integr Bioinform</source>
          <year>2008</year>
          <volume>5</volume>
          <issue>2</issue>
          <fpage>92</fpage>
        </element-citation>
      </ref>
      <ref id="CR108">
        <label>108.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Howe</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Bradford</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Conlin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Eagle</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Fashena</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Frazer</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ZFIN, the Zebrafish Model Organism Database: increased support for mutants and transgenics</article-title>
          <source>Nucleic Acids Res</source>
          <year>2013</year>
          <volume>41</volume>
          <fpage>D854</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gks938</pub-id>
          <pub-id pub-id-type="pmid">23074187</pub-id>
        </element-citation>
      </ref>
      <ref id="CR109">
        <label>109.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bradford</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Conlin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dunn</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fashena</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Frazer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Howe</surname>
              <given-names>DG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ZFIN: enhancements and updates to the zebrafish model organism database</article-title>
          <source>Nucleic Acids Res</source>
          <year>2011</year>
          <volume>39</volume>
          <fpage>D822</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkq1077</pub-id>
          <pub-id pub-id-type="pmid">21036866</pub-id>
        </element-citation>
      </ref>
      <ref id="CR110">
        <label>110.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sprague</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bayraktaroglu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bradford</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Conlin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dunn</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fashena</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Zebrafish Information Network: the zebrafish model organism database provides expanded support for genotypes and phenotypes</article-title>
          <source>Nucleic Acids Res</source>
          <year>2007</year>
          <volume>36</volume>
          <fpage>D768</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkm956</pub-id>
          <pub-id pub-id-type="pmid">17991680</pub-id>
        </element-citation>
      </ref>
      <ref id="CR111">
        <label>111.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>RYN</given-names>
            </name>
            <name>
              <surname>Sternberg</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <article-title>Building a cell and anatomy ontology of <italic>Caenorhabditis elegans</italic></article-title>
          <source>Comp. Funct. Genomics</source>
          <year>2003</year>
          <volume>4</volume>
          <fpage>121</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1002/cfg.248</pub-id>
          <pub-id pub-id-type="pmid">18629098</pub-id>
        </element-citation>
      </ref>
      <ref id="CR112">
        <label>112.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Osumi-Sutherland</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Reeve</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mungall</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Neuhaus</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ruttenberg</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jefferis</surname>
              <given-names>GSXE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A strategy for building neuroanatomy ontologies</article-title>
          <source>Bioinformatics</source>
          <year>2012</year>
          <volume>28</volume>
          <fpage>1262</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bts113</pub-id>
          <pub-id pub-id-type="pmid">22402613</pub-id>
        </element-citation>
      </ref>
      <ref id="CR113">
        <label>113.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Baldock</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Formalization of mouse embryo anatomy</article-title>
          <source>Bioinformatics</source>
          <year>2004</year>
          <volume>20</volume>
          <fpage>259</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btg400</pub-id>
          <pub-id pub-id-type="pmid">14734318</pub-id>
        </element-citation>
      </ref>
      <ref id="CR114">
        <label>114.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Little</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Georgas</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Baldock</surname>
              <given-names>RA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A high-resolution anatomical ontology of the developing murine genitourinary tract</article-title>
          <source>Gene Expr Patterns</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>680</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="doi">10.1016/j.modgep.2007.03.002</pub-id>
          <pub-id pub-id-type="pmid">17452023</pub-id>
        </element-citation>
      </ref>
      <ref id="CR115">
        <label>115.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Segerdell</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bowes</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Pollet</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Vize</surname>
              <given-names>PD</given-names>
            </name>
          </person-group>
          <article-title>An ontology for <italic>Xenopus</italic> anatomy and development</article-title>
          <source>BMC Dev Biol</source>
          <year>2008</year>
          <volume>8</volume>
          <fpage>92</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-213X-8-92</pub-id>
          <pub-id pub-id-type="pmid">18817563</pub-id>
        </element-citation>
      </ref>
      <ref id="CR116">
        <label>116.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belmamoune</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Verbeek</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>Developmental Anatomy Ontology of Zebrafish: an integrative semantic framework</article-title>
          <source>J Integr Bioinform</source>
          <year>2007</year>
          <volume>4</volume>
          <fpage>65</fpage>
        </element-citation>
      </ref>
      <ref id="CR117">
        <label>117.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Slyke</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Bradford</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Westerfield</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Haendel</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>The zebrafish anatomy and stage ontologies: representing the anatomy and development of <italic>Danio rerio</italic></article-title>
          <source> J Biomed Semantics</source>
          <year>2014</year>
          <volume>5</volume>
          <fpage>12</fpage>
          <pub-id pub-id-type="doi">10.1186/2041-1480-5-12</pub-id>
          <pub-id pub-id-type="pmid">24568621</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Breast Cancer Res Treat</journal-id>
      <journal-id journal-id-type="iso-abbrev">Breast Cancer Res. Treat</journal-id>
      <journal-title-group>
        <journal-title>Breast Cancer Research and Treatment</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0167-6806</issn>
      <issn pub-type="epub">1573-7217</issn>
      <publisher>
        <publisher-name>Springer US</publisher-name>
        <publisher-loc>New York</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27206678</article-id>
      <article-id pub-id-type="pmc">4903105</article-id>
      <article-id pub-id-type="publisher-id">3833</article-id>
      <article-id pub-id-type="doi">10.1007/s10549-016-3833-9</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Preclinical Study</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Orucevic</surname>
            <given-names>Amila</given-names>
          </name>
          <address>
            <phone>865-305-9080</phone>
            <email>aorucevic@utmck.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Heidel</surname>
            <given-names>Robert E.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bell</surname>
            <given-names>John L.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Pathology, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Hwy, Knoxville, TN 37920 USA </aff>
        <aff id="Aff2"><label/>Department of Surgery, University of Tennessee Medical Center at Knoxville, 1924 Alcoa Hwy, Knoxville, TN 37920 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>20</day>
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2016</year>
      </pub-date>
      <volume>157</volume>
      <fpage>427</fpage>
      <lpage>435</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>5</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>The aim of our study is to investigate patient selection for the 21-gene recurrence score assay (RS) for breast cancer (BC) and the RS impact on chemotherapy administration (Chemo) in clinical practice across the United States through the retrospective observational study of National Cancer Data Base (NCDB) patients from 2010 to 2012. NCDB captures ~70&#xA0;% of all newly diagnosed malignancies in the USA annually. The 2010&#x2013;2012 period depicts data from the beginning of the NCDB that required recording of molecular assays and their data release in April 2015. De-identified demographic and clinical variables of patients that had RS results were analyzed. 513,080 patients had BC; 406,525 were estrogen receptor-positive (ER+). 74,334/91,651 patients with RS recorded as a numerical value (0&#x2013;100) were analyzed (18.2&#xA0;% of ER+). Patients&#x2019; ages ranged from 18 to 90 (mean&#xA0;=&#xA0;58.8, median&#xA0;=&#xA0;59); 99.1&#xA0;% were females. Patients of Caucasian race, from regions with &lt;7&#xA0;% having no high school education, and &gt;$63,000 median household income were more likely to be tested than patients of other races, education, or income (<italic>p</italic>&#xA0;&lt;&#xA0;0.001). 58.1&#xA0;% of tests were performed in ER+/lymph node-negative/&gt;1&#xA0;cm tumors; 16.4&#xA0;% included &#x2265;N1 disease; 9.9&#xA0;% included T1a, T3, Stage III and IV, or HER2-positive cancers. Low-risk RS result had 92.2&#xA0;% negative predictive value for no Chemo. Intermediate-risk RS result had 40.1&#xA0;% positive predictive value (PPV); high-risk RS had 81.2&#xA0;% PPV for Chemo. RS is obtained in ~1/5 of ER&#xA0;+&#xA0;BC patients across the USA. Further studies investigating influence and implementation of the newest evidence-based management guidelines regarding patients&#x2019; selection for RS test and chemotherapy administration upon obtaining of test results are warranted.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>21-gene recurrence score assay</kwd>
        <kwd>Oncotype DX</kwd>
        <kwd>Breast cancer</kwd>
        <kwd>Clinical practice</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media New York 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>The 21-gene recurrence score (RS) assay for breast cancer, commercially available since January 2005 (Oncotype DX, Genomic Health Inc, Redwood City, CA), is designed for use in early-stage estrogen receptor-positive (ER+), human epidermal growth factor receptor-2 (HER2)-negative, node-negative invasive breast cancers to predict disease recurrence of tamoxifen-treated patients [<xref ref-type="bibr" rid="CR1">1</xref>]. The test provides a low, intermediate, or high 10-year risk RS for breast cancer [<xref ref-type="bibr" rid="CR1">1</xref>]. Based on the score, the addition of adjuvant chemotherapy to endocrine therapy is recommended for high-risk RS, while no benefit is seen for low-risk RS [<xref ref-type="bibr" rid="CR2">2</xref>]; the benefits of adjuvant chemotherapy in addition to endocrine therapy for intermediate-risk RS are unclear [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
      <p>The payment for Oncotype DX (OncoDX) test was approved by the Centers for Medicare &amp; Medicaid Services (CMS) in 2006 [<xref ref-type="bibr" rid="CR3">3</xref>]. Since 2010, the test has also been used for ER+/HER2- and 1&#x2013;3 lymph node-positive postmenopausal women with breast cancer and provides low-, intermediate-, and high-risk 5-year RS and mortality score in these patients [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
      <p>Since inception, patient selection for the OncoDX test has been evolving, reaching the level of category 2A evidence in the National Comprehensive Cancer Network (NCCN) guidelines for breast cancer version 2.2015 [<xref ref-type="bibr" rid="CR5">5</xref>]. The NCCN panel suggested the OncoDX assay as &#x201C;an option when evaluating patients with primary tumors characterized as 0.6&#x2013;1&#xA0;cm with unfavorable features or &gt;1&#xA0;cm, and node-negative, hormone receptor-positive, and HER2-negative&#x201D;.</p>
      <p>However, the most recent version of the NCCN breast cancer guidelines 1.2016 [<xref ref-type="bibr" rid="CR6">6</xref>] as well as just published American Society of Clinical Oncology (ASCO) Clinical Practice Guideline [<xref ref-type="bibr" rid="CR7">7</xref>] endorsed OncoDX assay as both a prognostic and predictive test for breast cancer recurrence and response to chemotherapy. This update coincided with Trial Assigning Individualized Options for Treatment (TAILORx) interim findings published in the New England Journal of Medicine [<xref ref-type="bibr" rid="CR8">8</xref>] which claimed prospective prognostic and predictive validation of OncoDX assay. This trial, however, utilized different cut-off values for the low-, intermediate-, and high-risk RS from the commercial test values. Interestingly though, the traditional commercial test cut-off values are referenced by the newest NCCN guidelines [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>Data on utilization and impact of the OncoDX breast cancer assay in clinical practice so far are based on small single or multi-institutional studies or meta-analysis [<xref ref-type="bibr" rid="CR9">9</xref>&#x2013;<xref ref-type="bibr" rid="CR13">13</xref>], as well as impact of the test in countries other than the United States [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Only a few recent publications studied utilization and impact of the test in limited population groups in the United States [<xref ref-type="bibr" rid="CR16">16</xref>&#x2013;<xref ref-type="bibr" rid="CR19">19</xref>].</p>
      <p>Since the data on appropriate utilization and impact of the OncoDX assay in everyday clinical practice across the entire United States population are still lacking, we investigated the impact of the test across the United States in a retrospective observational study of National Cancer Data Base (NCDB) patients from 2010 to 2012. We examined racial and socioeconomic factors in test utilization, practices used for ordering the test, and the impact of test results on adjuvant chemotherapy use. We also compared chemotherapy utilization and vital status of patients when applying commercial OncoDx cut-off values [<xref ref-type="bibr" rid="CR2">2</xref>] versus the new TAILORx trial-defined cut-off values [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec3">
        <title>National Cancer Data Base (NCDB) and study approval</title>
        <p>NCDB is a clinical oncology database, acquiring data from hospital tumor registries, gathered from more than 1500 Commission on Cancer (CoC)-accredited facilities. NCDB, jointly sponsored by the American College of Surgeons (ACoS) and the American Cancer Society (ACS), currently captures ~70&#xA0;% of all newly diagnosed malignancies in the USA annually [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
        <p>The 2010&#x2013;2012 study period captures NCDB data from the beginning of the NCDB required recording of molecular assay test results in different types of cancers and the NCDB data released in April 2015. For breast cancer, NCDB captured data on genomic tests with only three separate codes which identified &#x201C;Oncotype DX test,&#x201D; &#x201C;MammaPrint test,&#x201D; and &#x201C;Other&#x201D; as separate tests. In 2010&#x2013;2012 time period, 97,510 genomic tests for breast cancer were captured by NCDB, with Oncotype DX test dominating by the number of tests performed (91,651 tests&#xA0;=&#xA0;94&#xA0;%). MammaPrint test was performed in 2518 cases (2.5&#xA0;%), and other tests, including the ones performed but of unknown type, were done in 3341 patients (3.4&#xA0;%).</p>
        <p>Data regarding patients&#x2019; and institutions&#x2019; names were de-identified by the NCDB prior to the release of the file and therefore met the criteria of 45 CFR 46.102 d research. Since the information received was not individually identifiable, the research was not a deemed research with human subjects; therefore, our Institutional Review Board was not required.</p>
      </sec>
      <sec id="Sec4">
        <title>Patients&#x2019; selection</title>
        <p>Demographic and clinicopathologic variables of patients with OncoDX results expressed as a numerical value (0&#x2013;100) were analyzed. Those with performed OncoDX assay but unknown numerical results were excluded.</p>
      </sec>
      <sec id="Sec5">
        <title>Analysis</title>
        <p>Tables&#xA0;<xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref> define the demographic, clinical, and pathologic characteristics of this study population.
</p>
        <p>Chemotherapy administration (Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>), recorded as &#x201C;chemotherapy at any CoC facility&#x201D; was used as a variable for analysis of chemotherapy administration. Negative predictive value for no chemotherapy administration for low-risk RS and positive predictive value for chemotherapy administration for intermediate- and high-risk RS were calculated.
</p>
        <p>Chemotherapy utilization and vital status of patients tested with OncoDX (Table&#xA0;<xref rid="Tab4" ref-type="table">4</xref>) were compared using traditional, commercial OncoDX cut-off values for low-, intermediate-, and high-risk RS versus TAILORx trial new cut-off values for the test.</p>
      </sec>
      <sec id="Sec6">
        <title>Statistical analysis</title>
        <p>Normality of continuous variables was assured using skewness and kurtosis statistics. Any skewness or kurtosis statistic above an absolute value of 2.0 was considered normal. Levene&#x2019;s Test of Equality of Variances was used to test for homogeneity of variance in between-subjects comparisons of continuous outcomes. Frequency statistics were used to analyze categorical variables. Unadjusted odds ratios with 95&#xA0;% confidence intervals were used to test associations with categorical outcomes. Logistic regression was used to generate adjusted odds ratios with 95&#xA0;% confidence intervals. Residual analysis was conducted to assess the model fit. Normality and homoscedasticity were also assessed using plots of standardized residuals.</p>
        <p>Statistical significance was assumed at an alpha value of 0.05, and all analyses were conducted using SPSS Version 23 (Armonk, NY; IBM Corp).</p>
      </sec>
    </sec>
    <sec id="Sec7" sec-type="results">
      <title>Results</title>
      <p>The NCDB registered 513,080 patients with invasive breast carcinoma from 1/1/2010 to 12/31/2012 with 406,525 patients recorded as ER-positive. Of note, the NCDB records ER assay results from pathology reports or separate clinical laboratory report sources based on reported immunohistochemical results or much less frequently based on the amount of cytosol protein in the tumor sample measured in femtomoles of cytosol protein per milligram (fmol/mg) and not based on mRNA results from Genomic Health. However, there is no way to know which test was used by NCDB for reported ER results available for our analysis.</p>
      <p>The OncoDX test was performed in 91,651 patients; 86,409 patients had known OncoDX results, and 74,334 patients had tests recorded as a numerical value from 0 to 100.</p>
      <p>Ages ranged from 18 to 90; 99.1&#xA0;% were females. Percent of breast cancer patients per age group was similar for low-, intermediate-, and high-risk score in patients 41&#x2013;70&#xA0;years old, but there was an increasing trend toward high-risk score in patients younger than 40 and older than 70&#xA0;years of age. While this was expected in younger patients, it was unexpected in elderly patients (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Percent of breast cancer patients per age group was similar for low-, intermediate-, and high-risk score in patients 41&#x2013;70&#xA0;years old, but there was an increasing trend towards high-risk score in patients younger than 40 and older than 70&#xA0;years of age. While this was expected in younger patients, it was unexpected in elderly patients</p></caption><graphic xlink:href="10549_2016_3833_Fig1_HTML" id="MO1"/></fig></p>
      <p>Race and socioeconomic disparity analysis showed that patients of Caucasian race, from regions with &lt;7&#xA0;% having no high school education, and &gt;$63,000 median household income were more likely to be tested with OncoDX than patients of other races, lower levels of education, or lower incomes (<italic>p</italic>&#xA0;&lt;&#xA0;0.001; Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).</p>
      <p>US geographic location (geographic regions defined by NCDB), also revealed significant impact on test utilization (New England used as a referent in calculating odds ratio for being tested with OncoDX, Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Race and socioeconomic characteristics of a 21-gene recurrence score assay for breast cancer (Oncotype DX) in patients tested compared to patients eligible for testing (ER-positive, lymph node-negative, HER2-negative patients with tumor size between 0.6&#xA0;cm and 5&#xA0;cm)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Characteristics</th><th align="left">Patients eligible for Oncotype DX test</th><th align="left">Oncotype DX test performed</th><th align="left">
<italic>p</italic> value*</th><th align="left">Odds ratio</th><th align="left">95&#xA0;% CI</th></tr></thead><tbody><tr><td align="left">
<bold>Race</bold>
</td><td char="." align="char">174,079</td><td align="left">63,392</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">White</td><td char="." align="char">151,560</td><td align="left">55,712 (36.8&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">Referent</td><td align="left"/></tr><tr><td align="left">Black</td><td char="." align="char">13,958</td><td align="left">4653 (33.3&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">0.860</td><td char="&#x2013;" align="char">0.829&#x2013;0.892</td></tr><tr><td align="left">Other</td><td char="." align="char">6945</td><td align="left">2461 (35.4&#xA0;%)</td><td char="." align="char">0.025</td><td char="." align="left">0.944</td><td char="&#x2013;" align="char">0.898&#x2013;0.993</td></tr><tr><td align="left">Unknown</td><td char="." align="char">1616</td><td align="left">566 (35.0&#xA0;%)</td><td char="." align="char">0.150</td><td char="." align="left">0.927</td><td char="&#x2013;" align="char">0.837&#x2013;1.028</td></tr><tr><td align="left">
<bold>Median income quartiles 2008&#x2013;2012</bold>
</td><td char="." align="char">172,730</td><td align="left">62,948</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&gt;$63000</td><td char="." align="char">66,219</td><td align="left">25,913 (39.1&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">Referent</td><td align="left"/></tr><tr><td align="left">&lt;$38000</td><td char="." align="char">23,096</td><td align="left">7450 (32.3&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">0.741</td><td char="&#x2013;" align="char">0.718&#x2013;0.764</td></tr><tr><td align="left">$38000&#x2013;$47999</td><td char="." align="char">36,569</td><td align="left">12,564 (34.4&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">0.814</td><td char="&#x2013;" align="char">0.793&#x2013;0.836</td></tr><tr><td align="left">$48000&#x2013;$62999</td><td char="." align="char">46,846</td><td align="left">17,021 (36.3&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">0.888</td><td char="&#x2013;" align="char">0.866&#x2013;.910</td></tr><tr><td align="left">
<bold>Percent no high school degree 2008&#x2013;2012</bold>
</td><td char="." align="char">172,792</td><td align="left">62,978</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">&lt;7&#xA0;%</td><td char="." align="char">52,617</td><td align="left">20,978 (39.9&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">Referent</td><td align="left"/></tr><tr><td align="left">&#x2265;21&#xA0;%</td><td char="." align="char">22,475</td><td align="left">6857 (30.5&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">0.662</td><td char="&#x2013;" align="char">0.640&#x2013;0.685</td></tr><tr><td align="left">13&#x2013;20.9&#xA0;%</td><td char="." align="char">39,273</td><td align="left">13,325 (33.9&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">0.775</td><td char="&#x2013;" align="char">0.754&#x2013;0.796</td></tr><tr><td align="left">7&#x2013;12.9&#xA0;%</td><td char="." align="char">58,427</td><td align="left">21,818 (37.3&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">0.899</td><td char="&#x2013;" align="char">0.877&#x2013;0.921</td></tr><tr><td align="left">
<bold>US geographic location</bold>
</td><td char="." align="char">174,079</td><td align="left">63,392</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">New England (CT, MA, ME, NH, RI, VT)</td><td char="." align="char">10,652</td><td align="left">4013 (37.7&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">Referent</td><td align="left"/></tr><tr><td align="left">Middle Atlantic (NJ, NY, PA)</td><td char="." align="char">26,294</td><td align="left">11,810 (44.9&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">1.349</td><td char="&#x2013;" align="char">1.288&#x2013;1.413</td></tr><tr><td align="left">South Atlantic (DC, DE, FL, GA, MD, NC, SC, VA, WV)</td><td char="." align="char">38,319</td><td align="left">13,858 (36.2&#xA0;%)</td><td char="." align="char">0.004</td><td char="." align="left">0.937</td><td char="&#x2013;" align="char">0.897&#x2013;0.980</td></tr><tr><td align="left">East North Central (IL, IN, MI, OH, WI)</td><td char="." align="char">30,617</td><td align="left">12,298 (40.2&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">1.111</td><td char="&#x2013;" align="char">1.061&#x2013;1.162</td></tr><tr><td align="left">East South Central (AL, KY, MS, TN)</td><td char="." align="char">10,010</td><td align="left">3308 (33.0&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">0.817</td><td char="&#x2013;" align="char">0.771&#x2013;0.865</td></tr><tr><td align="left">West North Central (IA, KS, MN, MO, ND, NE, SD)</td><td char="." align="char">13,344</td><td align="left">5218 (39.1&#xA0;%)</td><td char="." align="char">0.024</td><td char="." align="left">1.062</td><td char="&#x2013;" align="char">1.008&#x2013;1.119</td></tr><tr><td align="left">West South Central (AR, LA, OK, TX)</td><td char="." align="char">12,384</td><td align="left">3065 (24.7&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">0.544</td><td char="&#x2013;" align="char">0.514&#x2013;0.576</td></tr><tr><td align="left">Mountain (AZ, CO, ID, MT, NM, NV, UT, WY)</td><td char="." align="char">9110</td><td char="(" align="left">3424 (37.6&#xA0;%)</td><td char="." align="char">0.898</td><td char="." align="left">0.996</td><td char="&#x2013;" align="char">0.940&#x2013;1.055</td></tr><tr><td align="left">Pacific (AK, CA, HI, OR, WA)</td><td char="." align="char">23,349</td><td char="(" align="left">6398 (27.4&#xA0;%)</td><td char="." align="char">&lt;0.001</td><td char="." align="left">0.624</td><td char="&#x2013;" align="char">0.595&#x2013;0.656</td></tr><tr><td align="left">
<bold>Urban vs rural</bold>
</td><td char="." align="char">169,207</td><td char="(" align="left">61,748</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Urban</td><td char="." align="char">166,495</td><td char="(" align="left">60,748 (36.5&#xA0;%)</td><td align="left"/><td char="." align="left">Referent</td><td align="left"/></tr><tr><td align="left">Rural</td><td char="." align="char">2712</td><td char="(" align="left">1000 (36.9&#xA0;%)</td><td char="." align="char">0.678</td><td char="." align="left">1.017</td><td char="&#x2013;" align="char">0.940&#x2013;1.100</td></tr></tbody></table><table-wrap-foot><p>*&#xA0;Patients of Caucasian race, from regions with &lt;7&#xA0;% having no high school education, and &gt;$63,000 median household income were more likely to be tested with Oncotype DX test than patients of other races, education, or income (<italic>p</italic>&#xA0;&lt;&#xA0;0.001). Urban versus rural location did not have a significant impact on Oncotype DX test utilization</p></table-wrap-foot></table-wrap></p>
      <p>The NCCN-defined intermediate-risk guidelines valid at the time of the study (ER+/lymph node-negative/&gt;1.0&#xA0;cm tumors) were followed in 58.1&#xA0;% of tested patients; 16.4&#xA0;% tests were performed in patients with &#x2265;N1 disease. The majority of tests were performed on patients with T1c tumors, followed by T1b tumors (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>).</p>
      <p>Interestingly, 24&#xA0;% of ordered tests did not follow the guidelines applicable at the time of the study: 2.9&#xA0;% of tested patients were HER2-positive; 3.2&#xA0;% had T1a tumors; 16.4&#xA0;% had positive lymph nodes, and 1.5&#xA0;% had advanced III&amp;IV cancer stage (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Clinicopathologic characteristics of invasive breast carcinomas tested with a 21-gene recurrence score assay for breast cancer (Oncotype DX)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="4">Oncotype DX risk recurrence scores</th></tr><tr><th align="left">Low-risk score 0&#x2013;17</th><th align="left">Intermediate-risk score 18&#x2013;30</th><th align="left">High-risk score 31&#x2013;100</th><th align="left">Total for all scores 0&#x2013;100</th></tr></thead><tbody><tr><td align="left"># and &#xA0;% of analyzed patients per score</td><td char="(" align="left">41,682 (56.1&#xA0;%)</td><td char="(" align="left">24,965 (33.6&#xA0;%)</td><td char="(" align="left">7687 (10.3&#xA0;%)</td><td char="(" align="left">74,334* (100&#xA0;%)</td></tr><tr><td align="left" colspan="5">
<bold>Age</bold>
</td></tr><tr><td align="left">Median (interquartile range) year</td><td char="(" align="left">59.0 (51-59)</td><td char="(" align="left">59.0 (51-66)</td><td char="(" align="left">59.0 (51&#x2013;67)</td><td char="(" align="left">59.0 (51&#x2013;66)</td></tr><tr><td align="left">Mean (year)&#xA0;&#xB1;&#xA0;SD</td><td char="(" align="left">58.91&#xA0;&#xB1;&#xA0;10.42</td><td char="(" align="left">58.59&#xA0;&#xB1;&#xA0;10.63</td><td char="(" align="left">58.89&#xA0;&#xB1;&#xA0;11.41</td><td char="(" align="left">58.8&#xA0;&#xB1;&#xA0;10.6</td></tr><tr><td align="left" colspan="5">
<bold>Comorbidities # and % per score</bold>
</td></tr><tr><td align="left">0</td><td char="(" align="left">35,649 (85.5&#xA0;%)</td><td char="(" align="left">21,407 (85.7&#xA0;%)</td><td char="(" align="left">6484 (84.4&#xA0;%)</td><td char="(" align="left">63,540 (85.5&#xA0;%)</td></tr><tr><td align="left">1</td><td char="(" align="left">5118 (12.3&#xA0;%)</td><td char="(" align="left">3.063 (12.3&#xA0;%)</td><td char="(" align="left">1005 (13.1&#xA0;%)</td><td char="(" align="left">9186 (12.4&#xA0;%)</td></tr><tr><td align="left">&#x2265;2</td><td char="(" align="left">915 (2.2&#xA0;%)</td><td char="(" align="left">495 (2.0&#xA0;%)</td><td char="(" align="left">198 (2.6&#xA0;%)</td><td char="(" align="left">1608 (2.1&#xA0;%)</td></tr><tr><td align="left" colspan="5">
<bold>Tumor size (greatest dimension)</bold>
</td></tr><tr><td align="left">Median (interquartile range) (cm)</td><td char="(" align="left">1.5 (1.0&#x2013;2.0)</td><td char="(" align="left">1.5 (1.1&#x2013;2.1)</td><td char="(" align="left">1.7 (1.2&#x2013;2.5)</td><td char="(" align="left">1.5 (1.1&#x2013;2.1)</td></tr><tr><td align="left">Mean (cm)</td><td char="(" align="left">2.4&#xA0;&#xB1;&#xA0;8.6</td><td char="(" align="left">2.4&#xA0;&#xB1;&#xA0;8.1</td><td char="(" align="left">2.67&#xA0;&#xB1;&#xA0;8.4</td><td char="(" align="left">2.45&#xA0;&#xB1;&#xA0;8.4</td></tr><tr><td align="left" colspan="5">Tumor distribution&#x2014;# and % per score</td></tr><tr><td char="(" align="char">0.1&#x2013;0.5&#xA0;cm</td><td char="(" align="left">1424 (3.4&#xA0;%)</td><td char="(" align="left">712 (2.9&#xA0;%)</td><td char="(" align="left">238 (3.1&#xA0;%)</td><td char="(" align="left">2374 (3.2&#xA0;%)</td></tr><tr><td char="(" align="char">0.6&#x2013;1.0&#xA0;cm</td><td char="(" align="left">9,223 (22.1&#xA0;%)</td><td char="(" align="left">5,217 (20.9&#xA0;%)</td><td char="(" align="left">1184 (15.4&#xA0;%)</td><td char="(" align="left">15,624 (21.0&#xA0;%)</td></tr><tr><td char="(" align="char">1.1&#x2013;2.0&#xA0;cm</td><td char="(" align="left">21,113 (50.7&#xA0;%)</td><td char="(" align="left">12,620 (50.6&#xA0;%)</td><td char="(" align="left">3518 (45.8&#xA0;%)</td><td char="(" align="left">37,251 (50.2&#xA0;%)</td></tr><tr><td char="(" align="char">2.1&#x2013;3.0&#xA0;cm</td><td char="(" align="left">6898 (16.6&#xA0;%)</td><td char="(" align="left">4480 (18.0&#xA0;%)</td><td char="(" align="left">1843 (24&#xA0;%)</td><td char="(" align="left">13,221 (17.8&#xA0;%)</td></tr><tr><td char="(" align="char">3.1&#x2013;4.0&#xA0;cm</td><td char="(" align="left">1664 (4.0&#xA0;%)</td><td char="(" align="left">1091 (4.4&#xA0;%)</td><td char="(" align="left">564 (7.3&#xA0;%)</td><td char="(" align="left">3319 (4.5&#xA0;%)</td></tr><tr><td char="(" align="char">4.1&#x2013;5.0&#xA0;cm</td><td char="(" align="left">595 (1.4&#xA0;%)</td><td char="(" align="left">403 (1.6&#xA0;%)</td><td char="(" align="left">196 (2.6&#xA0;%)</td><td char="(" align="left">1194 (1.6&#xA0;%)</td></tr><tr><td align="left">&#x2265;5.1&#xA0;cm</td><td char="(" align="left">656 (1.6&#xA0;%)</td><td char="(" align="left">384 (1.5&#xA0;%)</td><td char="(" align="left">123 (1.6&#xA0;%)</td><td char="(" align="left">1163 (1.6&#xA0;%)</td></tr><tr><td align="left">Unknown</td><td char="(" align="left">67 (0.2&#xA0;%)</td><td char="(" align="left">39 (0.2&#xA0;%)</td><td char="(" align="left">13 (0.2&#xA0;%)</td><td char="(" align="left">119 (0.2&#xA0;%)</td></tr><tr><td align="left" colspan="5">
<bold>Histologic grade of tumor&#x2014;# and % per score</bold>
</td></tr><tr><td align="left">Low</td><td char="(" align="left">14,013 (33.6&#xA0;%)</td><td char="(" align="left">5473 (21.9&#xA0;%)</td><td char="(" align="left">351 (4.6&#xA0;%)</td><td char="(" align="left">19,837 (26.7&#xA0;%)</td></tr><tr><td align="left">Intermediate</td><td char="(" align="left">22,200 (53.3&#xA0;%)</td><td char="(" align="left">13,537 (54.2&#xA0;%)</td><td char="(" align="left">2572 (33.5&#xA0;%)</td><td char="(" align="left">38,309 (51.5&#xA0;%)</td></tr><tr><td align="left">High</td><td char="(" align="left">3355 (8&#xA0;%)</td><td char="(" align="left">4826 (19.3&#xA0;%)</td><td char="(" align="left">4,479 (58.3&#xA0;%)</td><td char="(" align="left">12,660 (17&#xA0;%)</td></tr><tr><td align="left">Unknown</td><td char="(" align="left">2114 (5.1&#xA0;%)</td><td char="(" align="left">1,129 (4.5&#xA0;%)</td><td char="(" align="left">285 (3.7&#xA0;%)</td><td char="(" align="left">3528 (4.7&#xA0;%)</td></tr><tr><td align="left">
<bold>Number of positive lymph nodes # and &#xA0;% per score</bold>
</td><td align="left" colspan="3"/><td char="(" align="left">Total #&#xA0;=&#xA0;72,568</td></tr><tr><td align="left">0</td><td char="(" align="left">33,615 (82.5&#xA0;%)</td><td char="(" align="left">20,332 (83.4&#xA0;%)</td><td char="(" align="left">6430 (86.4&#xA0;%)</td><td char="(" align="left">60,377 (81.2&#xA0;%)</td></tr><tr><td align="left">1</td><td char="(" align="left">5258 (12.9&#xA0;%)</td><td char="(" align="left">2946 (12.1&#xA0;%)</td><td char="(" align="left">709 (9.5&#xA0;%)</td><td char="(" align="left">8913 (12&#xA0;%)</td></tr><tr><td align="left">2&#x2013;3</td><td char="(" align="left">1597 (3.9&#xA0;%)</td><td char="(" align="left">912 (3.7&#xA0;%)</td><td char="(" align="left">217 (2.9&#xA0;%)</td><td char="(" align="left">2726 (3.7&#xA0;%)</td></tr><tr><td align="left">&#x2265;4</td><td char="(" align="left">287 (0.7&#xA0;%)</td><td char="(" align="left">175 (0.7&#xA0;%)</td><td char="(" align="left">90 (1.2&#xA0;%)</td><td char="(" align="left">552 (0.7&#xA0;%)</td></tr><tr><td align="left">
<bold>Cancer stage # and &#xA0;% per score</bold>
</td><td align="left" colspan="3"/><td char="(" align="char">Total #&#xA0;=&#xA0;74,191</td></tr><tr><td align="left">I</td><td align="left">28,742 (69.1&#xA0;%)</td><td align="left">17,000 (68.2&#xA0;%)</td><td align="left">4569 (59.7&#xA0;%)</td><td align="left">50,311 (67.8&#xA0;%)</td></tr><tr><td align="left">II</td><td align="left">12,078 (29.0&#xA0;%)</td><td align="left">7453 (29.9&#xA0;%)</td><td align="left">2871 (37.5&#xA0;%)</td><td align="left">22,402 (30.21&#xA0;%)</td></tr><tr><td align="left">III</td><td align="left">519 (1.2&#xA0;%)</td><td align="left">315 (1.3&#xA0;%)</td><td align="left">131 (1.7&#xA0;%)</td><td align="left">965 (1.3&#xA0;%)</td></tr><tr><td align="left">IV</td><td align="left">47 (0.1&#xA0;%)</td><td align="left">34 (0.1&#xA0;%)</td><td align="left">33 (0.4&#xA0;%)</td><td align="left">114 (0.2&#xA0;%)</td></tr><tr><td align="left">Unknown</td><td align="left">224 (0.5&#xA0;%)</td><td align="left">121 (0.5&#xA0;%)</td><td align="left">54 (0.7&#xA0;%)</td><td align="left">399 (0.5&#xA0;%)</td></tr><tr><td align="left" colspan="5">
<bold>Estrogen receptor expression&#x2014;# and % per score</bold>
</td></tr><tr><td align="left">Negative</td><td align="left">145 (0.3&#xA0;%)</td><td align="left">149 (0.6&#xA0;%)</td><td align="left">614 (8&#xA0;%)</td><td align="left">908 (1.2&#xA0;%)</td></tr><tr><td align="left">Positive</td><td align="left">41,445 (99.4&#xA0;%</td><td align="left">24,773 (99.2&#xA0;%)</td><td align="left">7040 (91.6&#xA0;%)</td><td align="left">73,258 (98.6&#xA0;%)</td></tr><tr><td align="left">Borderline</td><td align="left">2 (&lt;&#xA0;0.01&#xA0;%)</td><td align="left">1 (&lt;&#xA0;0.01&#xA0;%)</td><td align="left">14 (0.2&#xA0;%)</td><td align="left">17 (&lt;&#xA0;0.01)</td></tr><tr><td align="left">Unknown</td><td align="left">90 (0.2&#xA0;%)</td><td align="left">42 (0.2&#xA0;%)</td><td align="left">19 (0.2&#xA0;%)</td><td align="left">151 (0.2&#xA0;%)</td></tr><tr><td align="left" colspan="5">
<bold>Progesterone receptor expression&#x2014;# and % per score</bold>
</td></tr><tr><td align="left">Negative</td><td align="left">1578 (3.8&#xA0;%)</td><td align="left">3528 (14.2&#xA0;%)</td><td align="left">3126 (40.7&#xA0;%)</td><td align="left">8242 (11.1&#xA0;%)</td></tr><tr><td align="left">Positive</td><td align="left">39,997 (95.9&#xA0;%)</td><td align="left">21,337 (85.5&#xA0;%)</td><td align="left">4508 (58.6&#xA0;%)</td><td align="left">65,822 (88.5&#xA0;%)</td></tr><tr><td align="left">Borderline</td><td align="left">20 (&lt;&#xA0;0.01&#xA0;%)</td><td align="left">38 (0.2&#xA0;%)</td><td align="left">26 (0.3&#xA0;%)</td><td align="left">84 (0.1&#xA0;%)</td></tr><tr><td align="left">Unknown</td><td align="left">107 (0.3&#xA0;%)</td><td align="left">52 (0.2&#xA0;%)</td><td align="left">27 (0.4&#xA0;%)</td><td align="left">186 (0.3&#xA0;%)</td></tr><tr><td align="left" colspan="5">
<bold>HER2 expression&#x2014;# and % per score</bold>
</td></tr><tr><td align="left">Negative</td><td align="left">39,686 (95.2&#xA0;%)</td><td align="left">23,304 (93.3&#xA0;%)</td><td align="left">6415 (83.5&#xA0;%)</td><td align="left">69,405 (93.4&#xA0;%)</td></tr><tr><td align="left">Positive</td><td align="left">573 (1.4&#xA0;%)</td><td align="left">647 (2.6&#xA0;%)</td><td align="left">916 (11.9&#xA0;%)</td><td align="left">2,136 (2.9&#xA0;%)</td></tr><tr><td align="left">Borderline</td><td align="left">601 (1.4&#xA0;%)</td><td align="left">536 (2.1&#xA0;%)</td><td align="left">210 (2.7&#xA0;%)</td><td align="left">1347 (1.8&#xA0;%)</td></tr><tr><td align="left">Unknown</td><td align="left">822 (2&#xA0;%)</td><td align="left">478 (1.9&#xA0;%)</td><td align="left">146 (1.9&#xA0;%)</td><td align="left">1446 (1.9&#xA0;%)</td></tr></tbody></table><table-wrap-foot><p>*&#xA0;From 91,651 patients that had Oncotype DX test performed from 2010 to 2012, 74,334 patients (81.1&#xA0;%) had known Oncotype DX test score recorded as a numerical value (0&#x2013;100) and were analyzed. 74,344 is the total number of patients, if different, it is stated in the column &#x201C;total for all scores 0&#x2013;100&#x201D;</p></table-wrap-foot></table-wrap></p>
      <p>Low-risk RS had 92.2&#xA0;% negative predictive value for no adjuvant chemotherapy administration. Intermediate-risk RS had 40.1&#xA0;% positive predictive value and high-risk RS had 81.2&#xA0;% positive predictive value for adjuvant chemotherapy administration (Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table&#xA0;3</label><caption><p>A 21-gene recurrence score breast cancer assay (Oncotype DX) score and chemotherapy administration</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Oncotype DX score</th><th align="left" colspan="3">Chemotherapy</th><th align="left"/></tr><tr><th align="left">No</th><th align="left">Yes</th><th align="left">Unknown</th><th align="left">Total for chemotherapy values</th></tr></thead><tbody><tr><td align="left">Low-risk recurrence score (0&#x2013;17)</td><td char="(" align="char">38,057 (91.3&#xA0;%)</td><td char="(" align="char">3218 (7.7&#xA0;%)</td><td char="(" align="char">407 (1&#xA0;%)</td><td char="(" align="char">41,682 (100&#xA0;%)</td></tr><tr><td align="left">Intermediate-risk recurrence score (18&#x2013;30)</td><td char="(" align="char">14,827 (59.4&#xA0;%)</td><td char="(" align="char">9942 (38.8&#xA0;%)</td><td char="(" align="char">196 (0.8&#xA0;%)</td><td char="(" align="char">24,965 (100&#xA0;%)</td></tr><tr><td align="left">High-risk recurrence score (31&#x2013;100)</td><td char="(" align="char">1430 (18.6&#xA0;%)</td><td char="(" align="char">6214 (80.8&#xA0;%)</td><td char="(" align="char">43 (0.6&#xA0;%)</td><td char="(" align="char">7687 (100&#xA0;%)</td></tr><tr><td align="left">Total for all risk recurrence score values</td><td char="(" align="char">54,314 (73.1&#xA0;%)</td><td char="(" align="char">19,374 (26.1&#xA0;%)</td><td char="(" align="char">646 (0.9&#xA0;%)</td><td char="(" align="char">74,334 (100&#xA0;%)</td></tr></tbody></table><table-wrap-foot><p>Upon obtaining of the Oncotype DX recurrence risk score results, 73,688/74,334 (99.1&#xA0;%) of patients had known chemotherapy administration results</p></table-wrap-foot></table-wrap></p>
      <p>Comparison of commercial OncoDX cut-off values for low-, intermediate-, and high-risk RS (0&#x2013;17, 18&#x2013;30, and 31&#x2013;100, respectively) with the new TAILORx trial-defined cut-off values (0&#x2013;10, 11&#x2013;25, and 26&#x2013;100, respectively) (Table&#xA0;<xref rid="Tab4" ref-type="table">4</xref>) revealed that the majority of patients tested fell into the low-risk RS (0&#x2013;17) with commercial OncoDX cut-off values (56.1&#xA0;%), while the majority of patients (61.3&#xA0;%) with TAILORx trial-defined values fell into the intermediate-risk RS (11&#x2013;25). Chemotherapy for high-risk OncoDX RS was not administered in almost 20&#xA0;% of patients (26&#xA0;% for TAILORx values) and was administered to 7.7&#xA0;% of patients with low-risk RS (5.3&#xA0;% for TAILORx values).</p>
      <p>Vital status was known in 62.2&#xA0;% of cohort&#x2019;s patients; 677/46245 (1.5&#xA0;%) patients were expired at the end of 3-year study period (Table&#xA0;<xref rid="Tab4" ref-type="table">4</xref>). This statistic represents overall mortality since NCDB does not record cancer-related mortality.</p>
      <p>RS was a significant predictor of vital status in both commercial and TAILORx trial-defined cut-off values (<italic>p</italic>&#xA0;&lt;&#xA0;0.001; Table&#xA0;<xref rid="Tab4" ref-type="table">4</xref>): Patients with intermediate- and high-risk RS were 1.37&#x2013;2.76 times more likely to die, respectively, than patients with low-risk RS (95&#xA0;% CI 1.15&#x2013;1.62 and 2.26&#x2013;3.37, respectively) (Table&#xA0;<xref rid="Tab4" ref-type="table">4</xref>) for commercial test cut-off values.<table-wrap id="Tab4"><label>Table&#xA0;4</label><caption><p>Chemotherapy administration and vital status of the patients with invasive breast carcinoma tested with a 21-gene recurrence score assay for breast cancer (Oncotype DX): National Cancer Data Base analysis from 2010 to 2012 comparing commercial Oncotype Dx cut-off values [<xref ref-type="bibr" rid="CR2">2</xref>] to the new TAILORx trial-defined cut-off values [<xref ref-type="bibr" rid="CR8">8</xref>] for low-, intermediate-, and high-risk recurrence scores</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="3">Commercial Oncotype DX cut-off values</th><th align="left" colspan="3">New TAILORx trial-defined cut-off values</th></tr><tr><th align="left">Low-risk score 0&#x2013;17</th><th align="left">Intermediate-risk score 18&#x2013;30</th><th align="left">High- risk score 31&#x2013;100</th><th align="left">Low- risk score 0&#x2013;10</th><th align="left">Intermediate-risk score 11&#x2013;25</th><th align="left">High- risk score 26&#x2013;100</th></tr></thead><tbody><tr><td align="left"># and % of analyzed patients per score; total&#xA0;=&#xA0;74,334*</td><td char="(" align="char">41,682 (56.1&#xA0;%)</td><td char="(" align="char">24,965 (33.6&#xA0;%)</td><td char="(" align="char">7687 (10.3&#xA0;%)</td><td char="(" align="char">15,887 (21.4&#xA0;%)</td><td char="(" align="char">45,549 (61.3&#xA0;%)</td><td char="(" align="char">12,898 (17.4&#xA0;%)</td></tr><tr><td align="left" colspan="7">
<bold>Chemotherapy (# and % of analyzed patients per score; total&#xA0;=&#xA0;74,334)</bold>
</td></tr><tr><td align="left">Chemotherapy not received</td><td char="(" align="char">38,057 (91.3&#xA0;%)</td><td char="(" align="char">14,827 (59.4&#xA0;%)</td><td char="(" align="char">1430 (18.6&#xA0;%)</td><td char="(" align="char">14,888 (93.7&#xA0;%)</td><td char="(" align="char">36,073 (79.2&#xA0;%)</td><td char="(" align="char">3353 (26&#xA0;%)</td></tr><tr><td align="left">Chemotherapy received</td><td char="(" align="char">3218 (7.7&#xA0;%)</td><td char="(" align="char">9942 (39.8&#xA0;%)</td><td char="(" align="char">6214 (80.8&#xA0;%)</td><td char="(" align="char">844 (5.3&#xA0;%)</td><td char="(" align="char">9069 (19.9&#xA0;%)</td><td char="(" align="char">9461 (73.4&#xA0;%)</td></tr><tr><td align="left">Chemotherapy unknown</td><td char="(" align="char">407 (1&#xA0;%)</td><td char="(" align="char">196 (0.8&#xA0;%)</td><td char="(" align="char">43 (0.6&#xA0;%)</td><td char="(" align="char">155 (1&#xA0;%)</td><td char="(" align="char">407 (0.9&#xA0;%)</td><td char="(" align="char">84 (0.7&#xA0;%)</td></tr><tr><td align="left" colspan="7">
<bold>Vital status&#x2014;# and % per score; total&#xA0;=&#xA0;46,245</bold>
</td></tr><tr><td align="left">Dead</td><td char="(" align="char">280 (1.1&#xA0;%)</td><td char="(" align="char">246 (1.5&#xA0;%)</td><td char="(" align="char">151 (3&#xA0;%)</td><td char="(" align="char">113 (1.2&#xA0;%)</td><td char="(" align="char">349 (1.2&#xA0;%)</td><td char="(" align="char">215 (2.6&#xA0;%)</td></tr><tr><td align="left">Alive</td><td char="(" align="char">24,813 (98.9&#xA0;%)</td><td char="(" align="char">15,912 (98.5&#xA0;%)</td><td char="(" align="char">4843 (97&#xA0;%)</td><td char="(" align="char">9056 (98.8&#xA0;%)</td><td char="(" align="char">28,298 (98.8&#xA0;%)</td><td char="(" align="char">8214 (97.4&#xA0;%)</td></tr></tbody></table><table-wrap-foot><p>*&#xA0;From 91,651 patients that had Oncotype DX test performed from 2010 to 2012, 74,334 patients (81.1&#xA0;%) had known Oncotype DX test score recorded as a numerical value (0&#x2013;100) and were analyzed here. 677/46,245 patients died in this study period (1.5&#xA0;% overall mortality)</p><p>Patients with intermediate- and high-risk recurrence score were 1.37&#x2013;2.76 times more likely to die, respectively, than patients with low-risk recurrence score (95&#xA0;% CI 1.15&#x2013;1.62 and 2.26&#x2013;3.37, respectively) for commercial test cut-off values. With TAILORx cut-off values, patients with high-risk recurrence score were 2.1 times more likely to die than patients with low-risk recurrence score (95&#xA0;% CI 1.66&#x2013;2.63), but there was no significant difference between low-risk recurrence score and intermediate-risk recurrence score</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec8" sec-type="discussion">
      <title>Discussion</title>
      <p>To our knowledge, this is the first study that describes utilization and impact of 21-gene recurrence score assay for breast cancer (OncoDX) in clinical practices across the entire United States.</p>
      <p>This study revealed that there were significant racial and socioeconomic disparities in test utilization: patients of Caucasian race, from regions with &lt;7&#xA0;% having no high school education, and with &gt;$63,000 median household income were more likely to be tested with OncoDX test than patients of other races, lower levels of education, or lower incomes. Racial disparity regarding OncoDX utilization similar to our data was also observed by Roberts et al. in 1468 breast cancer patients from the phase III Carolina Breast Cancer Study [<xref ref-type="bibr" rid="CR18">18</xref>], and by Lund et al. [<xref ref-type="bibr" rid="CR21">21</xref>] in 2186 breast cancer patients from tumor registries in three Atlanta area hospitals. In both studies, breast cancer patients of black race were less likely to undergo OncoDX testing than Caucasian patients. However, the racial disparity was not observed in Roberts&#x2019; study [<xref ref-type="bibr" rid="CR18">18</xref>] if the test utilization was measured only in lymph node-negative patients. In addition, no disparity in test utilization was seen regarding the level of education or income in lymph node-negative patients [<xref ref-type="bibr" rid="CR18">18</xref>], which is dissimilar to the data seen in our study. Guth et al. published results [<xref ref-type="bibr" rid="CR11">11</xref>] from 374 breast cancer patients in New York City revealed that Caucasian patients and patients with higher income were more likely to be tested with OncoDX, similar to the data in our study. That study also showed that type of facility in which patients were treated also influenced the utilization of OncoDX assay, such as treatment in a tertiary center, findings consistent with our study (data not shown).</p>
      <p>US geographic location showed a significant impact on OncoDX test utilization in our study: patients from Middle Atlantic location and West North Central location were 35 and 6&#xA0;%, respectively, more likely to be tested with OncoDX than patients from New England. Patients from West South Central, Pacific, East South Central, and South Atlantic were 46 to 7&#xA0;% less likely to be tested with OncoDX, while there was no difference in test utilization for patients living in Mountain geographic locations when compared to the patients from New England. To our knowledge, we are the first to describe US geographic location differences in OncoDX test ordering. Reasons for these observed differences will be explored in future studies.</p>
      <p>Practices used for ordering of the OncoDX test were not optimally followed as per the NCCN guidelines applicable at the time of the study [<xref ref-type="bibr" rid="CR22">22</xref>], with 24&#xA0;% of tests ordered in a non-guideline-concordant fashion, such as HER2-positive cancers, T1a tumors, lymph node-positive, and stage III&amp;IV cancers. Several other studies [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>] revealed non-guideline-concordant ordering of the test similar to the results in our study. The test was ordered in guideline-concordant fashion when the test was paid for by CMS [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], or when the test was being prospectively validated for chemotherapy decision impact or economic impact [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>].</p>
      <p>The impact of the OncoDX test results on adjuvant chemotherapy use was reasonable for low- and high-risk RS (7.7&#xA0;% negative predictive value and 80.8&#xA0;% positive predictive value, respectively), but was far from satisfactory in the intermediate-risk score group (40.1&#xA0;% positive predictive value for chemotherapy administration&#x2014;Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>). The impact of the OncoDX test results on adjuvant chemotherapy use was improved for low- and high-risk scores when our analysis was performed on patients on whom the test was performed in a guideline-concordant fashion for the 2010&#x2013;2012 study time period (ER-positive, lymph node-negative, HER2-negative, with tumor size between 0.6 and 5&#xA0;cm). The latter analysis revealed a 4.6&#xA0;% negative predictive value for low-risk score (1306/28,582 patients) and 88.6&#xA0;% positive predictive value for high-risk score (3850/4343 patients). The impact was still far from predictive in the intermediate-risk score group (42.4&#xA0;% positive predictive value for chemotherapy administration, 6655/15,685).</p>
      <p>The predictive value of OncoDX test results for chemotherapy administration benefits led to the endorsement of this test in the newest version (1.2016) of the NCCN guidelines [<xref ref-type="bibr" rid="CR6">6</xref>] which notes the test to be superior to other available molecular tests. Similarly, recently published ASCO Clinical Practice Guideline for use of biomarkers to guide clinical decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer [<xref ref-type="bibr" rid="CR7">7</xref>] found OncoDX test to be evidence based, with high evidence quality and strong strength of recommendation to guide decisions on the need for adjuvant chemotherapy in node-negative patients. Our NCDB data analysis revealed that 7.7&#xA0;% of patients in the low-risk OncoDX RS category received chemotherapy. Conversely, almost 20&#xA0;% of patients with high-risk OncoDX RS category did not receive chemotherapy. The impact of a high-risk RS results on chemotherapy administration in our study population was similar to results obtained in a study of prospective evaluation of OncoDX for breast cancer decision making in Ontario [<xref ref-type="bibr" rid="CR25">25</xref>]. In the study from Ontario, 81&#xA0;% of patients that were recommended to receive chemotherapy based on their OncoDX risk RS, received chemotherapy, however, only 2&#xA0;% of patients with low-risk RS received chemotherapy. So far, no clear evidence-based guidelines have been established for chemotherapy administration for patients with intermediate-risk RS.</p>
      <p>Availability of the final results of the TAILORx trial in 2020 will hopefully give more clarity to definitive evidence-based guidelines for all 21-gene recurrence score breast cancer assay test results including intermediate-risk scores. Requesting an expensive test, obtaining an intermediate-risk score result, and then not having clear guidelines for treatment recommendations is an expensive process, which appears to be leading to non-actionable information. Going forward, as a health care financial policy, this is especially concerning since up to 2/3 of the tested patients may fall into this intermediate-risk group. It is imperative that health care providers continually revisit guidelines and treatment recommendations and address appropriateness of intervention and cost in order to expend our resources prudently.</p>
      <p>The TAILORx trial interim report findings [<xref ref-type="bibr" rid="CR8">8</xref>] noted prospective validation of OncoDX 21-gene RS assay for breast cancer although notably introduced an entirely different range of cut-off values for the low-, intermediate-, and high-risk RS from the traditional commercial test values. Interestingly, the TAILORx trial revealed that the overall survival in patients with really low-risk RS was 98&#xA0;% at 5&#xA0;years of follow-up; our NCDB data analysis revealed similar overall survival for all groups at 98.5&#xA0;%, however, with only 3&#xA0;years of follow-up. Noteworthy, our data analysis revealed that high-risk RS was a significant predictor of worse overall survival in comparison with a low-risk RS, suggesting that the test, if appropriately interpreted and applied, may have not only have prognostic relevance for recurrence but also for overall survival.</p>
      <p>Limitations as well as strengths of our study both lie in the methodology of data collection by the NCDB. The NCDB does not record recurrences of breast cancer at a distant or locoregional site, and does not record breast cancer-specific mortality, making follow-up studies of these patients for population-based validation of OncoDX 10-year RS results impossible. Another limitation includes the lack of record on the type of comorbidities encountered, which could potentially influence chemotherapy administration decisions. In addition, the NCDB neither identify the type of physician who orders OncoDX test (surgeon vs oncologist), nor can identify the balance between the patient and the clinician in decision making for or against chemotherapy use once the OncoDX test results are known, both of which greatly influence chemotherapy administration decisions. We also acknowledge the accepted NCDB process of recording data which allows inclusion of records that are only partially complete. The OncoDX test was performed in 91,651 patients from 2010 to 2012, but the test results were unknown in 5242 (5.7&#xA0;%) patients, or recorded only as low-, intermediate-, and high-risk RS, without associated numerical values in 12,075 (13.2&#xA0;%) patients, rendering almost 20&#xA0;% of results unusable for some parts of our study.</p>
      <p>A significant strength of this study is that data are derived from a very large number of patients across the United States in a database that includes more than 1500 CoC accredited facilities and approximately 70&#xA0;% of all newly diagnosed malignancies.</p>
    </sec>
    <sec id="Sec9" sec-type="conclusion">
      <title>Conclusions</title>
      <p>This NCDB analysis reveals that race, socioeconomic status, and US geographic location impact utilization of the OncoDX test result in clinical practices across the United States. These data also reveal that at least 10&#xA0;% of tests are ordered in a non-guideline-concordant fashion (up to 24&#xA0;% if guidelines applicable during the time of the study are applied). Compliance with treatment recommendations based on OncoDX test results is reasonable for low- and high-risk RS. The impact of an intermediate-risk RS resulting in only a 40.1&#xA0;% positive predictive value for chemotherapy administration suggests the need for clearer, evidence-based guidelines.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>RS</term>
          <def>
            <p>Recurrence score</p>
          </def>
        </def-item>
        <def-item>
          <term>Chemo</term>
          <def>
            <p>Chemotherapy administration</p>
          </def>
        </def-item>
        <def-item>
          <term>OncoDX</term>
          <def>
            <p>Oncotype DX</p>
          </def>
        </def-item>
        <def-item>
          <term>NCDB</term>
          <def>
            <p>National Cancer Data Base</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <sec id="FPar1">
        <title>Disclaimers</title>
        <p>The NCDB is a joint project of the Commission on Cancer (CoC) of the American College of Surgeons and the American Cancer Society. The CoC&#x2019;s NCDB and the hospitals participating in the CoC NCDB are the source of the de-identified data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.</p>
      </sec>
    </ack>
    <notes notes-type="conflict-interest">
      <title>Compliance with ethical standards</title>
      <sec id="FPar2">
        <title>Conflict of Interest</title>
        <p>The authors declare that they have no conflict of interest.</p>
      </sec>
      <sec id="FPar3">
        <title>Ethical Standards</title>
        <p>The experiments (data analyses) comply with the current laws of the country in which they were performed (United States of America).</p>
      </sec>
      <sec id="FPar4">
        <title>Ethical Approval</title>
        <p>&#x201C;All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.&#x201D; For retrospective studies (applies to our study): &#x201C;For this type of study formal consent is not required&#x201D;.</p>
      </sec>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paik</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shak</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cronin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baehner</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hiller</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Wickerham</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Bryant</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wolmark</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer</article-title>
          <source>N Engl J Med</source>
          <year>2004</year>
          <volume>351</volume>
          <issue>27</issue>
          <fpage>2817</fpage>
          <lpage>2826</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa041588</pub-id>
          <pub-id pub-id-type="pmid">15591335</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paik</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Shak</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Cronin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Baehner</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bryant</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Costantino</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Geyer</surname>
              <given-names>CE</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Wickerham</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Wolmark</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer</article-title>
          <source>J Clin Oncol</source>
          <year>2006</year>
          <volume>24</volume>
          <issue>23</issue>
          <fpage>3726</fpage>
          <lpage>3734</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2005.04.7985</pub-id>
          <pub-id pub-id-type="pmid">16720680</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barthelemy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Heitz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mathelin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Polesi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Asmane</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Litique</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Rob</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bergerat</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Kurtz</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals</article-title>
          <source>Crit Rev Oncol/Hematol</source>
          <year>2011</year>
          <volume>79</volume>
          <issue>2</issue>
          <fpage>196</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="doi">10.1016/j.critrevonc.2010.06.005</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albain</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Barlow</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Shak</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hortobagyi</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Livingston</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>IT</given-names>
            </name>
            <name>
              <surname>Ravdin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bugarini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Baehner</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Sledge</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Winer</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Hudis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ingle</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Pritchard</surname>
              <given-names>KI</given-names>
            </name>
            <name>
              <surname>Shepherd</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gralow</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Yoshizawa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Allred</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Osborne</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>DF</given-names>
            </name>
          </person-group>
          <article-title>Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial</article-title>
          <source>Lancet Oncol</source>
          <year>2010</year>
          <volume>11</volume>
          <issue>1</issue>
          <fpage>55</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1016/S1470-2045(09)70314-6</pub-id>
          <pub-id pub-id-type="pmid">20005174</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <mixed-citation publication-type="other">Breast Cancer Version 2.2015 (2015) National Comprehensive Cancer Network. <ext-link ext-link-type="uri" xlink:href="http://www.nccn.org">www.nccn.org</ext-link>. Accessed 20 Dec 2015</mixed-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <mixed-citation publication-type="other">Breast cancer Version 1.2016 NCCN Clinical Practice Guidelines in Oncology (2015) National Comprehensive Cancer Network (NCCN). <ext-link ext-link-type="uri" xlink:href="http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf">www.nccn.org/professionals/physician_gls/pdf/breast.pdf</ext-link>. Accessed 20 Dec 2015</mixed-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Ismaila</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>McShane</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Andre</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Collyar</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Gonzalez-Angulo</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Hammond</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Kuderer</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Mennel</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>van Poznak</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bast</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>DF</given-names>
            </name>
          </person-group>
          <article-title>Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology clinical practice guideline</article-title>
          <source>J Clin Oncol</source>
          <year>2016</year>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sparano</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Makower</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Pritchard</surname>
              <given-names>KI</given-names>
            </name>
            <name>
              <surname>Albain</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Geyer</surname>
              <given-names>CE</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Dees</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>JA</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Zujewski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lively</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Badve</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Saphner</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>LI</given-names>
            </name>
            <name>
              <surname>Whelan</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Ellis</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Paik</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Ravdin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Keane</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Gomez Moreno</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Goggins</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Brufsky</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Toppmeyer</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Kaklamani</surname>
              <given-names>VG</given-names>
            </name>
            <name>
              <surname>Atkins</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Berenberg</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Sledge</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Prospective validation of a 21-gene expression assay in breast cancer</article-title>
          <source>N Engl J Med</source>
          <year>2015</year>
          <volume>373</volume>
          <issue>21</issue>
          <fpage>2005</fpage>
          <lpage>2014</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa1510764</pub-id>
          <pub-id pub-id-type="pmid">26412349</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Augustovski</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Soto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Caporale</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Gibbons</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ciapponi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Decision-making impact on adjuvant chemotherapy allocation in early node-negative breast cancer with a 21-gene assay: systematic review and meta-analysis</article-title>
          <source>Breast Cancer Res Treat</source>
          <year>2015</year>
          <volume>152</volume>
          <issue>3</issue>
          <fpage>611</fpage>
          <lpage>625</lpage>
          <pub-id pub-id-type="doi">10.1007/s10549-015-3483-3</pub-id>
          <pub-id pub-id-type="pmid">26126971</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlson</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis</article-title>
          <source>Breast Cancer Res Treat</source>
          <year>2013</year>
          <volume>141</volume>
          <issue>1</issue>
          <fpage>13</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.1007/s10549-013-2666-z</pub-id>
          <pub-id pub-id-type="pmid">23974828</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guth</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Fineberg</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fei</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bickell</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <article-title>Utilization of Oncotype DX in an inner city population: race or place?</article-title>
          <source>Int J Breast Cancer</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>653805</fpage>
          <pub-id pub-id-type="doi">10.1155/2013/653805</pub-id>
          <pub-id pub-id-type="pmid">24455283</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sparano</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Paik</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Development of the 21-gene assay and its application in clinical practice and clinical trials</article-title>
          <source>J Clin Oncol</source>
          <year>2008</year>
          <volume>26</volume>
          <issue>5</issue>
          <fpage>721</fpage>
          <lpage>728</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2007.15.1068</pub-id>
          <pub-id pub-id-type="pmid">18258979</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hassett</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Silver</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Blayney</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Edge</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Herman</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Hudis</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Marcom</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Pettinga</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Share</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Theriault</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>YN</given-names>
            </name>
            <name>
              <surname>Vandergrift</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Niland</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Weeks</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer</article-title>
          <source>J Clin Oncol</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>18</issue>
          <fpage>2218</fpage>
          <lpage>2226</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2011.38.5740</pub-id>
          <pub-id pub-id-type="pmid">22585699</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Romano</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Foa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vataire</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Chantelard</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Herve</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Barletta</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Durieux</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Salmon</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Economic impact of gene expression profiling in patients with early-stage breast cancer in France</article-title>
          <source>PLoS ONE</source>
          <year>2015</year>
          <volume>10</volume>
          <issue>6</issue>
          <fpage>e0128880</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0128880</pub-id>
          <pub-id pub-id-type="pmid">26086912</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kip</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Monteban</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Steuten</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Long-term cost-effectiveness of Oncotype DX((R)) versus current clinical practice from a Dutch cost perspective</article-title>
          <source>J Comp Eff Res</source>
          <year>2015</year>
          <volume>4</volume>
          <issue>5</issue>
          <fpage>433</fpage>
          <lpage>445</lpage>
          <pub-id pub-id-type="doi">10.2217/cer.15.18</pub-id>
          <pub-id pub-id-type="pmid">25872415</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dinan</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Mi</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Hirsch</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Lyman</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Curtis</surname>
              <given-names>LH</given-names>
            </name>
          </person-group>
          <article-title>Initial trends in the use of the 21-gene recurrence score assay for patients with breast cancer in the medicare population, 2005&#x2013;2009</article-title>
          <source>JAMA Oncol</source>
          <year>2015</year>
          <volume>1</volume>
          <issue>2</issue>
          <fpage>158</fpage>
          <lpage>166</lpage>
          <pub-id pub-id-type="doi">10.1001/jamaoncol.2015.43</pub-id>
          <pub-id pub-id-type="pmid">26181015</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dusetzina</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Dinan</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Reeder-Hayes</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Troester</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Carey</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Wheeler</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
          <article-title>Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving Oncotype DX testing</article-title>
          <source>Breast Cancer Res Treat</source>
          <year>2015</year>
          <volume>153</volume>
          <issue>1</issue>
          <fpage>191</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="doi">10.1007/s10549-015-3518-9</pub-id>
          <pub-id pub-id-type="pmid">26216535</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Weinberger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dusetzina</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Dinan</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Reeder-Hayes</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Carey</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Troester</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Wheeler</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
          <article-title>Racial variation in the uptake of Oncotype DX testing for early-stage breast cancer</article-title>
          <source>J Clin Oncol</source>
          <year>2016</year>
          <volume>34</volume>
          <issue>2</issue>
          <fpage>130</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2015.63.2489</pub-id>
          <pub-id pub-id-type="pmid">26598755</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Enewold</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Geiger</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Zujewski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Harlan</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy</article-title>
          <source>Breast Cancer Res Treat</source>
          <year>2015</year>
          <volume>151</volume>
          <issue>1</issue>
          <fpage>149</fpage>
          <lpage>156</lpage>
          <pub-id pub-id-type="doi">10.1007/s10549-015-3366-7</pub-id>
          <pub-id pub-id-type="pmid">25859924</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <mixed-citation publication-type="other">About National Cancer Data Base. American College of Surgeons. <ext-link ext-link-type="uri" xlink:href="https://www.facs.org/quality-programs/cancer/ncdb/about">https://www.facs.org/quality-programs/cancer/ncdb/about</ext-link>. Accessed 6 Dec 2015</mixed-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lund</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Mosunjac</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Gabram-Mendola</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rizzo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bumpers</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Hearn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zelnak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Styblo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>O&#x2019;Regan</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome</article-title>
          <source>Cancer</source>
          <year>2012</year>
          <volume>118</volume>
          <issue>3</issue>
          <fpage>788</fpage>
          <lpage>796</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.26180</pub-id>
          <pub-id pub-id-type="pmid">21720988</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlson</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Allred</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>BO</given-names>
            </name>
            <name>
              <surname>Burstein</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Edge</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Erban</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Farrar</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Forero</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Giordano</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Gradishar</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Hudis</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Ljung</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Mankoff</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Marcom</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>McCormick</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pierce</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Sachdev</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Somlo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Wolff</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Zellars</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Invasive breast cancer</article-title>
          <source>J Natl Compr Canc Netw</source>
          <year>2011</year>
          <volume>9</volume>
          <issue>2</issue>
          <fpage>136</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="pmid">21310842</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swain</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yoshizawa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rothney</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sing</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Quantitative gene expression by recurrence score in ER-positive breast cancer, by age</article-title>
          <source>Adv Ther</source>
          <year>2015</year>
          <volume>32</volume>
          <issue>12</issue>
          <fpage>1222</fpage>
          <lpage>1236</lpage>
          <pub-id pub-id-type="doi">10.1007/s12325-015-0268-3</pub-id>
          <pub-id pub-id-type="pmid">26610382</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldstein</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Badve</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Childs</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Yoshizawa</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rowley</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shak</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Baehner</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Ravdin</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Sledge</surname>
              <given-names>GW</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Shulman</surname>
              <given-names>LN</given-names>
            </name>
            <name>
              <surname>Martino</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sparano</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features</article-title>
          <source>J Clin Oncol</source>
          <year>2008</year>
          <volume>26</volume>
          <issue>25</issue>
          <fpage>4063</fpage>
          <lpage>4071</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2007.14.4501</pub-id>
          <pub-id pub-id-type="pmid">18678838</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levine</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Julian</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Bedard</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Eisen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Trudeau</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bordeleau</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pritchard</surname>
              <given-names>KI</given-names>
            </name>
          </person-group>
          <article-title>Prospective evaluation of the 21-gene recurrence score assay for breast cancer decision-making in Ontario</article-title>
          <source>J Clin Oncol</source>
          <year>2015</year>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smyth</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Keane</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Grogan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hennessy</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>O&#x2019;Reilly</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Coate</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>O&#x2019;Connor</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Verleger</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Schoeman</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>O&#x2019;Reilly</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Walshe</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland</article-title>
          <source>Breast Cancer Res Treat</source>
          <year>2015</year>
          <volume>153</volume>
          <issue>3</issue>
          <fpage>573</fpage>
          <lpage>582</lpage>
          <pub-id pub-id-type="doi">10.1007/s10549-015-3555-4</pub-id>
          <pub-id pub-id-type="pmid">26364296</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
